Omics of Covid-19 disease

Maybe, specific information might be found in the raw readout of proteomic datasets.

Searchterm applied

(gives 9900 papers on june 7th 2022)

http://www.moremed.org/SiteSearch.php?S1=transcriptom*+OR+transcription*+OR+proteom*+OR+gene+expression+OR+interactom*+OR+omics+OR+hub+genes+OR+epigenom*+OR+dna+methylation+OR+metabolom*+OR+gene+chip+OR+transcripts+OR+microarray+OR+receptorom*+OR+glycom*+OR+differential+expression&S2=covid19+OR+covid-19+OR+sars-cov2+OR+sars-cov-2+&S3=&submit=submit&px1=proxy.nationallizenzen.de&px2=&px3=&px4=&R=all&Y0=1500&Y1=2025

Covid Omics Databases and Webservers

34845454 2021. Identifying disease-critical cell types and cellular processes across the human body by integration of single-cell profiles and human genetics.
34127975 2021. Implicating Gene and Cell Networks Responsible for Differential COVID-19 Host Responses via an Interactive Single Cell Web Portal.
34075382 2021. CovidExpress: an interactive portal for intuitive investigation on SARS-CoV-2 related transcriptomes.
32587962 2020. The IMEx Coronavirus interactome: an evolving map of Coronaviridae-Host molecular interactions.
33206959 2020. The IMEx coronavirus interactome: an evolving map of Coronaviridae-host molecular interactions.
33413085 2021. H2V: a database of human genes and proteins that respond to SARS-CoV-2, SARS-CoV, and MERS-CoV infection.
34448623 2021. A Novel Pathway Network Analytics Method Based on Graph Theory.
33605735 2021. Open Science Resources for the Mass Spectrometry-Based Analysis of SARS-CoV-2.
32930583 2020. Quantification of mRNA Expression Using Single-Molecule Nanopore Sensing.
33553941 2021. SARSCOVIDB-A New Platform for the Analysis of the Molecular Impact of SARS-CoV-2 Viral Infection.
33501381 2020. Fostering global data sharing: highlighting the recommendations of the Research Data Alliance COVID-19 working group.
34718395 2022. A comprehensive review of the analysis and integration of omics data for SARS-CoV-2 and COVID-19.
34424948 2021. DeepDRIM: a deep neural network to reconstruct cell-type-specific gene regulatory network using single-cell RNA-seq data.
34111889 2021. Single-cell multi-omics sequencing: application trends, COVID-19, data analysis issues and prospects.
34076249 2021. Transcriptomic studies revealed pathophysiological impact of COVID-19 to predominant health conditions.
34009288 2021. Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19.
33592108 2021. Data science in unveiling COVID-19 pathogenesis and diagnosis: evolutionary origin to drug repurposing.
33416848 2021. SARS-CoV-2 3D database: understanding the coronavirus proteome and evaluating possible drug targets.
33057582 2021. Web tools to fight pandemics: the COVID-19 experience.
34767776 2021. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas.
33657410 2021. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas.
34471261 2021. Multiomics: unraveling the panoramic landscapes of SARS-CoV-2 infection.
34348131 2021. The COVIDome Explorer researcher portal.
33310371 2021. Recent trends on omics and bioinformatics approaches to study SARS-CoV-2: A bibliometric analysis and mini-review.
33301953 2021. Next-generation computational tools and resources for coronavirus research: From detection to vaccine discovery.
32864402 2020. Dataset of mutational analysis, miRNAs targeting SARS-CoV-2 genes and host gene expression in SARS-CoV and SARS-CoV-2 infections.
32835036 2020. Quantitative proteomic dataset from oro- and naso-pharyngeal swabs used for COVID-19 diagnosis: Detection of viral proteins and host's biological processes altered by the infection.
35134150 2022. SCANNER: a web platform for annotation, visualization and sharing of single cell RNA-seq data.
33009914 2021. A database resource and online analysis tools for coronaviruses on a historical and global scale.
32404885 2020. The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic.
33194800 2020. Systems Biology Approaches for Therapeutics Development Against COVID-19.
35003208 2021. COVID-19 Transcriptomic Atlas: A Comprehensive Analysis of COVID-19 Related Transcriptomics Datasets.
34975833 2021. Understanding Gene Expression and Transcriptome Profiling of COVID-19: An Initiative Towards the Mapping of Protective Immunity Genes Against SARS-CoV-2 Infection.
32670298 2020. Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse.
34557504 2021. Unraveling Risk Genes of COVID-19 by Multi-Omics Integrative Analyses.
35047913 2021. The SIRAH-CoV-2 Initiative: A Coarse-Grained Simulations' Dataset of the SARS-CoV-2 Proteome.
35531299 2022. The Intricacy of the Viral-Human Protein Interaction Networks: Resources, Data, and Analyses.
33324374 2020. Comparative Transcriptome Analysis Reveals the Intensive Early Stage Responses of Host Cells to SARS-CoV-2 Infection.
33585554 2020. SARS-CoV-2 Proteins Exploit Host's Genetic and Epigenetic Mediators for the Annexation of Key Host Signaling Pathways.
34530086 2022. An overview of human proteins and genes involved in SARS-CoV-2 infection.
33263093 2021. Gene expression profiling of corona virus microarray datasets to identify crucial targets in COVID-19 patients.
34401607 2021. Systems level insights into the impact of airborne exposure on SARS-CoV-2 pathogenesis and COVID-19 outcome - A multi-omics big data study.
33553808 2020. Bioinformatics analyses of significant genes, related pathways, and candidate diagnostic biomarkers and molecular targets in SARS-CoV-2/COVID-19.
33809949 2021. A Resource for the Network Representation of Cell Perturbations Caused by SARS-CoV-2 Infection.
34209818 2021. Toward a Coronavirus Knowledge Graph.
35002537 2021. Identification of Differentially Expressed Genes in COVID-19 and Integrated Bioinformatics Analysis of Signaling Pathways.
35184750 2022. Systematic comparison of published host gene expression signatures for bacterial/viral discrimination.
34001247 2021. An atlas connecting shared genetic architecture of human diseases and molecular phenotypes provides insight into COVID-19 susceptibility.
34350693 2021. Comprehensive investigation of RNA-sequencing dataset reveals the hub genes and molecular mechanisms of coronavirus disease 2019 acute respiratory distress syndrome.
34675627 2021. Construction and Investigation of Competing Endogenous RNA Networks and Candidate Genes Involved in SARS-CoV-2 Infection.
34623759 2021. New insights into genetic characteristics between multiple myeloma and COVID-19: An integrative bioinformatics analysis of gene expression omnibus microarray and the cancer genome atlas data.
35269564 2022. COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19.
33207699 2020. Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2.
32236644 2020. Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis.
34522848 2021. An interactive single cell web portal identifies gene and cell networks in COVID-19 host responses.
34487344 2021. A pathway map of signaling events triggered upon SARS-CoV infection.
33730024 2021. Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes.
33901166 2021. The first few days of a SARS-CoV-2 infection viewed at single-cell resolution.
34260589 2021. COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity.
35468151 2022. Multi-omic analysis reveals enriched pathways associated with COVID-19 and COVID-19 severity.
35390032 2022. Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches.
35085325 2022. Identification of potentially anti-COVID-19 active drugs using the connectivity MAP.
33082228 2020. Transcriptional and proteomic insights into the host response in fatal COVID-19 cases.
35377064 2022. Differential transcriptomic landscapes of multiple organs from SARS-CoV-2 early infected rhesus macaques.
32664949 2020. SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis.
34127904 2021. Network-based transcriptomic analysis identifies the genetic effect of COVID-19 to chronic kidney disease patients: A bioinformatics approach.
32963239 2020. Consensus transcriptional regulatory networks of coronavirus-infected human cells.
34031435 2021. Integrative web-based analysis of omics data for study of drugs against SARS-CoV-2.
33782412 2021. Comprehensive transcriptomic analysis of COVID-19 blood, lung, and airway.
33510359 2021. Meta-analysis of host transcriptional responses to SARS-CoV-2 infection reveals their manifestation in human tumors.
34907210 2021. Identification of transcriptional regulatory network associated with response of host epithelial cells to SARS-CoV-2.
34376762 2021. Comparative transcriptome analyses reveal genes associated with SARS-CoV-2 infection of human lung epithelial cells.
33318519 2020. Gene expression network analysis provides potential targets against SARS-CoV-2.
33863870 2021. COVID-19: complexity of disease severity revealed by systemic and localized single cell immune atlas.
33859163 2021. Multi-platform omics analysis reveals molecular signature for COVID-19 pathogenesis, prognosis and drug target discovery.
32670298 2020. Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse.
34557504 2021. Unraveling Risk Genes of COVID-19 by Multi-Omics Integrative Analyses.
35047913 2021. The SIRAH-CoV-2 Initiative: A Coarse-Grained Simulations' Dataset of the SARS-CoV-2 Proteome.
35531299 2022. The Intricacy of the Viral-Human Protein Interaction Networks: Resources, Data, and Analyses.
33324374 2020. Comparative Transcriptome Analysis Reveals the Intensive Early Stage Responses of Host Cells to SARS-CoV-2 Infection.
33585554 2020. SARS-CoV-2 Proteins Exploit Host's Genetic and Epigenetic Mediators for the Annexation of Key Host Signaling Pathways.
34530086 2022. An overview of human proteins and genes involved in SARS-CoV-2 infection.
33263093 2021. Gene expression profiling of corona virus microarray datasets to identify crucial targets in COVID-19 patients.
34401607 2021. Systems level insights into the impact of airborne exposure on SARS-CoV-2 pathogenesis and COVID-19 outcome - A multi-omics big data study.
33553808 2020. Bioinformatics analyses of significant genes, related pathways, and candidate diagnostic biomarkers and molecular targets in SARS-CoV-2/COVID-19.
33809949 2021. A Resource for the Network Representation of Cell Perturbations Caused by SARS-CoV-2 Infection.
34209818 2021. Toward a Coronavirus Knowledge Graph.
35002537 2021. Identification of Differentially Expressed Genes in COVID-19 and Integrated Bioinformatics Analysis of Signaling Pathways.
34001247 2021. An atlas connecting shared genetic architecture of human diseases and molecular phenotypes provides insight into COVID-19 susceptibility.
34350693 2021. Comprehensive investigation of RNA-sequencing dataset reveals the hub genes and molecular mechanisms of coronavirus disease 2019 acute respiratory distress syndrome.
34675627 2021. Construction and Investigation of Competing Endogenous RNA Networks and Candidate Genes Involved in SARS-CoV-2 Infection.
34623759 2021. New insights into genetic characteristics between multiple myeloma and COVID-19: An integrative bioinformatics analysis of gene expression omnibus microarray and the cancer genome atlas data.
35269564 2022. COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19.
33207699 2020. Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2.
32236644 2020. Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis.
34522848 2021. An interactive single cell web portal identifies gene and cell networks in COVID-19 host responses.
34487344 2021. A pathway map of signaling events triggered upon SARS-CoV infection.
32806897 2020. Integrative Modeling of Quantitative Plasma Lipoprotein, Metabolic, and Amino Acid Data Reveals a Multiorgan Pathological Signature of SARS-CoV-2 Infection.
35150462 2022. Thrombosis pathways in COVID-19 vs. influenza-associated ARDS: A targeted proteomics approach.
33413422 2021. Transcriptome of nasopharyngeal samples from COVID-19 patients and a comparative analysis with other SARS-CoV-2 infection models reveal disparate host responses against SARS-CoV-2.
34876157 2021. Multi-omics approach to COVID-19: a domain-based literature review.
32811513 2020. The current landscape of coronavirus-host protein-protein interactions.
34319784 2021. Kinetic Multi-omic Analysis of Responses to SARS-CoV-2 Infection in a Model of Severe COVID-19.
34106002 2021. Viral and Host Transcriptomes in SARS-CoV-2-Infected Human Lung Cells.
35530264 2022. Plasma Proteomics of COVID-19-Associated Cardiovascular Complications: Implications for Pathophysiology and Therapeutics.
34254058 2021. Cov-MS: A Community-Based Template Assay for Mass-Spectrometry-Based Protein Detection in SARS-CoV-2 Patients.
35511435 2022. Single-cell transcriptomic profiling of lung endothelial cells identifies dynamic inflammatory and regenerative subpopulations.
35175937 2022. Temporal transcriptomic analysis using TrendCatcher identifies early and persistent neutrophil activation in severe COVID-19.
34618691 2021. Human nasal wash RNA-Seq reveals distinct cell-specific innate immune responses in influenza versus SARS-CoV-2.
33284134 2021. Metabolic reprogramming and epigenetic changes of vital organs in SARS-CoV-2-induced systemic toxicity.
34642644 2021. A Pilot Study of Urine Proteomics in COVID-19-Associated Acute Kidney Injury.
35368565 2022. Single-Cell RNA Sequencing of Urinary Cells Reveals Distinct Cellular Diversity in COVID-19-Associated AKI.
35110370 2022. Proteomic landscape of SARS-CoV-2- and MERS-CoV-infected primary human renal epithelial cells.
34425963 2021. Acute Kidney Injury in Severe COVID-19 Has Similarities to Sepsis-Associated Kidney Injury: A Multi-Omics Study.
35604092 2022. The Translational Landscape of SARS-CoV-2-infected Cells Reveals Suppression of Innate Immune Genes.
34766152 2021. Application of omics technology to combat the COVID-19 pandemic.
33833618 2021. Whole-Transcriptome RNA Sequencing Reveals Significant Differentially Expressed mRNAs, miRNAs, and lncRNAs and Related Regulating Biological Pathways in the Peripheral Blood of COVID-19 Patients.
35547845 2022. Whole Genome DNA and RNA Sequencing of Whole Blood Elucidates the Genetic Architecture of Gene Expression Underlying a Wide Range of Diseases.
33758879 2021. The COVIDome Explorer Researcher Portal.
32743614 2020. Large-scale Multi-omic Analysis of COVID-19 Severity.
33398303 2020. An atlas connecting shared genetic architecture of human diseases and molecular phenotypes provides insight into COVID-19 susceptibility.
33435351 2021. Comprehensive Meta-Analysis of COVID-19 Global Metabolomics Datasets.
34153417 2021. Construction of an autophagy interaction network based on competitive endogenous RNA reveals the key pathways and central genes of SARS-CoV-2 infection in vivo.
34118193 2021. Global analysis of protein-RNA interactions in SARS-CoV-2-infected cells reveals key regulators of infection.
33989516 2021. The SARS-CoV-2 RNA interactome.
35504488 2022. Mapping molecular gene signatures mediated by SARS-COV-2 and large-scale and genome-wide transcriptomics comparative analysis among respiratory viruses of medical importance.
34400346 2021. Proteomic Signature of Host Response to SARS-CoV-2 Infection in the Nasopharynx.
34089862 2021. Proteomics-Based Insights Into the SARS-CoV-2-Mediated COVID-19 Pandemic: A Review of the First Year of Research.
34664389 2021. COVID19 Disease Map, a computational knowledge repository of virus-host interaction mechanisms.
35300459 2022. Transcriptogram analysis reveals relationship between viral titer and gene sets responses during Corona-virus infection.
34876692 2021. A single-cell transcriptomic landscape of the lungs of patients with COVID-19.
34315893 2021. Single-cell transcriptome of bronchoalveolar lavage fluid reveals sequential change of macrophages during SARS-CoV-2 infection in ferrets.
34315889 2021. The trans-omics landscape of COVID-19.
33597532 2021. Dysregulated transcriptional responses to SARS-CoV-2 in the periphery.
34381043 2021. Temporal omics analysis in Syrian hamsters unravel cellular effector responses to moderate COVID-19.
33879890 2021. Single-cell multi-omics analysis of the immune response in COVID-19.
34876996 2021. Post-mortem tissue proteomics reveals the pathogenesis of multi-organ injuries of COVID-19.
33915569 2021. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets.
33915568 2021. A molecular single-cell lung atlas of lethal COVID-19.
34237774 2021. Mapping the human genetic architecture of COVID-19.
33274348 2020. CovMulNet19, Integrating Proteins, Diseases, Drugs, and Symptoms: A Network Medicine Approach to COVID-19.
34031419 2021. Comparative transcriptome analysis reveals key epigenetic targets in SARS-CoV-2 infection.
35100418 2022. AggMapNet: enhanced and explainable low-sample omics deep learning with feature-aggregated multi-channel networks.
34761257 2022. SCoV2-MD: a database for the dynamics of the SARS-CoV-2 proteome and variant impact predictions.
34718748 2022. MVIP: multi-omics portal of viral infection.
34634820 2022. SCovid: single-cell atlases for exposing molecular characteristics of COVID-19 across 10 human tissues.
34554255 2022. COVID19db: a comprehensive database platform to discover potential drugs and targets of COVID-19 at whole transcriptomic scale.
35557984 2022. Weighted Gene Co-Expression Network Analysis to Identify Potential Biological Processes and Key Genes in COVID-19-Related Stroke.
34457122 2021. Comprehensive Analysis of the Systemic Transcriptomic Alternations and Inflammatory Response during the Occurrence and Progress of COVID-19.
32667665 2020. Transcriptome-based drug repositioning for coronavirus disease 2019 (COVID-19).
33842903 2021. Secondary analysis of transcriptomes of SARS-CoV-2 infection models to characterize COVID-19.
33868814 2021. Multi-schema computational prediction of the comprehensive SARS-CoV-2 vs. human interactome.
32566414 2020. Host transcriptome-guided drug repurposing for COVID-19 treatment: a meta-analysis based approach.
33730024 2021. Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes.
33901166 2021. The first few days of a SARS-CoV-2 infection viewed at single-cell resolution.
34260589 2021. COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity.
35468151 2022. Multi-omic analysis reveals enriched pathways associated with COVID-19 and COVID-19 severity.
35390032 2022. Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches.
35085325 2022. Identification of potentially anti-COVID-19 active drugs using the connectivity MAP.
33082228 2020. Transcriptional and proteomic insights into the host response in fatal COVID-19 cases.
35377064 2022. Differential transcriptomic landscapes of multiple organs from SARS-CoV-2 early infected rhesus macaques.
32664949 2020. SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis.
34127904 2021. Network-based transcriptomic analysis identifies the genetic effect of COVID-19 to chronic kidney disease patients: A bioinformatics approach.
32963239 2020. Consensus transcriptional regulatory networks of coronavirus-infected human cells.
34031435 2021. Integrative web-based analysis of omics data for study of drugs against SARS-CoV-2.
33782412 2021. Comprehensive transcriptomic analysis of COVID-19 blood, lung, and airway.
34907210 2021. Identification of transcriptional regulatory network associated with response of ho
34376762 2021. Comparative transcriptome analyses reveal genes associated with SARS-CoV-2 infection of human lung epithelial cells.
33318519 2020. Gene expression network analysis provides potential targets against SARS-CoV-2.
33863870 2021. COVID-19: complexity of disease severity revealed by systemic and localized single cell immune atlas.
33859163 2021. Multi-platform omics analysis reveals molecular signature for COVID-19 pathogenesis, prognosis and drug target discovery.
33846224 2021. Longitudinal Peripheral Blood Transcriptional Analysis Reveals Molecular Signatures of Disease Progression in COVID-19 Patients.
33813307 2021. A SARS-CoV-2 -human metalloproteome interaction map.
33735949 2021. OverCOVID: an integrative web portal for SARS-CoV-2 bioinformatics resources.
34080738 2021. Critical COVID-19 is associated with distinct leukocyte phenotypes and transcriptome patterns.
33162722 2020. A comprehensive overview of proteomics approach for COVID 19: new perspectives in target therapy strategies.
34550702 2021. Discovery Proteomics for COVID-19: Where We Are Now.
34379420 2021. A Multi-omics Longitudinal Study Reveals Alteration of the Leukocyte Activation Pathway in COVID-19 Patients.
33666082 2021. Ubiquitin-Modified Proteome of SARS-CoV-2-Infected Host Cells Reveals Insights into Virus-Host Interaction and Pathogenesis.
34080435 2021. Proteomic Analysis Identifies Prolonged Disturbances in Pathways Related to Cholesterol Metabolism and Myocardium Function in the COVID-19 Recovery Stage.
34077217 2021. Mass Spectrometric Analysis of Urine from COVID-19 Patients for Detection of SARS-CoV-2 Viral Antigen and to Study Host Response.
33464917 2021. Proteomic Approaches to Study SARS-CoV-2 Biology and COVID-19 Pathology.
33426872 2021. Role of Multiomics Data to Understand Host-Pathogen Interactions in COVID-19 Pathogenesis.
33103435 2020. Computational Identification of Human Biological Processes and Protein Sequence Motifs Putatively Targeted by SARS-CoV-2 Proteins Using Protein-Protein Interaction Networks.
32654489 2020. Repurpose Open Data to Discover Therapeutics for COVID-19 Using Deep Learning.
33245774 2021. PAGER-CoV: a comprehensive collection of pathways, annotated gene-lists and gene signatures for coronavirus disease studies.
35511057 2022. deepHPI: a comprehensive deep learning platform for accurate prediction and visualization of host-pathogen protein-protein interactions.

Other interesting papers

these were retrieved by the filtered omics search and seem to be important

35310032 2022. Integrating Metabolomics and Network Pharmacology to Explore the Protective Effect of Ginsenoside Re against Radiotherapy Injury in Mice.
35184750 2022. Systematic comparison of published host gene expression signatures for bacterial/viral discrimination.
34403366 2021. Self-sustaining IL-8 loops drive a prothrombotic neutrophil phenotype in severe COVID-19.
32903321 2020. Localization of Cell Receptor-Related Genes of SARS-CoV-2 in the Kidney through Single-Cell Transcriptome Analysis.
35339689 2022. Key benefits of dexamethasone and antibody treatment in COVID-19 hamster models revealed by single-cell transcriptomics.
34312385 2021. Single-cell RNA sequencing reveals ex vivo signatures of SARS-CoV-2-reactive T cells through 'reverse phenotyping'.
34262047 2021. Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity.
34116393 2021. Magnesium treatment on methylation changes of transmembrane serine protease 2 (TMPRSS2).
33521378 2021. Hypoxia-inducible factor (HIF): The link between obesity and COVID-19.
33991451 2021. Hypoxia induces expression of angiotensin-converting enzyme II in alveolar epithelial cells: Implications for the pathogenesis of acute lung injury in COVID-19.
34673800 2021. Klotho deficiency intensifies hypoxia-induced expression of IFN-alpha/beta through upregulation of RIG-I in kidneys.
33661927 2021. Hypoxia-induced inflammation: Profiling the first 24-hour posthypoxic plasma and central nervous system changes.
34108245 2021. HIF-1alpha is a negative regulator of interferon regulatory factors: Implications for interferon production by hypoxic monocytes. st epithelial cells to SARS-CoV-2.
35502829 2022. Bees can be trained to identify SARS-CoV-2 infected samples.
35543533 2022. Impaired exercise capacity in post-COVID syndrome: the role of VWF-ADAMTS13 axis.
35496775 2022. Cognitive deficits and memory impairments after COVID-19 (Covishield) vaccination.
35211628 2022. 29 m(6)A-RNA Methylation (Epitranscriptomic) Regulators Are Regulated in 41 Diseases including Atherosclerosis and Tumors Potentially via ROS Regulation - 102 Transcriptomic Dataset Analyses.
33307139 2021. Total infectomes of 162 SARS-CoV-2 cases using meta-transcriptomic sequencing.
35291496 2022. SARS-CoV-2 infecting endothelial cells, biochemical alterations, autopsy findings and outcomes in COVID-19, suggest role of hypoxia-inducible factor-1.
33913550 2021. SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways.
35064792 2022. Disturbed lipid and amino acid metabolisms in COVID-19 patients.
34626364 2022. Activation of STAT3 signaling pathway in the kidney of COVID-19 patients.
33724837 2021. Systemic Perturbations in Amine and Kynurenine Metabolism Associated with Acute SARS-CoV-2 Infection and Inflammatory Cytokine Responses.
34920080 2022. The spike protein of SARS-CoV-2 induces heme oxygenase-1: Pathophysiologic implications.
34835015 2021. SARS-CoV-2 Spike Protein S1-Mediated Endothelial Injury and Pro-Inflammatory State Is Amplified by Dihydrotestosterone and Prevented by Mineralocorticoid Antagonism.
33991451 2021. Hypoxia induces expression of angiotensin-converting enzyme II in alveolar epithelial cells: Implications for the pathogenesis of acute lung injury in COVID-19.
34673800 2021. Klotho deficiency intensifies hypoxia-induced expression of IFN-alpha/beta through upregulation of RIG-I in kidneys.
33661927 2021. Hypoxia-induced inflammation: Profiling the first 24-hour posthypoxic plasma and central nervous system changes.
34108245 2021. HIF-1alpha is a negative regulator of interferon regulatory factors: Implications for interferon production by hypoxic monocytes.

Full Dataset

the two collections above are the most on-topic results. there were much more items of covid interest retrieved. temporally, anything e.g. about 2000 of 10000 primary results including the above contents will be shown here, later, the above items will be subtracted"

33399506 2021. The RSNA International COVID-19 Open Radiology Database (RICORD).
33932453 2021. Nrf2 activation putatively mediates clinical benefits of low-dose radiotherapy in COVID-19 pneumonia and acute respiratory distress syndrome (ARDS): Novel mechanistic considerations.
34146958 2021. SARS-CoV2 infection impairs the metabolism and redox function of cellular glutathione.
35599705 2022. Molecular analysis of vascular gene expression.
35547851 2022. CNBP restricts SARS-CoV2 by regulating IFN and disrupting RNA-protein condensates.
35434729 2022. A path-based analysis of infected cell line and COVID-19 patient transcriptome reveals novel potential targets and drugs against SARS-CoV-2.
35194601 2022. The mechanism of RNA capping by SARS-CoV-2.
34845442 2021. Severe COVID-19 infection is associated with aberrant cytokine production by infected lung epithelial cells rather than by systemic immune dysfunction.
33821262 2021. Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19.
34127967 2021. Type I Interferon Transcriptional Network Regulates Expression of Coinhibitory Receptors in Human T cells.
34127963 2021. Plasma Proteomics of COVID-19 Associated Cardiovascular Complications: Implications for Pathophysiology and Therapeutics.
33469573 2021. COVID-19 ARDS is characterized by a dysregulated host response that differs from cytokine storm and is modified by dexamethasone.
33564755 2021. miR-24 targets SARS-CoV-2 co-factor Neuropilin-1 in human brain microvascular endothelial cells: Insights for COVID-19 neurological manifestations.
34462739 2021. Upper airway gene expression reveals a more robust innate and adaptive immune response to SARS-CoV-2 in children compared with older adults.
34401873 2021. SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis and cytokine release.
33236003 2020. SARS-CoV-2 Infected Cardiomyocytes Recruit Monocytes by Secreting CCL2.
32702734 2020. Potentially repurposable drugs for COVID-19 identified from SARS-CoV-2 Host Protein Interactome.
32702714 2020. Interactome of SARS-CoV-2 / nCoV19 modulated host proteins with computationally predicted PPIs.
32702730 2020. In silico Drug Repurposing to combat COVID-19 based on Pharmacogenomics of Patient Transcriptomic Data.
33398261 2020. Broad Auto-Reactive IgM Responses Are Common In Critically Ill COVID-19 Patients.
34051791 2021. Dysregulation of COVID-19 related gene expression in the COPD lung.
33823870 2021. Adhatoda Vasica attenuates inflammatory and hypoxic responses in preclinical mouse models: potential for repurposing in COVID-19-like conditions.
32664949 2020. SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis.
32597823 2020. AhR and IDO1 in pathogenesis of Covid-19 and the "Systemic AhR Activation Syndrome:" a translational review and therapeutic perspectives.
34252234 2022. Long noncoding RNAs in respiratory viruses: A review.
34773448 2021. C-reactive protein as an effector molecule in Covid-19 pathogenesis.
35232816 2022. The key features of SARS-CoV-2 leader and NSP1 required for viral escape of NSP1-mediated repression.
34937774 2022. sgDI-tector: defective interfering viral genome bioinformatics for detection of coronavirus subgenomic RNAs.
34127534 2021. Genes with 5' terminal oligopyrimidine tracts preferentially escape global suppression of translation by the SARS-CoV-2 Nsp1 protein.
34315815 2021. SARS-CoV-2 infection triggers widespread host mRNA decay leading to an mRNA export block.
32699064 2020. Viral subversion of nonsense-mediated mRNA decay.
33268501 2020. The viral protein NSP1 acts as a ribosome gatekeeper for shutting down host translation and fostering SARS-CoV-2 translation.
33530819 2021. Peripheral blood microRNAs and the COVID-19 patient: methodological considerations, technical challenges and practice points.
32615049 2021. The emerging role and significance of circular RNAs in viral infections and antiviral immune responses: possible implication as theranostic agents.
34248311 2021. Genetic Control of Human Infection with SARS-CoV-2.
34127904 2021. Network-based transcriptomic analysis identifies the genetic effect of COVID-19 to chronic kidney disease patients: A bioinformatics approach.
34305429 2021. Relevance between COVID-19 and host genetics of immune response.
34366686 2021. Integrated multi-omics approach identified molecular mechanism and pathogenetic processes of COVID-19 that affect patient with Parkinson's disorder.
35648852 2022. A systems biology approach identifies candidate drugs to reduce mortality in severely ill patients with COVID-19.
35108055 2022. Dexamethasone sensitizes to ferroptosis by glucocorticoid receptor-induced dipeptidase-1 expression and glutathione depletion.
34516880 2021. Platelets amplify endotheliopathy in COVID-19.
33888467 2021. SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity.
33277324 2021. MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program.
33547084 2021. Nsp1 protein of SARS-CoV-2 disrupts the mRNA export machinery to inhibit host gene expression.
33536218 2021. A diagnostic host response biosignature for COVID-19 from RNA profiling of nasal swabs and blood.
34407940 2021. Age-dependent regulation of SARS-CoV-2 cell entry genes and cell death programs correlates with COVID-19 severity.
33239293 2020. Regeneration of the pulmonary vascular endothelium after viral pneumonia requires COUP-TF2.
32494691 2020. Surviving COVID-19: A disease tolerance perspective.
32596474 2020. Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2.
33457042 2021. A large-scale transcriptional study reveals inhibition of COVID-19 related cytokine storm by traditional Chinese medicines.
35290573 2022. A urinary proteomic landscape of COVID-19 progression identifies signaling pathways and therapeutic options.
34387838 2022. Overview of SARS-CoV-2 genome-encoded proteins.
35508791 2022. Identification of serum metabolites enhancing inflammatory responses in COVID-19.
33564978 2021. Single-cell transcriptomes of peripheral blood cells indicate and elucidate severity of COVID-19.
32963239 2020. Consensus transcriptional regulatory networks of coronavirus-infected human cells.
33664060 2021. SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8(+) T cell responses.
34376481 2021. Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients.
35277538 2022. Computational identification of host genomic biomarkers highlighting their functions, pathways and regulators that influence SARS-CoV-2 infections and drug repurposing.
35102215 2022. Metabolomics study of COVID-19 patients in four different clinical stages.
35079083 2022. Dual RNA-Seq analysis of SARS-CoV-2 correlates specific human transcriptional response pathways directly to viral expression.
35181735 2022. Immune transcriptome analysis of COVID-19 patients infected with SARS-CoV-2 variants carrying the E484K escape mutation identifies a distinct gene module.
35393464 2022. Host-pathogen dynamics in longitudinal clinical specimens from patients with COVID-19.
35477940 2022. Integrated analysis of transcriptomic data reveals the platelet response in COVID-19 disease.
34556735 2021. Network neighbors of viral targets and differentially expressed genes in COVID-19 are drug target candidates.
34535740 2021. Prolyl isomerase Pin1 plays an essential role in SARS-CoV-2 proliferation, indicating its possibility as a novel therapeutic target.
34615949 2021. Transcriptomic analysis revealed increased expression of genes involved in keratinization in the tears of COVID-19 patients.
34615934 2021. Drug repositioning by merging active subnetworks validated in cancer and COVID-19.
34675292 2021. Inferring a causal relationship between ceramide levels and COVID-19 respiratory distress.
34675242 2021. Meta-analysis of COVID-19 single-cell studies confirms eight key immune responses.
34750486 2021. Drug repurposing for coronavirus (SARS-CoV-2) based on gene co-expression network analysis.
34031435 2021. Integrative web-based analysis of omics data for study of drugs against SARS-CoV-2.
34017039 2021. Metabolomics and computational analysis of the role of monoamine oxidase activity in delirium and SARS-COV-2 infection.
33782412 2021. Comprehensive transcriptomic analysis of COVID-19 blood, lung, and airway.
33762619 2021. Mining of high throughput screening database reveals AP-1 and autophagy pathways as potential targets for COVID-19 therapeutics.
33737694 2021. Metabolomics analysis reveals a modified amino acid metabolism that correlates with altered oxygen homeostasis in COVID-19 patients.
33737684 2021. Proteomic blood profiling in mild, severe and critical COVID-19 patients.
34112877 2021. Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19.
34226623 2021. UVC disinfects SARS-CoV-2 by induction of viral genome damage without apparent effects on viral morphology and proteins.
34226622 2021. Understanding protection from SARS-CoV-2 using metabolomics.
34282210 2021. Targeted metabolomics identifies high performing diagnostic and prognostic biomarkers for COVID-19.
34272434 2021. Proteomics and metabonomics analyses of Covid-19 complications in patients with pulmonary fibrosis.
33420163 2021. Host mitochondrial transcriptome response to SARS-CoV-2 in multiple cell models and clinical samples.
33510359 2021. Meta-analysis of host transcriptional responses to SARS-CoV-2 infection reveals their manifestation in human tumors.
33510353 2021. Network theoretic analysis of JAK/STAT pathway and extrapolation to drugs and viruses including COVID-19.
33504824 2021. Altered high-density lipoprotein composition and functions during severe COVID-19.
33479353 2021. Network analysis of Down syndrome and SARS-CoV-2 identifies risk and protective factors for COVID-19.
33637823 2021. Homologies between SARS-CoV-2 and allergen proteins may direct T cell-mediated heterologous immune responses.
33627767 2021. Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approach.
34857794 2021. Multiscale interactome analysis coupled with off-target drug predictions reveals drug repurposing candidates for human coronavirus disease.
34907210 2021. Identification of transcriptional regulatory network associated with response of host epithelial cells to SARS-CoV-2.
34433832 2021. Homology between SARS CoV-2 and human proteins.
34413339 2021. SARS-CoV-2 infection initiates interleukin-17-enriched transcriptional response in different cells from multiple organs.
34404832 2021. Inhibiting SARS-CoV-2 infection in vitro by suppressing its receptor, angiotensin-converting enzyme 2, via aryl-hydrocarbon receptor signal.
34376762 2021. Comparative transcriptome analyses reveal genes associated with SARS-CoV-2 infection of human lung epithelial cells.
33883570 2021. Evidence of a dysregulated vitamin D endocrine system in SARS-CoV-2 infected patient's lung cells.
33846375 2021. A study of differential circRNA and lncRNA expressions in COVID-19-infected peripheral blood.
32929138 2020. Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition.
33033346 2020. The specific metabolome profiling of patients infected by SARS-COV-2 supports the key role of tryptophan-nicotinamide pathway and cytosine metabolism.
33077837 2020. Finding disease modules for cancer and COVID-19 in gene co-expression networks with the Core&Peel method.
33177594 2020. SARS-CoV-2 receptor is co-expressed with elements of the kinin-kallikrein, renin-angiotensin and coagulation systems in alveolar cells.
33173052 2020. Lung transcriptome of a COVID-19 patient and systems biology predictions suggest impaired surfactant production which may be druggable by surfactant therapy.
33293627 2020. SARS-CoV-2 receptor ACE2 is co-expressed with genes related to transmembrane serine proteases, viral entry, immunity and cellular stress.
33376242 2020. In-depth blood proteome profiling analysis revealed distinct functional characteristics of plasma proteins between severe and non-severe COVID-19 patients.
33318519 2020. Gene expression network analysis provides potential targets against SARS-CoV-2.
32843695 2020. Immunoinformatic identification of B cell and T cell epitopes in the SARS-CoV-2 proteome.
33431511 2021. Single-cell RNA sequencing reveals SARS-CoV-2 infection dynamics in lungs of African green monkeys.
34581622 2021. A prenylated dsRNA sensor protects against severe COVID-19.
32680882 2020. Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2.
35047828 2020. Mini review: Recent progress in RT-LAMP enabled COVID-19 detection.
35091530 2022. Proteomic and phosphoproteomic profiling of COVID-19-associated lung and liver injury: a report based on rhesus macaques.
35091528 2022. Integrated histopathological, lipidomic, and metabolomic profiles reveal mink is a useful animal model to mimic the pathogenicity of severe COVID-19 patients.
35075101 2022. SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules.
34322127 2021. A Single-Cell Atlas of Lymphocyte Adaptive Immune Repertoires and Transcriptomes Reveals Age-Related Differences in Convalescent COVID-19 Patients.
34276672 2021. Enhanced Expression of Autoantigens During SARS-CoV-2 Viral Infection.
34262555 2021. Systems Immunology Analysis Reveals the Contribution of Pulmonary and Extrapulmonary Tissues to the Immunopathogenesis of Severe COVID-19 Patients.
34248940 2021. Endothelial Immunity Trained by Coronavirus Infections, DAMP Stimulations and Regulated by Anti-Oxidant NRF2 May Contribute to Inflammations, Myelopoiesis, COVID-19 Cytokine Storms and Thromboembolism.
34135895 2021. Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients.
34108966 2021. Transcriptional Changes in CD16+ Monocytes May Contribute to the Pathogenesis of COVID-19.
33995382 2021. SARS-CoV-2 Induces Lymphocytopenia by Promoting Inflammation and Decimates Secondary Lymphoid Organs.
33936086 2021. SARS-CoV-2 Spike Targets USP33-IRF9 Axis via Exosomal miR-148a to Activate Human Microglia.
33936072 2021. Single-Cell RNA Sequencing Analysis of the Immunometabolic Rewiring and Immunopathogenesis of Coronavirus Disease 2019.
33868293 2021. MicroLet-7b Regulates Neutrophil Function and Dampens Neutrophilic Inflammation by Suppressing the Canonical TLR4/NF-kappaB Pathway.
33868239 2021. Genetics Insight for COVID-19 Susceptibility and Severity: A Review.
33796097 2021. Immune Interaction Map of Human SARS-CoV-2 Target Genes: Implications for Therapeutic Avenues.
33717140 2021. Epigenetic Landscapes of Single-Cell Chromatin Accessibility and Transcriptomic Immune Profiles of T Cells in COVID-19 Patients.
33679760 2021. Cyclic-di-GMP Induces STING-Dependent ILC2 to ILC1 Shift During Innate Type 2 Lung Inflammation.
33362771 2020. A Network-Based Analysis Reveals the Mechanism Underlying Vitamin D in Suppressing Cytokine Storm and Virus in SARS-CoV-2 Infection.
33329603 2020. Type I Interferon (IFN)-Regulated Activation of Canonical and Non-Canonical Signaling Pathways.
33042157 2020. Mast Cells in Alveolar Septa of COVID-19 Patients: A Pathogenic Pathway That May Link Interstitial Edema to Immunothrombosis.
33013872 2020. Excessive Neutrophils and Neutrophil Extracellular Traps in COVID-19.
32983174 2020. Re-analysis of Single Cell Transcriptome Reveals That the NR3C1-CXCL8-Neutrophil Axis Determines the Severity of COVID-19.
32670298 2020. Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse.
35258762 2022. Integrated analysis of gut microbiome and host immune responses in COVID-19.
35192147 2022. PathogenTrack and Yeskit: tools for identifying intracellular pathogens from single-cell RNA-sequencing datasets as illustrated by application to COVID-19.
34557504 2021. Unraveling Risk Genes of COVID-19 by Multi-Omics Integrative Analyses.
34368185 2021. Potential Implications of a Type 1 Interferon Gene Signature on COVID-19 Severity and Chronic Inflammation in Sickle Cell Disease.
35047913 2021. The SIRAH-CoV-2 Initiative: A Coarse-Grained Simulations' Dataset of the SARS-CoV-2 Proteome.
35572676 2022. Metabolomic Profiling of Plasma Reveals Differential Disease Severity Markers in COVID-19 Patients.
35531299 2022. The Intricacy of the Viral-Human Protein Interaction Networks: Resources, Data, and Analyses.
35464969 2022. Rapid and Accurate Detection of SARS Coronavirus 2 by Nanopore Amplicon Sequencing.
35391730 2022. Inflammatory Bowel Disease and COVID-19: How Microbiomics and Metabolomics Depict Two Sides of the Same Coin.
35369457 2022. Inflammatory Profiles of Tracheal Biopsies From SARS-CoV-2 Patients.
35222346 2022. The Hidden Enemy Within: Non-canonical Peptides in Virus-Induced Autoimmunity.
34925252 2021. Longitudinal Metabolomics Reveals Ornithine Cycle Dysregulation Correlates With Inflammation and Coagulation in COVID-19 Severe Patients.
34917069 2021. The Triangle Relationship Between Long Noncoding RNA, RIG-I-like Receptor Signaling Pathway, and Glycolysis.
34899651 2021. Suppression and Activation of Intracellular Immune Response in Initial Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
34659188 2021. Coronavirus Nsp1: Immune Response Suppression and Protein Expression Inhibition.
34650546 2021. ORF3a Protein of Severe Acute Respiratory Syndrome Coronavirus 2 Inhibits Interferon-Activated Janus Kinase/Signal Transducer and Activator of Transcription Signaling via Elevating Suppressor of Cytokine Signaling 1.
33815307 2021. Genomic Feature Analysis of Betacoronavirus Provides Insights Into SARS and COVID-19 Pandemics.
33329483 2020. Rapid Scanning Electron Microscopy Detection and Sequencing of Severe Acute Respiratory Syndrome Coronavirus 2 and Other Respiratory Viruses.
33324374 2020. Comparative Transcriptome Analysis Reveals the Intensive Early Stage Responses of Host Cells to SARS-CoV-2 Infection.
33178176 2020. Differential Expression of Viral Transcripts From Single-Cell RNA Sequencing of Moderate and Severe COVID-19 Patients and Its Implications for Case Severity.
33071996 2020. Proteomics Insights Into the Molecular Basis of SARS-CoV-2 Infection: What We Can Learn From the Human Olfactory Axis.
35620480 2022. Identifying Methylation Signatures and Rules for COVID-19 With Machine Learning Methods.
35573725 2022. Comparative Analysis of Long Non-Coding RNA Expression and Immune Response in Mild and Severe COVID-19.
35480886 2022. Serum NMR Profiling Reveals Differential Alterations in the Lipoproteome Induced by Pfizer-BioNTech Vaccine in COVID-19 Recovered Subjects and Naive Subjects.
35372520 2022. Host Cell Glycocalyx Remodeling Reveals SARS-CoV-2 Spike Protein Glycomic Binding Sites.
34938772 2021. Metabolic and Lipidomic Markers Differentiate COVID-19 From Non-Hospitalized and Other Intensive Care Patients.
33693030 2021. Circulating Exosomes Are Strongly Involved in SARS-CoV-2 Infection.
33585567 2020. SARS-CoV-2 and Glutamine: SARS-CoV-2 Triggered Pathogenesis via Metabolic Reprograming of Glutamine in Host Cells.
33585554 2020. SARS-CoV-2 Proteins Exploit Host's Genetic and Epigenetic Mediators for the Annexation of Key Host Signaling Pathways.
33195414 2020. Identifying Pathways and Networks Associated With the SARS-CoV-2 Cell Receptor ACE2 Based on Gene Expression Profiles in Normal and SARS-CoV-2-Infected Human Tissues.
32974389 2020. SR/RS Motifs as Critical Determinants of Coronavirus Life Cycle.
34512253 2021. Nervous System-Systemic Crosstalk in SARS-CoV-2/COVID-19: A Unique Dyshomeostasis Syndrome.
35520289 2022. Network Pharmacology and Comparative Transcriptome Reveals Biotargets and Mechanisms of Curcumol Treating Lung Adenocarcinoma Patients With COVID-19.
34070662 2021. Breast Milk and COVID-19: From Conventional Data to "Omics" Technologies to Investigate Changes Occurring in SARS-CoV-2 Positive Mothers.
35639648 2022. Pregnancy, Preeclampsia, and COVID-19: Susceptibility and Mechanisms: A Review Study.
35282650 2022. The Key Genes Underlying Pathophysiology Correlation Between the Acute Myocardial Infarction and COVID-19.
34675627 2021. Construction and Investigation of Competing Endogenous RNA Networks and Candidate Genes Involved in SARS-CoV-2 Infection.
33110916 2020. Exploring Host Genetic Polymorphisms Involved in SARS-CoV Infection Outcomes: Implications for Personalized Medicine in COVID-19.
34569339 2021. A scoping review of the pathophysiology of COVID-19.
33610778 2021. SARS-CoV-2 and immune-microbiome interactions: Lessons from respiratory viral infections.
34623759 2021. New insights into genetic characteristics between multiple myeloma and COVID-19: An integrative bioinformatics analysis of gene expression omnibus microarray and the cancer genome atlas data.
34104087 2021. SARS-CoV-2 infection activates a subset of intrinsic pathways to inhibit type I interferons in vitro and in vivo.
33526974 2021. Severe acute respiratory syndrome coronavirus (SARS-CoV)-2 infection induces dysregulation of immunity: in silico gene expression analysis.
35328409 2022. SARS-CoV-2 Membrane Protein: From Genomic Data to Structural New Insights.
35163833 2022. AKR1B10, One of the Triggers of Cytokine Storm in SARS-CoV2 Severe Acute Respiratory Syndrome.
35269564 2022. COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19.
34638812 2021. Untargeted Metabolic Profiling of Extracellular Vesicles of SARS-CoV-2-Infected Patients Shows Presence of Potent Anti-Inflammatory Metabolites.
34638691 2021. The MiR-320 Family Is Strongly Downregulated in Patients with COVID-19 Induced Severe Respiratory Failure.
34502454 2021. The Serum Metabolome of Moderate and Severe COVID-19 Patients Reflects Possible Liver Alterations Involving Carbon and Nitrogen Metabolism.
34681944 2021. Alveolar Regeneration in COVID-19 Patients: A Network Perspective.
34681641 2021. G-Quadruplex Targeting in the Fight against Viruses: An Update.
34884813 2021. Pathogenesis and Treatment of Cytokine Storm Induced by Infectious Diseases.
34073578 2021. Ceramide and Related Molecules in Viral Infections.
33807682 2021. CNBP Binds and Unfolds In Vitro G-Quadruplexes Formed in the SARS-CoV-2 Positive and Negative Genome Strands.
33806254 2021. Ribosome-Profiling Reveals Restricted Post Transcriptional Expression of Antiviral Cytokines and Transcription Factors during SARS-CoV-2 Infection.
34200325 2021. Evidence for Biological Age Acceleration and Telomere Shortening in COVID-19 Survivors.
34205975 2021. Multifaced Roles of HDL in Sepsis and SARS-CoV-2 Infection: Renal Implications.
34360824 2021. SARS-CoV-2 Infected Pediatric Cerebral Cortical Neurons: Transcriptomic Analysis and Potential Role of Toll-like Receptors in Pathogenesis.
34360778 2021. Detecting and Profiling Endogenous RNA G-Quadruplexes in the Human Transcriptome.
34360732 2021. The Good and Bad of Nrf2: An Update in Cancer and New Perspectives in COVID-19.
33430309 2021. Mapping the SARS-CoV-2-Host Protein-Protein Interactome by Affinity Purification Mass Spectrometry and Proximity-Dependent Biotin Labeling: A Rational and Straightforward Route to Discover Host-Directed Anti-SARS-CoV-2 Therapeutics.
33669808 2021. Ex uno, plures-From One Tissue to Many Cells: A Review of Single-Cell Transcriptomics in Cardiovascular Biology.
34947989 2021. MicroRNA-Mediated Regulation of the Virus Cycle and Pathogenesis in the SARS-CoV-2 Disease.
35008724 2021. Exploring the Catalytic Mechanism of the RNA Cap Modification by nsp16-nsp10 Complex of SARS-CoV-2 through a QM/MM Approach.
35459913 2022. Novel potential metabolic biomarker panel for early detection of severe COVID-19 using full-spectrum metabolome and whole-transcriptome analyses.
34531370 2021. Single-cell immune profiling reveals distinct immune response in asymptomatic COVID-19 patients.
34732709 2021. Sensing of cytoplasmic chromatin by cGAS activates innate immune response in SARS-CoV-2 infection.
33677468 2021. Dynamic blood single-cell immune responses in patients with COVID-19.
34083512 2021. Sera proteomic features of active and recovered COVID-19 patients: potential diagnostic and prognostic biomarkers.
34330889 2021. Multimodal single-cell omics analysis identifies epithelium-immune cell interactions and immune vulnerability associated with sex differences in COVID-19.
34253708 2021. The zinc finger transcription factor, KLF2, protects against COVID-19 associated endothelial dysfunction.
33419962 2021. Pathological features of COVID-19-associated liver injury-a preliminary proteomics report based on clinical samples.
33619245 2021. Genome and epigenome editing identify CCR9 and SLC6A20 as target genes at the 3p21.31 locus associated with severe COVID-19.
34916489 2021. COVID-19 induces new-onset insulin resistance and lipid metabolic dysregulation via regulation of secreted metabolic factors.
34893580 2021. Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks.
33863870 2021. COVID-19: complexity of disease severity revealed by systemic and localized single cell immune atlas.
33859163 2021. Multi-platform omics analysis reveals molecular signature for COVID-19 pathogenesis, prognosis and drug target discovery.
32883951 2020. COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm.
33037188 2020. SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation.
33024075 2020. Salvianolic acid C potently inhibits SARS-CoV-2 infection by blocking the formation of six-helix bundle core of spike protein.
33024073 2020. Main protease of SARS-CoV-2 serves as a bifunctional molecule in restricting type I interferon antiviral signaling.
33097684 2020. Omics study reveals abnormal alterations of breastmilk proteins and metabolites in puerperant women with COVID-19.
33060566 2020. Pathological features of COVID-19-associated lung injury: a preliminary proteomics report based on clinical samples.
32467561 2020. Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2.
32561706 2020. Temporal profiling of plasma cytokines, chemokines and growth factors from mild, severe and fatal COVID-19 patients.
32641705 2020. Single cell transcriptome revealed SARS-CoV-2 entry genes enriched in colon tissues and associated with coronavirus infection and cytokine production.
33361761 2020. Longitudinal transcriptome analyses show robust T cell immunity during recovery from COVID-19.
33941271 2021. Multi-omics reveals age-related differences in the diaphragm response to mechanical ventilation: a pilot study.
32578378 2020. Nanopore Targeted Sequencing for the Accurate and Comprehensive Detection of SARS-CoV-2 and Other Respiratory Viruses.
32714115 2020. Integrative Network Biology Framework Elucidates Molecular Mechanisms of SARS-CoV-2 Pathogenesis.
32714116 2020. Activation of the SARS-CoV-2 Receptor Ace2 by Cytokines Through Pan JAK-STAT Enhancers.
32742242 2020. Single-Cell Transcriptomic Analysis of SARS-CoV-2 Reactive CD4 (+) T Cells.
33475497 2020. SARS-CoV infection crosstalk with human host cell noncoding-RNA machinery: An in-silico approach.
35251616 2022. A novel concept of human antiviral protection: It's all about RNA (Review).
35528178 2022. Recognition of Immune Cell Markers of COVID-19 Severity with Machine Learning Methods.
35528173 2022. Discovering Common Pathophysiological Processes between COVID-19 and Cystic Fibrosis by Differential Gene Expression Pattern Analysis.
34307679 2021. Identifying COVID-19-Specific Transcriptomic Biomarkers with Machine Learning Methods.
35453568 2022. Molecular Mechanism of Pancreatic beta-Cell Failure in Type 2 Diabetes Mellitus.
34572329 2021. Epigenetic Mechanisms Underlying COVID-19 Pathogenesis.
33352880 2020. Evidence of SARS-CoV-2 Transcriptional Activity in Cardiomyocytes of COVID-19 Patients without Clinical Signs of Cardiac Involvement.
35625619 2022. Immune-Related Protein Interaction Network in Severe COVID-19 Patients toward the Identification of Key Proteins and Drug Repurposing.
35204689 2022. Looking at COVID-19 from a Systems Biology Perspective.
35169794 2022. Comparative analysis of cell-cell communication at single-cell resolution.
35350199 2022. Autoantibody discovery across monogenic, acquired, and COVID19-associated autoimmunity with scalable PhIP-Seq.
35313584 2022. Genetic control of the dynamic transcriptional response to immune stimuli and glucocorticoids at single cell resolution.
35313583 2022. Dynamic single-cell RNA sequencing reveals BCG vaccination curtails SARS-CoV-2 induced disease severity and lung inflammation.
35118467 2022. Variant to function mapping at single-cell resolution through network propagation.
35043114 2022. A single-cell atlas reveals shared and distinct immune responses and metabolism during SARS-CoV-2 and HIV-1 infections.
35233578 2022. Discovery and functional interrogation of SARS-CoV-2 protein-RNA interactions.
35233572 2022. Targeted Down Regulation Of Core Mitochondrial Genes During SARS-CoV-2 Infection.
35194610 2022. SARS-CoV-2 Nsp14 mediates the effects of viral infection on the host cell transcriptome.
35132419 2022. Human Cardiac Organoids to Model COVID-19 Cytokine Storm Induced Cardiac Injuries.
33907750 2022. Identification of druggable host targets needed for SARS-CoV-2 infection by combined pharmacological evaluation and cellular network directed prioritization both in vitro and in vivo.
34580671 2021. A BioID-derived proximity interactome for SARS-CoV-2 proteins.
34189529 2021. Predicting gene regulatory networks from multi-omics to link genetic risk variants and neuroimmunology to Alzheimer's disease phenotypes.
33173862 2021. The translational landscape of SARS-CoV-2 and infected cells.
34642692 2021. Longitudinal characterization of circulating neutrophils uncovers distinct phenotypes associated with disease severity in hospitalized COVID-19 patients.
34845443 2021. Unambiguous detection of SARS-CoV-2 subgenomic mRNAs with single cell RNA sequencing.
34845454 2021. Identifying disease-critical cell types and cellular processes across the human body by integration of single-cell profiles and human genetics.
33106807 2021. Adult Stem Cell-derived Complete Lung Organoid Models Emulate Lung Disease in COVID-19.
33972946 2021. ORAI1 establishes resistance to SARS-CoV-2 infection by regulating tonic type I interferon signaling.
33972943 2021. Signaling through FcgammaRIIA and the C5a-C5aR pathway mediates platelet hyperactivation in COVID-19.
34075374 2021. SARS-CoV-2 Nsp14 activates NF-kappaB signaling and induces IL-8 upregulation.
32995776 2021. Genes with 5' terminal oligopyrimidine tracts preferentially escape global suppression of translation by the SARS-CoV-2 Nsp1 protein.
33758858 2021. Systemic Tissue and Cellular Disruption from SARS-CoV-2 Infection revealed in COVID-19 Autopsies and Spatial Omics Tissue Maps.
33758849 2021. Comparative host interactomes of the SARS-CoV-2 nonstructural protein 3 and human coronavirus homologs.
33688643 2021. Published Anti-SARS-CoV-2 In Vitro Hits Share Common Mechanisms of Action that Synergize with Antivirals.
33791703 2021. ACE2 protein expression within isogenic cell lines is heterogeneous and associated with distinct transcriptomes.
33619493 2021. Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism.
33758859 2021. Longitudinal single-cell epitope and RNA-sequencing reveals the immunological impact of type 1 interferon autoantibodies in critical COVID-19.
32511352 2020. Shotgun Transcriptome and Isothermal Profiling of SARS-CoV-2 Infection Reveals Unique Host Responses, Viral Diversification, and Drug Interactions.
32587962 2020. The IMEx Coronavirus interactome: an evolving map of Coronaviridae-Host molecular interactions.
32587963 2020. Single-cell transcriptomic analysis of SARS-CoV-2 reactive CD4 (+) T cells.
32511305 2020. Analysis of Infected Host Gene Expression Reveals Repurposed Drug Candidates and Time-Dependent Host Response Dynamics for COVID-19.
32511372 2020. Nrf2 Activator PB125(R) as a Potential Therapeutic Agent Against COVID-19.
32676594 2020. Unique transcriptional changes in coagulation cascade genes in SARS-CoV-2-infected lung epithelial cells: A potential factor in COVID-19 coagulopathies.
32766585 2020. Multiomic Immunophenotyping of COVID-19 Patients Reveals Early Infection Trajectories.
32766588 2020. Direct exposure to SARS-CoV-2 and cigarette smoke increases infection severity and alters the stem cell-derived airway repair response.
32511341 2020. Network Analysis and Transcriptome Profiling Identify Autophagic and Mitochondrial Dysfunctions in SARS-CoV-2 Infection.
32511379 2020. Consensus transcriptional regulatory networks of coronavirus-infected human cells.
32699849 2020. Comparative multiplexed interactomics of SARS-CoV-2 and homologous coronavirus non-structural proteins identifies unique and shared host-cell dependencies.
32511382 2020. Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium.
32676602 2020. Severely ill COVID-19 patients display augmented functional properties in SARS-CoV-2-reactive CD8 + T cells.
32637948 2020. Genetic architecture of host proteins interacting with SARS-CoV-2.
33300002 2020. Chromatin remodeling in peripheral blood cells reflects COVID-19 symptom severity.
33330860 2020. Circular RNA profiling reveals abundant and diverse circRNAs of SARS-CoV-2, SARS-CoV and MERS-CoV origin.
33299989 2020. Evolution of the SARS-CoV-2 proteome in three dimensions (3D) during the first six months of the COVID-19 pandemic.
33299992 2020. Transcriptional response modules characterise IL-1beta and IL-6 activity in COVID-19.
33299987 2020. COVID-19 genetic risk variants are associated with expression of multiple genes in diverse immune cell types.
33330871 2020. Profound Treg perturbations correlate with COVID-19 severity.
33330870 2020. SARS-CoV-2 RNA reverse-transcribed and integrated into the human genome.
34013266 2020. Serial co-expression analysis of host factors from SARS-CoV viruses highly converges with former high-throughput screenings and proposes key regulators and co-option of cellular pathways.
32793903 2020. IFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infection.
32869031 2020. Elucidation of remdesivir cytotoxicity pathways through genome-wide CRISPR-Cas9 screening and transcriptomics.
32839770 2020. SARS-CoV-2 ORF9c Is a Membrane-Associated Protein that Suppresses Antiviral Responses in Cells.
32511381 2020. An in silico map of the SARS-CoV-2 RNA Structurome.
32511326 2020. Type 2 and interferon inflammation strongly regulate SARS-CoV-2 related gene expression in the airway epithelium.
34313294 2021. A lipidomic view of SARS-CoV-2.
34291285 2021. Biochemical composition, transmission and diagnosis of SARS-CoV-2.
33401144 2021. Entropy-driven electrochemiluminescence ultra-sensitive detection strategy of NF-kappaB p50 as the regulator of cytokine storm.
33612988 2021. Den molekularen Wirtszellveranderungen durch SARS-CoV-2 auf der Spur.
34315173 2021. Aberrant glycosylation of anti-SARS-CoV-2 spike IgG is a prothrombotic stimulus for platelets.
32573711 2020. Platelet gene expression and function in patients with COVID-19.
33635335 2021. A neutrophil activation signature predicts critical illness and mortality in COVID-19.
35180460 2022. Upregulation of cytokine signalling in platelets increases risk of thrombophilia in severe COVID-19 patients.
34837942 2021. A multitask transfer learning framework for the prediction of virus-human protein-protein interactions.
33941085 2021. The Coronavirus Network Explorer: mining a large-scale knowledge graph for effects of SARS-CoV-2 on host cell function.
33663372 2021. OmicLoupe: facilitating biological discovery by interactive exploration of multiple omic datasets and statistical comparisons.
33413085 2021. H2V: a database of human genes and proteins that respond to SARS-CoV-2, SARS-CoV, and MERS-CoV infection.
34922446 2021. GraphOmics: an interactive platform to explore and integrate multi-omics data.
33832440 2021. Common low complexity regions for SARS-CoV-2 and human proteomes as potential multidirectional risk factor in vaccine development.
33008363 2020. Real-time audio and visual display of the Coronavirus genome.
33482803 2021. A protocol for adding knowledge to Wikidata: aligning resources on human coronaviruses.
33980308 2021. Echinacea purpurea (L.) Moench treatment of monocytes promotes tonic interferon signaling, increased innate immunity gene expression and DNA repeat hypermethylated silencing of endogenous retroviral sequences.
35379171 2022. Predicted coronavirus Nsp5 protease cleavage sites in the human proteome.
34775962 2021. Analysis of transcriptomic data sets supports the role of IL-6 in NETosis and immunothrombosis in severe COVID-19.
33407110 2021. Rapid single cell evaluation of human disease and disorder targets using REVEAL: SingleCell.
35027067 2022. Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection.
35461273 2022. SARS-COV-2 as potential microRNA sponge in COVID-19 patients.
35421970 2022. Co-expression analysis to identify key modules and hub genes associated with COVID-19 in platelets.
34030677 2021. Extremes of age are associated with differences in the expression of selected pattern recognition receptor genes and ACE2, the receptor for SARS-CoV-2: implications for the epidemiology of COVID-19 disease.
34116667 2021. A blood RNA transcriptome signature for COVID-19.
33413329 2021. Computational analysis to repurpose drugs for COVID-19 based on transcriptional response of host cells to SARS-CoV-2.
35331159 2022. Regulation of SARS CoV-2 host factors in the kidney and heart in rats with 5/6 nephrectomy-effects of salt, ARB, DPP4 inhibitor and SGLT2 blocker.
35123426 2022. Possible kidney-lung cross-talk in COVID-19: in silico modeling of SARS-CoV-2 infection.
34774005 2021. Using genetics to understand the role of kidney function in COVID-19: a mendelian randomization study.
32883368 2020. A protein interaction map identifies existing drugs targeting SARS-CoV-2.
34715923 2021. Dysregulation of RNA interference components in COVID-19 patients.
33312949 2020. Single-Cell Sequencing of Glioblastoma Reveals Central Nervous System Susceptibility to SARS-CoV-2.
35002688 2021. Host Factor Interaction Networks Identified by Integrative Bioinformatics Analysis Reveals Therapeutic Implications in COPD Patients With COVID-19.
34531741 2021. Identification of Novel Gene Signatures using Next-Generation Sequencing Data from COVID-19 Infection Models: Focus on Neuro-COVID and Potential Therapeutics.
34163359 2021. Therapeutic Targeting of Transcription Factors to Control the Cytokine Release Syndrome in COVID-19.
34054532 2021. Multi-Omics Approach in the Identification of Potential Therapeutic Biomolecule for COVID-19.
33995033 2021. SARS-CoV-2 Switches 'on' MAPK and NFkappaB Signaling via the Reduction of Nuclear DUSP1 and DUSP5 Expression.
33935717 2021. Na(+)/K(+)-ATPase as a Target of Cardiac Glycosides for the Treatment of SARS-CoV-2 Infection.
33762960 2021. Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis.
33716737 2021. In silico Analyses of Immune System Protein Interactome Network, Single-Cell RNA Sequencing of Human Tissues, and Artificial Neural Networks Reveal Potential Therapeutic Targets for Drug Repurposing Against COVID-19.
33289972 2020. Mining a GWAS of Severe Covid-19.
33289971 2020. Mining a GWAS of Severe Covid-19.
34541878 2021. Activation of Type I and Type II Interferon Signaling in SARS-CoV-2-Positive Thyroid Tissue of Patients Dying from COVID-19.
34740309 2021. Bioinformatics analyses reveal cell-barrier junction modulations in lung epithelial cells on SARS-CoV-2 infection.
35301621 2022. Comparative trachea transcriptome analysis in SPF broiler chickens infected with avian infectious bronchitis and avian influenza viruses.
34545716 2021. Potential of application of the RNA interference phenomenon in the treatment of new coronavirus infection COVID-19.
32102777 2020. The 2019 novel coronavirus resource.
34127975 2021. Implicating Gene and Cell Networks Responsible for Differential COVID-19 Host Responses via an Interactive Single Cell Web Portal.
33501435 2021. Severe COVID-19 associated variants linked to chemokine receptor gene control in monocytes and macrophages.
34127970 2021. Identification of ACE2 modifiers by CRISPR screening.
34729561 2021. An Autoantigen Profile from Jurkat T-Lymphoblasts Provides a Molecular Guide for Investigating Autoimmune Sequelae of COVID-19.
34341788 2021. Single-Cell Profiling of the Antigen-Specific Response to BNT162b2 SARS-CoV-2 RNA Vaccine.
34341789 2021. Molecular Pathophysiology of Cardiac Injury and Cardiac Microthrombi in Fatal COVID-19: Insights from Clinico-histopathologic and Single Nuclei RNA Sequencing Analyses.
34312624 2021. SARS-CoV-2 Restructures the Host Chromatin Architecture.
33106805 2021. Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity.
32995793 2021. Fixed single-cell RNA sequencing for understanding virus infection and host response.
33501441 2021. Interferon-regulated genetic programs and JAK/STAT pathway activate the intronic promoter of the short ACE2 isoform in renal proximal tubules.
33362557 2020. Nutraceutical Targeting of Inflammation-Modulating microRNAs in Severe Forms of COVID-19: A Novel Approach to Prevent the Cytokine Storm.
33041797 2020. In Silico Prediction of Molecular Targets of Astragaloside IV for Alleviation of COVID-19 Hyperinflammation by Systems Network Pharmacology and Bioinformatic Gene Expression Analysis.
33013423 2020. Age-Dependent Assessment of Genes Involved in Cellular Senescence, Telomere, and Mitochondrial Pathways in Human Lung Tissue of Smokers, COPD, and IPF: Associations With SARS-CoV-2 COVID-19 ACE2-TMPRSS2-Furin-DPP4 Axis.
35185603 2021. COVID-19 and Mitochondrial Non-Coding RNAs: New Insights From Published Data.
35153822 2021. The Landscape of Aminoacyl-tRNA Synthetases Involved in Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
32754056 2020. SARS-CoV-2 Molecular Network Structure.
32695025 2020. Regulatory Cross Talk Between SARS-CoV-2 Receptor Binding and Replication Machinery in the Human Host.
35655464 2022. m6A Regulator-Mediated Methylation Modification Patterns and Characteristics in COVID-19 Patients.
34851327 2021. Case Report: First Confirmed Case of Coinfection of SARS-CoV-2 With Choclo orthohantavirus.
32903570 2020. RNA-Seq-Based Whole Transcriptome Analysis of IPEC-J2 Cells During Swine Acute Diarrhea Syndrome Coronavirus Infection.
34306168 2021. Potential drugs against COVID-19 revealed by gene expression profile, molecular docking and molecular dynamic simulation.
33224264 2020. Perversely expressed long noncoding RNAs can alter host response and viral proliferation in SARS-CoV-2 infection.
32763951 2020. A Comprehensive, Flexible Collection of SARS-CoV-2 Coding Regions.
33244381 2020. Investigating the human protein-host protein interactome of SARS-CoV-2 infection in the small intestine.
32234303 2020. Multiomics Evaluation of Gastrointestinal and Other Clinical Characteristics of COVID-19.
35248659 2022. Role of genomics in combating COVID-19 pandemic.
34530086 2022. An overview of human proteins and genes involved in SARS-CoV-2 infection.
34848322 2022. Understanding the role of telomere attrition and epigenetic signatures in COVID-19 severity.
34274470 2021. Therapeutic perceptions in antisense RNA-mediated gene regulation for COVID-19.
33737124 2021. Epidemiological transcriptomic data supports BCG protection in viral diseases including COVID-19.
33346100 2021. Recognition of plausible therapeutic agents to combat COVID-19: An omics data based combined approach.
33887367 2021. Inferring molecular mechanisms of dexamethasone therapy in severe COVID-19 from existing transcriptomic data.
35662463 2022. PEPPI: Whole-proteome Protein-protein Interaction Prediction through Structure and Sequence Similarity, Functional Association, and Machine Learning.
32929000 2020. RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges.
35233559 2021. Defense of COVID-19 by Human Organoids.
34315200 2021. Interplays between human microbiota and microRNAs in COVID-19 pathogenesis: a literature review.
32809918 2020. Oxytocin's anti-inflammatory and proimmune functions in COVID-19: a transcriptomic signature-based approach.
32437232 2020. Virus-induced genetics revealed by multidimensional precision medicine transcriptional workflow applicable to COVID-19.
33991451 2021. Hypoxia induces expression of angiotensin-converting enzyme II in alveolar epithelial cells: Implications for the pathogenesis of acute lung injury in COVID-19.
34494892 2022. Implications of the NADase CD38 in COVID pathophysiology.
35032732 2022. Integrated hepatic single-cell RNA sequencing and untargeted metabolomics reveals the immune and metabolic modulation of Qing-Fei-Pai-Du decoction in mice with coronavirus-induced pneumonia.
34517257 2021. Dehydrozingerone ameliorates Lipopolysaccharide induced acute respiratory distress syndrome by inhibiting cytokine storm, oxidative stress via modulating the MAPK/NF-kappaB pathway.
33780434 2021. Disparate temperature-dependent virus-host dynamics for SARS-CoV-2 and SARS-CoV in the human respiratory epithelium.
33730024 2021. Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes.
33901166 2021. The first few days of a SARS-CoV-2 infection viewed at single-cell resolution.
32898168 2020. In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age.
33730015 2021. Gene variants of coagulation related proteins that interact with SARS-CoV-2.
33684134 2021. A network-informed analysis of SARS-CoV-2 and hemophagocytic lymphohistiocytosis genes' interactions points to Neutrophil extracellular traps as mediators of thrombosis in COVID-19.
34260589 2021. COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity.
33544720 2021. SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19.
33534793 2021. ViralLink: An integrated workflow to investigate the effect of SARS-CoV-2 on intracellular signalling and regulatory pathways.
33835998 2021. Genome Scale-Differential Flux Analysis reveals deregulation of lung cell metabolism on SARS-CoV-2 infection.
32997660 2020. IL6-mediated HCoV-host interactome regulatory network and GO/Pathway enrichment analysis.
35239653 2022. Proteome-wide Mendelian randomization identifies causal links between blood proteins and severe COVID-19.
35482673 2022. A Phenome-Wide Association Study of genes associated with COVID-19 severity reveals shared genetics with complex diseases in the Million Veteran Program.
35421082 2022. Abnormal global alternative RNA splicing in COVID-19 patients.
35468151 2022. Multi-omic analysis reveals enriched pathways associated with COVID-19 and COVID-19 severity.
35436306 2022. An endogenously activated antiviral state restricts SARS-CoV-2 infection in differentiated primary airway epithelial cells.
35421120 2022. Dysregulation of the leukocyte signaling landscape during acute COVID-19.
35390032 2022. Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches.
35381016 2022. Detection of SARS-CoV-2 infection by microRNA profiling of the upper respiratory tract.
35085325 2022. Identification of potentially anti-COVID-19 active drugs using the connectivity MAP.
35085240 2022. Impact of high platelet turnover on the platelet transcriptome: Results from platelet RNA-sequencing in patients with sepsis.
35081105 2022. RNA Sequencing in COVID-19 patients identifies neutrophil activation biomarkers as a promising diagnostic platform for infections.
35045126 2022. Identification of hub genes associated with COVID-19 and idiopathic pulmonary fibrosis by integrated bioinformatics analysis.
34851990 2021. Towards risk stratification and prediction of disease severity and mortality in COVID-19: Next generation metabolomics for the measurement of host response to COVID-19 infection.
34807957 2021. Core genes involved in the regulation of acute lung injury and their association with COVID-19 and tumor progression: A bioinformatics and experimental study.
34762662 2021. Targeted proteomics as a tool to detect SARS-CoV-2 proteins in clinical specimens.
34673800 2021. Klotho deficiency intensifies hypoxia-induced expression of IFN-alpha/beta through upregulation of RIG-I in kidneys.
34460840 2021. Immunometabolic signatures predict risk of progression to sepsis in COVID-19.
34432798 2021. Oligonucleotide capture sequencing of the SARS-CoV-2 genome and subgenomic fragments from COVID-19 individuals.
34407143 2021. Genomics-guided identification of potential modulators of SARS-CoV-2 entry proteases, TMPRSS2 and Cathepsins B/L.
34379666 2021. Using symptom-based case predictions to identify host genetic factors that contribute to COVID-19 susceptibility.
34010280 2021. The Biobanque quebecoise de la COVID-19 (BQC19)-A cohort to prospectively study the clinical and biological determinants of COVID-19 clinical trajectories.
33661927 2021. Hypoxia-induced inflammation: Profiling the first 24-hour posthypoxic plasma and central nervous system changes.
33630927 2021. Transcriptomic profiling and genomic mutational analysis of Human coronavirus (HCoV)-229E -infected human cells.
33606823 2021. Exploring novel and potent cell penetrating peptides in the proteome of SARS-COV-2 using bioinformatics approaches.
33596252 2021. The analysis on the human protein domain targets and host-like interacting motifs for the MERS-CoV and SARS-CoV/CoV-2 infers the molecular mimicry of coronavirus.
33301474 2020. The transcriptomic profiling of SARS-CoV-2 compared to SARS, MERS, EBOV, and H1N1.
33079950 2020. Proteins associated with neutrophil degranulation are upregulated in nasopharyngeal swabs from SARS-CoV-2 patients.
35446921 2022. Profiling metabolites and lipoproteins in COMETA, an Italian cohort of COVID-19 patients.
35395058 2022. Ad26.COV2.S prevents upregulation of SARS-CoV-2 induced pathways of inflammation and thrombosis in hamsters and rhesus macaques.
34473805 2021. Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection.
34597346 2021. The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.
33780519 2021. Viral genomic, metagenomic and human transcriptomic characterization and prediction of the clinical forms of COVID-19.
34061905 2021. Extensive C->U transition biases in the genomes of a wide range of mammalian RNA viruses; potential associations with transcriptional mutations, damage- or host-mediated editing of viral RNA.
34320031 2021. Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection.
33635931 2021. Inhibition of anti-viral stress granule formation by coronavirus endoribonuclease nsp15 ensures efficient virus replication.
33556147 2021. Multimerization- and glycosylation-dependent receptor binding of SARS-CoV-2 spike proteins.
33539484 2021. Three-dimensional chromatin in infectious disease-A role for gene regulation and pathogenicity?
33524041 2021. Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab.
34882757 2021. Foxp3+ CD4+ regulatory T cells control dendritic cells in inducing antigen-specific immunity to emerging SARS-CoV-2 antigens.
34437657 2021. SARS-CoV-2 suppresses IFNbeta production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon.
33284859 2020. SARS-CoV-2 spike protein promotes IL-6 trans-signaling by activation of angiotensin II receptor signaling in epithelial cells.
34993416 2021. Repurposable drugs for SARS-CoV-2 and influenza sepsis with scRNA-seq data targeting post-transcription modifications.
35217532 2022. Specialized interferon action in COVID-19.
34969849 2022. A virus-specific monocyte inflammatory phenotype is induced by SARS-CoV-2 at the immune-epithelial interface.
35022217 2022. SNX27 suppresses SARS-CoV-2 infection by inhibiting viral lysosome/late endosome entry.
35131898 2022. Differential interferon-alpha subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection.
34452991 2021. Protease cleavage of RNF20 facilitates coronavirus replication via stabilization of SREBP1.
34433692 2021. Profound Treg perturbations correlate with COVID-19 severity.
33958444 2021. Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues.
34108245 2021. HIF-1alpha is a negative regulator of interferon regulatory factors: Implications for interferon production by hypoxic monocytes.
34045361 2021. Translational shutdown and evasion of the innate immune response by SARS-CoV-2 NSP14 protein.
34031243 2021. Transfer transcriptomic signatures for infectious diseases.
34001664 2021. Detection of differentially abundant cell subpopulations in scRNA-seq data.
33479166 2021. Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome inhibits translation initiation.
33472860 2021. Coronavirus replication-transcription complex: Vital and selective NMPylation of a conserved site in nsp9 by the NiRAN-RdRp subunit.
35538614 2022. Individual genetic variability mainly of Proinflammatory cytokines, cytokine receptors, and toll-like receptors dictates pathophysiology of COVID-19 disease.
33331649 2021. Dysregulation of the mevalonate pathway during SARS-CoV-2 infection: An in silico study.
33300133 2021. Understanding the pathophysiological changes via untargeted metabolomics in COVID-19 patients.
34695380 2021. Folding Intermediates, Heterogeneous Native Ensembles and Protein Function.
35363626 2022. Patterns of Inflammatory Cell Infiltration and Expression of STAT6 in the Lungs of Patients With COVID-19: An Autopsy Study.
34764623 2022. Decision and feature level fusion of deep features extracted from public COVID-19 data-sets.
34027422 2021. Platelet and Haemostasis are the Main Targets in Severe Cases of COVID-19 Infection; a System Biology Study.
35085577 2022. The importance of accessory protein variants in the pathogenicity of SARS-CoV-2.
33309308 2021. Integrated Bioinformatics Analysis for the Screening of Associated Pathways and Therapeutic Drugs in Coronavirus Disease 2019.
32611485 2020. Molecular Alterations Prompted by SARS-CoV-2 Infection: Induction of Hyaluronan, Glycosaminoglycan and Mucopolysaccharide Metabolism.
35319744 2022. Late Complications of COVID-19: A Morphologic, Imaging, and Droplet Digital Polymerase Chain Reaction Study of Lung Tissue.
33720333 2021. Comparison of In Situ Hybridization, Immunohistochemistry, and Reverse Transcription-Droplet Digital Polymerase Chain Reaction for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Testing in Tissue.
34258664 2021. Evolutionary insights into the furin cleavage sites of SARS-CoV-2 variants from humans and animals.
33083914 2021. Coronavirus: proteomics analysis of chicken kidney tissue infected with variant 2 (IS-1494)-like avian infectious bronchitis virus.
34089367 2021. Transcriptome analysis of primary chicken cells infected with infectious bronchitis virus strain K047-12 isolated in Korea.
32651741 2020. Gene expression pattern differences in primary human pulmonary epithelial cells infected with MERS-CoV or SARS-CoV-2.
33594340 2021. Pathogenesis, Symptomatology, and Transmission of SARS-CoV-2 through analysis of Viral Genomics and Structure.
34274539 2021. The mechanism behind flaring/triggering of autoimmunity disorders associated with COVID-19.
34508917 2021. Autoimmunity roots of the thrombotic events after COVID-19 vaccination.
32376402 2020. Transcriptional landscape of SARS-CoV-2 infection dismantles pathogenic pathways activated by the virus, proposes unique sex-specific differences and predicts tailored therapeutic strategies.
34859136 2021. A Nucleocapsid-based Transcomplementation Cell Culture System of SARS-CoV-2 to Recapitulate the Complete Viral Life Cycle.
35128085 2022. Common genetic aspects between COVID-19 and sarcoidosis: A network-based approach using gene expression data.
35469237 2022. Epigenetic regulation of autophagy in coronavirus disease 2019 (COVID-19).
34307909 2021. Analysis of SARS-CoV-2 infection associated cell entry proteins ACE2, CD147, PPIA, and PPIB in datasets from non SARS-CoV-2 infected neuroblastoma patients, as potential prognostic and infection biomarkers in neuroblastoma.
35663631 2022. Proteomic Analyses Unveil Actionable Disease Pathways in COVID-19: A Step Toward Targeted Therapies.
34903581 2021. SARS-CoV-2 expresses a microRNA-like small RNA able to selectively repress host genes.
34373319 2021. Targeted in situ cross-linking mass spectrometry and integrative modeling reveal the architectures of three proteins from SARS-CoV-2.
33097660 2020. SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling.
33082228 2020. Transcriptional and proteomic insights into the host response in fatal COVID-19 cases.
33571544 2021. Dissecting lipid metabolism alterations in SARS-CoV-2.
35377064 2022. Differential transcriptomic landscapes of multiple organs from SARS-CoV-2 early infected rhesus macaques.
34477316 2021. SGLT2-Inhibition reverts urinary peptide changes associated with severe COVID-19: An in-silico proof-of-principle of proteomics-based drug repurposing.
33860983 2021. Mass spectrometry-based proteomic platforms for better understanding of SARS-CoV-2 induced pathogenesis and potential diagnostic approaches.
33945677 2021. Longitudinal proteomic profiling provides insights into host response and proteome dynamics in COVID-19 progression.
33111431 2021. N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.
33987944 2021. Proteomic and metabolomic investigation of serum lactate dehydrogenase elevation in COVID-19 patients.
33615696 2021. Application of spectral library prediction for parallel reaction monitoring of viral peptides.
32462744 2020. Shortlisting SARS-CoV-2 Peptides for Targeted Studies from Experimental Data-Dependent Acquisition Tandem Mass Spectrometry Data.
34075354 2021. A matter of perspective-Cutting-edge technology-driven urine proteome in COVID-19.
33688631 2020. Urine proteome of COVID-19 patients.
34696164 2021. SnoRNAs and miRNAs Networks Underlying COVID-19 Disease Severity.
33467724 2021. Nucleocapsid and Spike Proteins of the Coronavirus SARS-CoV-2 Induce IL6 in Monocytes and Macrophages-Potential Implications for Cytokine Storm Syndrome.
35171039 2022. Endothelial inflammation and dysfunction in COVID-19.
35434485 2022. Replication-transcription complex of coronaviruses: functions of individual viral non-structural subunits, properties and architecture of their complexes.
35305698 2022. The molecular mechanism of SARS-CoV-2 evading host antiviral innate immunity.
32725480 2021. Prediction of the Receptorome for the Human-Infecting Virome.
34157565 2021. Age- and airway disease related gene expression patterns of key SARS-CoV-2 entry factors in human nasal epithelia.
34325286 2021. SARS-CoV-2 and other coronaviruses bind to phosphorylated glycans from the human lung.
34788642 2022. The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review.
34058265 2021. Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism.
32918943 2020. The role of host genetics in susceptibility to severe viral infections in humans and insights into host genetics of severe COVID-19: A systematic review.
32987033 2020. Transcription-based drug repurposing for COVID-19.
32368569 2020. The molecular biology of intracellular events during Coronavirus infection cycle.
35632741 2022. SARS-CoV-2 Envelope (E) Protein Binds and Activates TLR2 Pathway: A Novel Molecular Target for COVID-19 Interventions.
35632738 2022. High Expression of HERV-K (HML-2) Might Stimulate Interferon in COVID-19 Patients.
35632779 2022. Signaling Pathway Reporter Screen with SARS-CoV-2 Proteins Identifies nsp5 as a Repressor of p53 Activity.
35336960 2022. Differential Peripheral Blood Glycoprotein Profiles in Symptomatic and Asymptomatic COVID-19.
35336922 2022. Multiorgan and Vascular Tropism of SARS-CoV-2.
35337019 2022. A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.
35215921 2022. Carbohydrate Ligands for COVID-19 Spike Proteins.
35215915 2022. Secondary Structure of Subgenomic RNA M of SARS-CoV-2.
35215969 2022. Unlike Chloroquine, Mefloquine Inhibits SARS-CoV-2 Infection in Physiologically Relevant Cells.
35632654 2022. Associations and Disease-Disease Interactions of COVID-19 with Congenital and Genetic Disorders: A Comprehensive Review.
34696353 2021. SARS-CoV-2 Subgenomic RNAs: Characterization, Utility, and Perspectives.
34578338 2021. Enrichment of SARS-CoV-2 Entry Factors and Interacting Intracellular Genes in Tissue and Circulating Immune Cells.
34834944 2021. Abnormal Blood Coagulation and Kidney Damage in Aged Hamsters Infected with Severe Acute Respiratory Syndrome Coronavirus 2.
34835019 2021. Single-Cell RNAseq Profiling of Human gammadelta T Lymphocytes in Virus-Related Cancers and COVID-19 Disease.
34835015 2021. SARS-CoV-2 Spike Protein S1-Mediated Endothelial Injury and Pro-Inflammatory State Is Amplified by Dihydrotestosterone and Prevented by Mineralocorticoid Antagonism.
34960648 2021. JAK-STAT Pathway: A Novel Target to Tackle Viral Infections.
34835064 2021. CRISPR Screening: Molecular Tools for Studying Virus-Host Interactions.
34205098 2021. The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner.
34202098 2021. How Do Enveloped Viruses Exploit the Secretory Proprotein Convertases to Regulate Infectivity and Spread?
34200959 2021. Discovery of Antivirals Using Phage Display.
34452305 2021. SARS-CoV-2 N Protein Targets TRIM25-Mediated RIG-I Activation to Suppress Innate Immunity.
33435561 2021. Transcriptomic Analysis of Respiratory Tissue and Cell Line Models to Examine Glycosylation Machinery during SARS-CoV-2 Infection.
33668405 2021. Comparative Transcriptome Profiling of Human and Pig Intestinal Epithelial Cells after Porcine Deltacoronavirus Infection.
34960725 2021. Plasma Proteome Fingerprints Reveal Distinctiveness and Clinical Outcome of SARS-CoV-2 Infection.
34960822 2021. Microarray-Based Detection of Antibodies against SARS-CoV-2 Proteins, Common Respiratory Viruses and Type I Interferons.
34960687 2021. Single-Cell and Bulk RNASeq Profiling of COVID-19 Patients Reveal Immune and Inflammatory Mechanisms of Infection-Induced Organ Damage.
34960772 2021. Adenovirus Biology, Recombinant Adenovirus, and Adenovirus Usage in Gene Therapy.
34960752 2021. Antibody-Dependent Enhancement of SARS-CoV-2 Infection of Human Immune Cells: In Vitro Assessment Provides Insight in COVID-19 Pathogenesis.
34452405 2021. Multi-Tissue Transcriptomic-Informed In Silico Investigation of Drugs for the Treatment of Dengue Fever Disease.
34452458 2021. Detection of SARS-CoV-2 Derived Small RNAs and Changes in Circulating Small RNAs Associated with COVID-19.
32218151 2020. Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of Viral Proteins.
32512929 2020. The Prediction of miRNAs in SARS-CoV-2 Genomes: hsa-miR Databases Identify 7 Key miRs Linked to Host Responses and Virus Pathogenicity-Related KEGG Pathways Significant for Comorbidities.
32698440 2020. Tiotropium is Predicted to be a Promising Drug for COVID-19 Through Transcriptome-Based Comprehensive Molecular Pathway Analysis.
33291220 2020. The International Virus Bioinformatics Meeting 2020.
33322045 2020. Novel Broad-Spectrum Antiviral Inhibitors Targeting Host Factors Essential for Replication of Pathogenic RNA Viruses.
31744152 2019. A Multi-Omics Study of Chicken Infected by Nephropathogenic Infectious Bronchitis Virus.
33997298 2021. -------A type I IFN, prothrombotic hyperinflammatory neutrophil signature is distinct for COVID-19 ARDS--.
33501381 2020. Fostering global data sharing: highlighting the recommendations of the Research Data Alliance COVID-19 working group.
33313418 2020. Integrative vectors for regulated expression of SARS-CoV-2 proteins implicated in RNA metabolism.
35343064 2022. RNA-protein interactomes as invaluable resources to study RNA viruses: Insights from SARS CoV-2 studies.
32638509 2020. The interface between coronaviruses and host cell RNA biology: Novel potential insights for future therapeutic intervention.
34326952 2021. Immunometabolic bases of type 2 diabetes in the severity of COVID-19.
34168400 2021. Interplay between nuclear factor erythroid 2-related factor 2 and inflammatory mediators in COVID-19-related liver injury.
32975064 2020. Quantitative Proteomic Analysis of the Expression of SARS-CoV-2 Receptors in the Gut of Patients with Chronic Enterocolitis.
35657140 2022. Screening the hub genes and analyzing the mechanisms in discharged COVID-19 patients retesting positive through bioinformatics analysis.
35133846 2022. Metabolic Snapshot of Plasma Samples Reveals New Pathways Implicated in SARS-CoV-2 Pathogenesis.
33605735 2021. Open Science Resources for the Mass Spectrometry-Based Analysis of SARS-CoV-2.
34672606 2021. Advances and Utility of the Human Plasma Proteome.
32794723 2020. Biological Rationale for the Repurposing of BCG Vaccine against SARS-CoV-2.
33141192 2020. Newly Discovered Cellular Pathway Blocks Ebola, COVID-19 Viruses.
33393161 2022. Recent advancements in glycoproteomic studies: Glycopeptide enrichment and derivatization, characterization of glycosylation in SARS CoV2, and interacting glycoproteins.
34287999 2022. Structural insights into the distinctive RNA recognition and therapeutic potentials of RIG-I-like receptors.
35622336 2022. Single-Cell Analysis and Tracking of Antigen-Specific T Cells: Integrating Paired Chain AIRR-Seq and Transcriptome Sequencing: A Method by the AIRR Community.
35554915 2022. Antiviral Strategies Against SARS-CoV-2: A Systems Biology Approach.
35554907 2022. Profiling SARS-CoV-2 Infection by High-Throughput Shotgun Proteomics.
34902130 2022. Scenarios for the Integration of Microarray Gene Expression Profiles in COVID-19-Related Studies.
32833216 2020. Ribopuromycylation in Coronavirus-Infected Cells.
32833213 2020. Proximity Labeling for the Identification of Coronavirus-Host Protein Interactions.
34571150 2022. Transcriptome analysis of host response to porcine epidemic diarrhea virus nsp15 in IPEC-J2 cells.
33691178 2021. First description of natural concomitant infection of avian nephritis virus and infectious bronchitis virus reveals exacerbated inflammatory response and renal damage in broiler chicks.
34132373 2021. SARSCoV2 spike proteininduced host inflammatory response signature in human corneal epithelial cells.
35284913 2022. Th1, Th2 and Th17 inflammatory pathways synergistically predict cardiometabolic protein expression in serum of COVID-19 patients.
33683246 2021. A novel multi-omics-based highly accurate prediction of symptoms, comorbid conditions, and possible long-term complications of COVID-19.
32199615 2020. Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses.
35235083 2022. Identification of the Hub Genes and the Signaling Pathways in Human iPSC-Cardiomyocytes Infected by SARS-CoV-2.
34787756 2022. Identification of Key Pathways and Genes in SARS-CoV-2 Infecting Human Intestines by Bioinformatics Analysis.
33367597 2021. Structure and regulation of coronavirus genomes: state-of-the-art and novel insights from SARS-CoV-2 studies.
33040727 2020. Transcription Factor Nrf2 as a Potential Therapeutic Target for Prevention of Cytokine Storm in COVID-19 Patients.
34920080 2022. The spike protein of SARS-CoV-2 induces heme oxygenase-1: Pathophysiologic implications.
32544429 2020. Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach.
34237472 2021. In silico analysis of the aggregation propensity of the SARS-CoV-2 proteome: Insight into possible cellular pathologies.
33478554 2021. Mechanistic modeling of the SARS-CoV-2 disease map.
34220199 2021. Structure and Function of Major SARS-CoV-2 and SARS-CoV Proteins.
34014278 2021. 3DBionotes COVID-19 Edition.
33693506 2021. COVID-19: disease pathways and gene expression changes predict methylprednisolone can improve outcome in severe cases.
33017003 2021. VIRTUS: a pipeline for comprehensive virus analysis from conventional RNA-seq data.
34289024 2021. SPOT: a web-tool enabling swift profiling of transcriptomes.
32805023 2021. Mechanistic insights into SARS-CoV-2 epidemic via revealing the features of SARS-CoV-2 coding proteins and host responses upon its infection.
33244583 2021. Novel SARS-CoV-2 encoded small RNAs in the passage to humans.
32374823 2020. COVID-2019-associated overexpressed Prevotella proteins mediated host-pathogen interactions and their role in coronavirus outbreak.
33618659 2021. Effects of Cell Proteostasis Network on the Survival of SARS-CoV-2.
32754004 2020. Expansion of Single Cell Transcriptomics Data of SARS-CoV Infection in Human Bronchial Epithelial Cells to COVID-19.
35205046 2022. Viral and Host Genetic and Epigenetic Biomarkers Related to SARS-CoV-2 Cell Entry, Infection Rate, and Disease Severity.
34801852 2022. Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets.
33655247 2021. A single-cell and spatial atlas of autopsy tissues reveals pathology and cellular targets of SARS-CoV-2.
32587961 2021. Transcriptogram analysis reveals relationship between viral titer and gene sets responses during Corona-virus infection.
33655243 2021. The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.
33655248 2021. An Autoantigen Profile of Human A549 Lung Cells Reveals Viral and Host Etiologic Molecular Attributes of Autoimmunity in COVID-19.
33619490 2021. Association of CXCR6 with COVID-19 severity: Delineating the host genetic factors in transcriptomic regulation.
33619478 2021. The Host Interactome of Spike Expands the Tropism of SARS-CoV-2.
33594364 2021. Bifurcated monocyte states are predictive of mortality in severe COVID-19.
33594362 2021. Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19.
34845446 2021. Systematic temporal analysis of peripheral blood transcriptomes using TrendCatcher identifies early and persistent neutrophil activation as a hallmark of severe COVID-19.
34845452 2021. Genome-wide characterization of SARS-CoV-2 cytopathogenic proteins in the search of antiviral targets.
34931188 2021. SARS-CoV-2 Spike triggers barrier dysfunction and vascular leak via integrins and TGF-beta signaling.
34075382 2021. CovidExpress: an interactive portal for intuitive investigation on SARS-CoV-2 related transcriptomes.
34373855 2021. A Master Autoantigen-ome Links Alternative Splicing, Female Predilection, and COVID-19 to Autoimmune Diseases.
34462747 2021. Woodsmoke particulates alter expression of antiviral host response genes in human nasal epithelial cells infected with SARS-CoV-2 in a sex-dependent manner.
33532779 2021. Genome-scale metabolic modeling reveals SARS-CoV-2-induced metabolic changes and antiviral targets.
34075380 2021. Longitudinal immune dynamics of mild COVID-19 define signatures of recovery and persistence.
33851168 2021. An Autoantigen-ome from HS-Sultan B-Lymphoblasts Offers a Molecular Map for Investigating Autoimmune Sequelae of COVID-19.
33907748 2021. Rapid decay of host basal mRNAs during SARS-CoV-2 infection perturbs host antiviral mRNA biogenesis and export.
32676599 2020. Role of SARS-CoV-2 in altering the RNA binding protein and miRNA directed post-transcriptional regulatory networks in humans.
32908980 2020. Induction of a regulatory myeloid program in bacterial sepsis and severe COVID-19.
32935098 2020. Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors.
32511361 2020. The Host Cell ViroCheckpoint: Identification and Pharmacologic Targeting of Novel Mechanistic Determinants of Coronavirus-Mediated Hijacked Cell States.
35317263 2022. Using bioinformatics and systems biology to discover common pathogenetic processes between sarcoidosis and COVID-19.
34131597 2021. A bioinformatics approach for identifying potential molecular mechanisms and key genes involved in COVID-19 associated cardiac remodeling.
33398248 2021. Computationally predicted SARS-COV-2 encoded microRNAs target NFKB, JAK/STAT and TGFB signaling pathways.
33263093 2021. Gene expression profiling of corona virus microarray datasets to identify crucial targets in COVID-19 patients.
33821222 2021. An overview of basic molecular biology of SARS-CoV-2 and current COVID-19 prevention strategies.
34401607 2021. Systems level insights into the impact of airborne exposure on SARS-CoV-2 pathogenesis and COVID-19 outcome - A multi-omics big data study.
32835133 2020. Phylogenomic proximity and comparative proteomic analysis of SARS-CoV-2.
33553808 2020. Bioinformatics analyses of significant genes, related pathways, and candidate diagnostic biomarkers and molecular targets in SARS-CoV-2/COVID-19.
33093657 2021. Self-amplifying RNA vaccines for infectious diseases.
35328087 2022. Identification of Genetic Risk Factors of Severe COVID-19 Using Extensive Phenotypic Data: A Proof-of-Concept Study in a Cohort of Russian Patients.
35205390 2022. Conserved MicroRNAs in Human Nasopharynx Tissue Samples from Swabs Are Differentially Expressed in Response to SARS-CoV-2.
33809949 2021. A Resource for the Network Representation of Cell Perturbations Caused by SARS-CoV-2 Infection.
34209818 2021. Toward a Coronavirus Knowledge Graph.
34202032 2021. Direct Measurement of B Lymphocyte Gene Expression Biomarkers in Peripheral Blood Transcriptomics Enables Early Prediction of Vaccine Seroconversion.
34440372 2021. Methylation of Host Genes Associated with Coronavirus Infection from Birth to 26 Years.
33034007 2020. Combining fragment docking with graph theory to improve ligand docking for homology model structures.
34940501 2021. Developmental Aspects of SARS-CoV-2, Potential Role of Exosomes and Their Impact on the Human Transcriptome.
34669152 2022. Deciphering the link between Diabetes mellitus and SARS-CoV-2 infection through differential targeting of microRNAs in the human pancreas.
34297037 2021. Epigenetic and transcriptional control of interferon-beta.
34128960 2021. Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics.
34128959 2021. Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19.
34188786 2021. Extracellular vesicles carry SARS-CoV-2 spike protein and serve as decoys for neutralizing antibodies.
34193364 2022. Innate immune response analysis in COVID-19 and kawasaki disease reveals MIS-C predictors.
35205926 2022. Molecular Profiling Reveals Characteristic and Decisive Signatures in Patients after Allogeneic Stem Cell Transplantation Suffering from Invasive Pulmonary Aspergillosis.
35664804 2022. The Ramp Atlas: facilitating tissue and cell-specific ramp sequence analyses through an intuitive web interface.
35664994 2022. Whole Genome DNA and RNA Sequencing of Whole Blood Elucidates the Genetic Architecture of Gene Expression Underlying a Wide Range of Diseases.
35654986 2022. The impact of the suppression of highly connected protein interactions on the corona virus infection.
34448623 2021. A Novel Pathway Network Analytics Method Based on Graph Theory.
35060145 2022. Epigenetic modifications associated with genes implicated in cytokine storm: The potential biotherapeutic effects of vitamins and minerals in COVID-19.
32643596 2020. A review on histotechnology practices in COVID-19 pathology investigations.
34819389 2022. ORAI1 Limits SARS-CoV-2 Infection by Regulating Tonic Type I IFN Signaling.
34452933 2021. Suppressive Monocytes Impair MAIT Cells Response via IL-10 in Patients with Severe COVID-19.
35639922 2022. A distinct dexamethasone-dependent gene expression profile in the lungs of COVID-19 patients.
34558746 2021. Dynamic changes in human single-cell transcriptional signatures during fatal sepsis.
34931002 2022. Single-cell immunology of SARS-CoV-2 infection.
32591762 2020. COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis.
35410380 2022. Understanding COVID-19 through genome-wide association studies.
35410379 2022. Expanded COVID-19 phenotype definitions reveal distinct patterns of genetic association and protective effects.
33888907 2021. Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.
35301508 2022. Type I interferon transcriptional network regulates expression of coinhibitory receptors in human T cells.
34663977 2021. Altered ISGylation drives aberrant macrophage-dependent immune responses during SARS-CoV-2 infection.
34155406 2021. SARS-CoV-2-specific hotspots in virus-host interaction networks.
33277638 2021. Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison.
32788748 2020. Single-cell landscape of immunological responses in patients with COVID-19.
35177862 2022. Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19.
33654293 2021. Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics.
33837377 2021. Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19.
32812012 2020. Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection.
34158670 2021. A multi-omics investigation of the composition and function of extracellular vesicles along the temporal trajectory of COVID-19.
34471255 2021. Cellular host factors for SARS-CoV-2 infection.
35354968 2022. SARS-CoV-2 pathogenesis.
35255492 2022. Whole-genome sequencing reveals host factors underlying critical COVID-19.
33307546 2021. Genetic mechanisms of critical illness in COVID-19.
33979833 2021. SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis.
33845483 2021. Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.
32998156 2020. The major genetic risk factor for severe COVID-19 is inherited from Neanderthals.
32272481 2020. Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors.
32408336 2020. Proteomics of SARS-CoV-2-infected host cells reveals therapy targets.
35005991 2022. Mass Spectrometry-Based Proteomics Research to Fight COVID-19: An Expert Review on Hopes and Challenges.
34678084 2021. Top Trends in Multiomics Research: Evaluation of 52 Published Studies and New Ways of Thinking Terminology and Visual Displays.
34601771 2022. PDB-101: Educational resources supporting molecular explorations through biology and medicine.
32960510 2020. Urinary Proteomics Associates with COVID-19 Severity: Pilot Proof-of-Principle Data and Design of a Multicentric Diagnostic Study.
33141520 2020. Proteomic Biomarkers to Guide Stratification for Covid-19 Treatment: Exemplifying a Path Forward Toward Implementation?
35490333 2022. Clinical applications of plasma proteomics and peptidomics: Towards precision medicine.
32720461 2020. An overview of the immune mechanisms of viral myocarditis.
34995097 2022. Innate immunological pathways in COVID-19 pathogenesis.
35148199 2022. SLAMF7 engagement superactivates macrophages in acute and chronic inflammation.
35412852 2022. SARS-CoV-2 spike protein-induced cell fusion activates the cGAS-STING pathway and the interferon response.
34698500 2022. Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort.
35052382 2021. Detection of A-to-I RNA Editing in SARS-COV-2.
33916492 2021. Genotyping of the Major SARS-CoV-2 Clade by Short-Amplicon High-Resolution Melting (SA-HRM) Analysis.
33923155 2021. Investigating Cellular Trajectories in the Severity of COVID-19 and Their Transcriptional Programs Using Machine Learning Approaches.
33207533 2020. Computational Analysis of Targeting SARS-CoV-2, Viral Entry Proteins ACE2 and TMPRSS2, and Interferon Genes by Host MicroRNAs.
32646047 2020. Protein Coding and Long Noncoding RNA (lncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response.
33271804 2020. Transcriptional Differences for COVID-19 Disease Map Genes between Males and Females Indicate a Different Basal Immunophenotype Relevant to the Disease.
34168039 2021. Targeting the m(6)A RNA modification pathway blocks SARS-CoV-2 and HCoV-OC43 replication.
33521209 2022. Immune characteristics analysis reveals two key inflammatory factors correlated to the expressions of SARS-CoV-2 S1-specific antibodies.
34565757 2021. AI for the collective analysis of a massive number of genome sequences: various examples from the small genome of pandemic SARS-CoV-2 to the human genome.
33011745 2020. Predicting the response of the dental pulp to SARS-CoV2 infection: a transcriptome-wide effect cross-analysis.
34159627 2021. Genome-wide association analysis of COVID-19 mortality risk in SARS-CoV-2 genomes identifies mutation in the SARS-CoV-2 spike protein that colocalizes with P.1 of the Brazilian strain.
34183789 2021. An integrative multiomics analysis identifies putative causal genes for COVID-19 severity.
34436507 2021. Human-SARS-CoV-2 interactome and human genetic diversity: TMPRSS2-rs2070788, associated with severe influenza, and its population genetics caveats in Native Americans.
33237152 2020. Molecular mechanisms and pharmacological interventions in the replication cycle of human coronaviruses.
35002537 2021. Identification of Differentially Expressed Genes in COVID-19 and Integrated Bioinformatics Analysis of Signaling Pathways.
33395363 2021. Epigenetic mechanisms influencing COVID-19.
33197212 2021. The treatment of SARS-CoV2 with antivirals and mitigation of the cytokine storm syndrome: the role of gene expression.
33086021 2021. Epigenetic regulation of ACE2, the receptor of the SARS-CoV-2 virus(1).
35073995 2022. IDEAS: individual level differential expression analysis for single-cell RNA-seq data.
34844647 2021. treekoR: identifying cellular-to-phenotype associations by elucidating hierarchical relationships in high-dimensional cytometry data.
33413539 2021. HiDeF: identifying persistent structures in multiscale 'omics data.
34694399 2021. ADAR Editing in Viruses: An Evolutionary Force to Reckon with.
33713114 2021. The Missing Expression Level-Evolutionary Rate Anticorrelation in Viruses Does Not Support Protein Function as a Main Constraint on Sequence Evolution.
35501841 2022. Single-cell transcriptomics reveal a unique memory-like NK cell subset that accumulates with ageing and correlates with disease severity in COVID-19.
35610660 2022. Transcriptomic perspectives of memory-like NK cells and aging.
35184750 2022. Systematic comparison of published host gene expression signatures for bacterial/viral discrimination.
35172892 2022. Integrating single-cell sequencing data with GWAS summary statistics reveals CD16+monocytes and memory CD8+T cells involved in severe COVID-19.
34001247 2021. An atlas connecting shared genetic architecture of human diseases and molecular phenotypes provides insight into COVID-19 susceptibility.
34281603 2021. Single-nucleus transcriptome analysis of human brain immune response in patients with severe COVID-19.
33441124 2021. Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients.
33883027 2021. Genetic and non-genetic factors affecting the expression of COVID-19-relevant genes in the large airway epithelium.
33879239 2021. IFN-gamma and TNF-alpha drive a CXCL10+ CCL2+ macrophage phenotype expanded in severe COVID-19 lungs and inflammatory diseases with tissue inflammation.
32723359 2020. Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein.
33256807 2020. Pervasive generation of non-canonical subgenomic RNAs by SARS-CoV-2.
35332098 2022. Global mapping of RNA homodimers in living cells.
35064006 2022. Plasma cell-free RNA characteristics in COVID-19 patients.
33722935 2021. Subgenomic RNA identification in SARS-CoV-2 genomic sequencing data.
35074468 2022. Betacoronavirus-specific alternate splicing.
33691144 2021. Single-cell RNA sequencing reveals the sustained immune cell dysfunction in the pathogenesis of sepsis secondary to bacterial pneumonia.
33482326 2021. Transcriptome network analyses in human coronavirus infections suggest a rational use of immunomodulatory drugs for COVID-19 therapy.
32920121 2020. SARS-CoV-2 transcriptome analysis and molecular cataloguing of immunodominant epitopes for multi-epitope based vaccine design.
32771622 2020. Global multi-omics and systems pharmacological strategy unravel the multi-targeted therapeutic potential of natural bioactive molecules against COVID-19: An in silico approach.
35033679 2022. Genomic perspectives on the emerging SARS-CoV-2 omicron variant.
34774773 2021. Integrative Multi-omics Landscape of Non-structural Protein 3 of Severe Acute Respiratory Syndrome Coronaviruses.
34748989 2021. COVID-ONE-hi: The One-stop Database for COVID-19-specific Humoral Immunity and Clinical Parameters.
34560321 2021. Gut Microbiome Alterations in COVID-19.
33418085 2020. MicroPhenoDB Associates Metagenomic Data with Pathogenic Microbes, Microbial Core Genes, and Human Disease Phenotypes.
32739507 2020. From Mutation Signature to Molecular Mechanism in the RNA World: A Case of SARS-CoV-2.
35639883 2022. Analysis of SARS-CoV-2 known and novel subgenomic mRNAs in cell culture, animal model, and clinical samples using LeTRS, a bioinformatic tool to identify unique sequence identifiers.
34430958 2021. Concise Update on Genomics of COVID-19: Approach to Its latest Mutations, Escalated Contagiousness, and Vaccine Resistance.
33174592 2021. Composition of the immunoglobulin G glycome associates with the severity of COVID-19.
33135055 2021. Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2.
35091890 2022. Antibody glycosylation in COVID-19.
32504168 2020. Impact of glycoscience in fighting Covid-19.
35574937 2022. A high-risk gut microbiota configuration associates with fatal hyperinflammatory immune and metabolic responses to SARS-CoV-2.
34965194 2022. Alteration of the gut microbiota following SARS-CoV-2 infection correlates with disease severity in hamsters.
34632957 2021. Colonic expression of Ace2, the SARS-CoV-2 entry receptor, is suppressed by commensal human microbiota.
33685349 2021. SARS-CoV-2 infection in nonhuman primates alters the composition and functional activity of the gut microbiota.
33678150 2021. Integrated gut virome and bacteriome dynamics in COVID-19 patients.
34863291 2021. Gut microbiota imbalance in colorectal cancer patients, the risk factor of COVID-19 mortality.
35284643 2022. An experimental in silico study on COVID-19: Response of neutrophil-related genes to antibiotics.
35399374 2022. Unique peptide signatures of SARS-ComicronV-2 virus against human proteome reveal variants' immune escape and infectiveness.
34746476 2021. Metabologenomics approach to the discovery of novel compounds from Streptomyces sp. GMR22 as anti-SARS-CoV-2 drugs.
33898797 2021. Identification of PBMC-based molecular signature associational with COVID-19 disease severity.
33688586 2021. In silico analysis of altered expression of long non-coding RNA in SARS-CoV-2 infected cells and their possible regulation by STAT1, STAT3 and interferon regulatory factors.
34179538 2021. Computational search of hybrid human/SARS-CoV-2 dsRNA reveals unique viral sequences that diverge from those of other coronavirus strains.
34075347 2021. SARS-CoV-2 infection paralyzes cytotoxic and metabolic functions of the immune cells.
33392409 2021. Atlas of ACE2 gene expression reveals novel insights into transmission of SARS-CoV-2.
34458641 2021. Host gene variability and SARS-CoV-2 infection: A review article.
32984567 2020. A SARS-CoV-2 host infection model network based on genomic human Transcription Factors (TFs) depletion.
33364494 2020. Bioinformatic evaluation of the potential animal models for studying SARS-Cov-2.
33289002 2020. Enhancement of the IFN-beta-induced host signature informs repurposed drugs for COVID-19.
33883951 2021. Binding of the SARS-CoV-2 Spike Protein to the Asialoglycoprotein Receptor on Human Primary Hepatocytes and Immortalized Hepatocyte-Like Cells by Confocal Analysis.
33397514 2021. Mediators of SARS-CoV-2 entry are preferentially enriched in cardiomyocytes.
32475052 2020. Binding affinities of 438 HLA proteins to complete proteomes of seven pandemic viruses and distributions of strongest and weakest HLA peptide binders in populations worldwide.
34889978 2022. Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity.
34155559 2021. Association of CXCR6 with COVID-19 severity: delineating the host genetic factors in transcriptomic regulation.
33604698 2021. Multi-omics highlights ABO plasma protein as a causal risk factor for COVID-19.
34967936 2021. Embeddings from protein language models predict conservation and variant effects.
33726831 2021. Exploration and validation of related hub gene expression during SARS-CoV-2 infection of human bronchial organoids.
33390179 2021. Alu retrotransposons and COVID-19 susceptibility and morbidity.
33008459 2020. Practicing precision medicine with intelligently integrative clinical and multi-omics data analysis.
33949668 2021. Integrative genomics analysis reveals a 21q22.11 locus contributing risk to COVID-19.
33577681 2021. Integration of genetically regulated gene expression and pharmacological library provides therapeutic drug candidates.
34329437 2021. Single-cell RNA sequencing of SARS-CoV-2 cell entry factors in the preconceptional human endometrium.
33469197 2021. Maternal endothelial dysfunction in HIV-associated preeclampsia comorbid with COVID-19: a review.
34786557 2020. Plasmin Cascade Mediates Thrombotic Events in SARS-CoV-2 Infection via Complement and Platelet-Activating Systems.
34350693 2021. Comprehensive investigation of RNA-sequencing dataset reveals the hub genes and molecular mechanisms of coronavirus disease 2019 acute respiratory distress syndrome.
34289534 2021. High-resolution HLA genotyping identifies alleles associated with severe COVID-19: A preliminary study from India.
33124193 2020. Transcriptomic analysis reveals novel mechanisms of SARS-CoV-2 infection in human lung cells.
33728103 2021. Single Cell Transcriptomic Re-analysis of Immune Cells in Bronchoalveolar Lavage Fluids Reveals the Correlation of B Cell Characteristics and Disease Severity of Patients with SARS-CoV-2 Infection.
35151371 2022. Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVID-19 respiratory disease.
35139355 2022. Interferon-gamma primes macrophages for pathogen ligand-induced killing via a caspase-8 and mitochondrial cell death pathway.
34592166 2021. Early IFN-alpha signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19.
33891889 2021. Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children.
33577760 2021. Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity.
34051148 2021. Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease.
34048708 2021. SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2.
34022127 2021. Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets.
33382973 2021. Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid.
33765436 2021. Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19.
33765435 2021. Multi-cohort analysis of host immune response identifies conserved protective and detrimental modules associated with severity across viruses.
32783921 2020. Single-Cell Sequencing of Peripheral Mononuclear Cells Reveals Distinct Immune Response Landscapes of COVID-19 and Influenza Patients.
33128875 2020. Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19.
33296687 2020. Longitudinal Multi-omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19.
33232865 2021. SARS-CoV-2 attachment to host cells is possibly mediated via RGD-integrin interaction in a calcium-dependent manner and suggests pulmonary EDTA chelation therapy as a novel treatment for COVID 19.
35303126 2022. Identification of G-quadruplex DNA sequences in SARS-CoV2.
35434695 2022. Association of pyroptosis and severeness of COVID-19 as revealed by integrated single-cell transcriptome data analysis.
34228987 2021. SARS-CoV-2 Spike protein enhances ACE2 expression via facilitating Interferon effects in bronchial epithelium.
32946016 2020. Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine.
32503824 2020. Endoplasmic Reticulum Stress Markers in SARS-COV-2 Infection and Pneumonia: Case-Control Study.
32773420 2020. Transcriptome & viral growth analysis of SARS-CoV-2-infected Vero CCL-81 cells.
35216673 2022. A blood atlas of COVID-19 defines hallmarks of disease severity and specificity.
35032429 2022. Complement activation induces excessive T cell cytotoxicity in severe COVID-19.
34492226 2021. The interferon landscape along the respiratory tract impacts the severity of COVID-19.
34767776 2021. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas.
33836156 2021. TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation.
34062119 2021. Integrated analysis of multimodal single-cell data.
33382968 2021. Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks.
33333024 2021. Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses.
33147445 2021. Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells.
33147444 2021. Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection.
33503446 2021. Multi-organ proteomic landscape of COVID-19 autopsies.
34914922 2021. SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis.
33743211 2021. Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions.
33811809 2021. BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection.
33691138 2021. A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence.
33743212 2021. COVID-19 and the human innate immune system.
33713619 2021. Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19.
33657410 2021. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas.
32810438 2020. Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment.
33096020 2020. Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4(+) T Cells in COVID-19.
33080218 2020. SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses.
32330414 2020. The Architecture of SARS-CoV-2 Transcriptome.
32479746 2020. Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients.
32492406 2020. Proteomic and Metabolomic Characterization of COVID-19 Patient Sera.
33171100 2020. Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19.
32645325 2020. The Global Phosphorylation Landscape of SARS-CoV-2 Infection.
32643603 2020. Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment.
35139909 2022. Transcriptional landscape of circulating platelets from patients with COVID-19 reveals key subnetworks and regulators underlying SARS-CoV-2 infection: implications for immunothrombosis.
34496960 2021. Inferring SARS-CoV-2 functional genomics from viral transcriptome with identification of potential antiviral drugs and therapeutic targets.
34294141 2021. Genome-wide analysis of protein-protein interactions and involvement of viral proteins in SARS-CoV-2 replication.
34281608 2021. SARS-CoV-2: from its discovery to genome structure, transcription, and replication.
34672954 2022. An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.
34518653 2022. Fatal cytokine release syndrome by an aberrant FLIP/STAT3 axis.
33037393 2020. An aberrant STAT pathway is central to COVID-19.
35568706 2022. Sex differences in global metabolomic profiles of COVID-19 patients.
35288537 2022. Plasma proteomic and metabolomic characterization of COVID-19 survivors 6 months after discharge.
34716309 2021. Multi-omic approach identifies a transcriptional network coupling innate immune response to proliferation in the blood of COVID-19 cancer patients.
34035220 2021. Proteomics of extracellular vesicles in plasma reveals the characteristics and residual traces of COVID-19 patients without underlying diseases after 3 months of recovery.
33707411 2021. Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers.
34301919 2021. RBM15-mediated N6-methyladenosine modification affects COVID-19 severity by regulating the expression of multitarget genes.
34385425 2021. Looking for pathways related to COVID-19: confirmation of pathogenic mechanisms by SARS-CoV-2-host interactome.
33293527 2020. A cross-talk between epithelium and endothelium mediates human alveolar-capillary injury during SARS-CoV-2 infection.
35314694 2022. Genetic alteration of human MYH6 is mimicked by SARS-CoV-2 polyprotein: mapping viral variants of cardiac interest.
34006825 2021. Type-I interferon signatures in SARS-CoV-2 infected Huh7 cells.
33293514 2020. A blood transcriptome-based analysis of disease progression, immune regulation, and symptoms in coronavirus-infected patients.
33024578 2020. Benchmarking evolutionary tinkering underlying human-viral molecular mimicry shows multiple host pulmonary-arterial peptides mimicked by SARS-CoV-2.
35581179 2022. Proteomic characterization of Omicron SARS-CoV-2 host response.
34702802 2021. SARS-CoV-2 exploits host DGAT and ADRP for efficient replication.
34697287 2021. Comprehensive investigations revealed consistent pathophysiological alterations after vaccination with COVID-19 vaccines.
34103487 2021. Integrating longitudinal clinical laboratory tests with targeted proteomic and transcriptomic analyses reveal the landscape of host responses in COVID-19.
34465742 2021. Genome-wide association study of COVID-19 severity among the Chinese population.
32377375 2020. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing.
32194980 2020. Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2.
33357464 2021. Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors.
32407669 2020. Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients.
33359760 2021. Effects of vitamin D on macrophages and myeloid-derived suppressor cells (MDSCs) hyperinflammatory response in the lungs of COVID-19 patients.
32610096 2020. Omics-Driven Systems Interrogation of Metabolic Dysregulation in COVID-19 Pathogenesis.
32810597 2021. Identification of Transcription Factors Regulating SARS-CoV-2 Entry Genes in the Intestine.
34845370 2022. SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy.
34471261 2021. Multiomics: unraveling the panoramic landscapes of SARS-CoV-2 infection.
33318629 2021. Pathological and molecular examinations of postmortem testis biopsies reveal SARS-CoV-2 infection in the testis and spermatogenesis damage in COVID-19 patients.
32728199 2020. SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70.
35079870 2022. Citrullination in the pathology of inflammatory and autoimmune disorders: recent advances and future perspectives.
35039944 2022. Competing endogenous RNA network mediated by circ_3205 in SARS-CoV-2 infected cells.
32712910 2021. Understanding COVID-19 via comparative analysis of dark proteomes of SARS-CoV-2, human SARS and bat SARS-like coronaviruses.
34117968 2022. Mitochondrial DNA Heteroplasmy as an Informational Reservoir Dynamically Linked to Metabolic and Immunological Processes Associated with COVID-19 Neurological Disorders.
33751722 2021. Bioinformatic analyses hinted at augmented T helper 17 cell differentiation and cytokine response as the central mechanism of COVID-19-associated Guillain-Barre syndrome.
33211371 2021. Direct inhibitory effect on viral entry of influenza A and SARS-CoV-2 viruses by azithromycin.
34804904 2021. Role of COVID 19 Inflammatory Markers in Rhino-Orbito-Cerebral Mucormycosis: A Case Study in Predisposed Patients at a Designated Nodal Centre.
32345362 2020. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues.
34954105 2022. A new insight into sex-specific non-coding RNAs and networks in response to SARS-CoV-2.
34147651 2021. Global variation in SARS-CoV-2 proteome and its implication in pre-lockdown emergence and dissemination of 5 dominant SARS-CoV-2 clades.
34004362 2021. Analyzing host-viral interactome of SARS-CoV-2 for identifying vulnerable host proteins during COVID-19 pathogenesis.
34004360 2021. Differential host circRNA expression profiles in human lung epithelial cells infected with SARS-CoV-2.
33812037 2021. The role of microRNAs in modulating SARS-CoV-2 infection in human cells: a systematic review.
33848683 2021. Systematizing the genomic order and relatedness in the open reading frames (ORFs) of the coronaviruses.
33819681 2021. Immunogenicity and antigenicity based T-cell and B-cell epitopes identification from conserved regions of 10664 SARS-CoV-2 genomes.
33422682 2021. Identification of SARS-CoV-2 CTL epitopes for development of a multivalent subunit vaccine for COVID-19.
32473977 2020. Unfolding SARS-CoV-2 viral genome to understand its gene expression regulation.
32473352 2020. Understanding the B and T cell epitopes of spike protein of severe acute respiratory syndrome coronavirus-2: A computational way to predict the immunogens.
32712315 2020. Decoding the proteome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for cell-penetrating peptides involved in pathogenesis or applicable as drug delivery vectors.
32707288 2020. Deciphering the co-adaptation of codon usage between respiratory coronaviruses and their human host uncovers candidate therapeutics for COVID-19.
32615317 2020. Gene signatures of SARS-CoV/SARS-CoV-2-infected ferret lungs in short- and long-term models.
32526370 2020. What is the potential function of microRNAs as biomarkers and therapeutic targets in COVID-19?
33132111 2020. Overlapping host pathways between SARS-CoV-2 and its potential copathogens: An in silico analysis.
33130005 2020. A connectivity map-based drug repurposing study and integrative analysis of transcriptomic profiling of SARS-CoV-2 infection.
34841243 2021. Genetic epidemiology using whole genome sequencing and haplotype networks revealed the linkage of SARS-CoV-2 infection in nosocomial outbreak.
33014208 2020. How COVID-19 induces cytokine storm with high mortality.
33159646 2021. The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients.
34981034 2022. Systems Biology and Bioinformatics approach to Identify blood based signatures molecules and drug targets of patient with COVID-19.
33846694 2021. Computational prediction of potential siRNA and human miRNA sequences to silence orf1ab associated genes for future therapeutics against SARS-CoV-2.
33072849 2020. Understand variability of COVID-19 through population and tissue variations in expression of SARS-CoV-2 host genes.
32835074 2020. Identification and classification of differentially expressed genes reveal potential molecular signature associated with SARS-CoV-2 infection in lung adenocarcinomal cells.
34482267 2021. Prediction and analysis of microRNAs involved in COVID-19 inflammatory processes associated with the NF-kB and JAK/STAT signaling pathways.
33836368 2021. Identification of COVID-19 subtypes based on immunogenomic profiling.
34653729 2021. In vitro induction of interleukin-8 by SARS-CoV-2 Spike protein is inhibited in bronchial epithelial IB3-1 cells by a miR-93-5p agomiR.
34601331 2021. Cytokine storm in the pathophysiology of COVID-19: Possible functional disturbances of miRNAs.
33895478 2021. Acute and post-acute phase of COVID-19: Analyzing expression patterns of miRNA-29a-3p, 146a-3p, 155-5p, and let-7b-3p in PBMC.
32405156 2020. Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal.
34826456 2022. Identifying potential novel insights for COVID-19 pathogenesis and therapeutics using an integrated bioinformatics analysis of host transcriptome.
34517025 2021. Genomics-guided targeting of stress granule proteins G3BP1/2 to inhibit SARS-CoV-2 propagation.
33862077 2021. Notable sequence homology of the ORF10 protein introspects the architecture of SARS-CoV-2.
33359807 2021. SARS-Cov-2 ORF3a: Mutability and function.
34756970 2021. SARS-COV-2, infection, transmission, transcription, translation, proteins, and treatment: A review.
32599245 2020. Targeting hub genes and pathways of innate immune response in COVID-19: A network biology perspective.
34671206 2021. The intraviral protein-protein interaction of SARS-CoV-2 reveals the key role of N protein in virus-like particle assembly.
33907518 2021. SARS-CoV-2 main protease suppresses type I interferon production by preventing nuclear translocation of phosphorylated IRF3.
33907515 2021. Developing effective siRNAs to reduce the expression of key viral genes of COVID-19.
33907514 2021. The role of CD4(+)FoxP3(+) regulatory T cells in the immunopathogenesis of COVID-19: implications for treatment.
33767597 2021. Evaluation and characterization of HSPA5 (GRP78) expression profiles in normal individuals and cancer patients with COVID-19.
35018096 2022. Identification of the Key Immune-Related Genes in Chronic Obstructive Pulmonary Disease Based on Immune Infiltration Analysis.
33165417 2020. Network pharmacology-based study of the molecular mechanisms of Qixuekang in treating COVID-19 during the recovery period.
35320721 2022. Restriction factor screening identifies RABGAP1L-mediated disruption of endocytosis as a host antiviral defense.
35026155 2022. Proteomic and metabolomic profiling of urine uncovers immune responses in patients with COVID-19.
34998467 2022. SARS-CoV-2 reactive and neutralizing antibodies discovered by single-cell sequencing of plasma cells and mammalian display.
35477000 2022. Characterization and functional interrogation of the SARS-CoV-2 RNA interactome.
34587478 2021. Single-cell analysis of COVID-19, sepsis, and HIV infection reveals hyperinflammatory and immunosuppressive signatures in monocytes.
34672947 2021. Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CL(pro) substrate degradome.
34686343 2021. Compartmentalization-aided interaction screening reveals extensive high-order complexes within the SARS-CoV-2 proteome.
34624208 2021. Role of miR-2392 in driving SARS-CoV-2 infection.
34624207 2021. The N-terminal domain of SARS-CoV-2 nsp1 plays key roles in suppression of cellular gene expression and preservation of viral gene expression.
34644561 2021. Proteomics reveal cap-dependent translation inhibitors remodel the translation machinery and translatome.
34731648 2021. An airway organoid-based screen identifies a role for the HIF1alpha-glycolysis axis in SARS-CoV-2 infection.
34762851 2021. SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues.
33961823 2021. METTL3 regulates viral m6A RNA modification and host cell innate immune responses during SARS-CoV-2 infection.
33961822 2021. Transcriptional and epi-transcriptional dynamics of SARS-CoV-2 during cellular infection.
33730572 2021. Translational adaptation of human viruses to the tissues they infect.
34242574 2021. Antibody landscape against SARS-CoV-2 reveals significant differences between non-structural/accessory and structural proteins.
33357411 2021. Cell-Type-Specific Immune Dysregulation in Severely Ill COVID-19 Patients.
33440148 2021. MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells.
34297909 2021. Compartmentalization-aided interaction screening reveals extensive high-order complexes within the SARS-CoV-2 proteome.
34348131 2021. The COVIDome Explorer researcher portal.
33852916 2021. Hypoxic and pharmacological activation of HIF inhibits SARS-CoV-2 infection of lung epithelial cells.
32946807 2020. A Single-Cell RNA Expression Map of Human Coronavirus Entry Factors.
32979938 2020. Evasion of Type I Interferon by SARS-CoV-2.
33007239 2020. Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects.
33147460 2020. Interferon Regulatory Factors IRF1 and IRF7 Directly Regulate Gene Expression in Bats in Response to Viral Infection.
35474751 2022. Rapid synchronous type 1 IFN and virus-specific T cell responses characterize first wave non-severe SARS-CoV-2 infections.
35474745 2022. Multi-omics in COVID-19: Seeing the unseen but overlooked in the clinic.
35233546 2022. System-wide transcriptome damage and tissue identity loss in COVID-19 patients.
34723226 2021. The systemic inflammatory landscape of COVID-19 in pregnancy: Extensive serum proteomic profiling of mother-infant dyads with in utero SARS-CoV-2.
33969320 2021. Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions.
34075365 2021. Broad auto-reactive IgM responses are common in critically ill patients, including those with COVID-19.
33521697 2021. A distinct innate immune signature marks progression from mild to severe COVID-19.
34873589 2021. People critically ill with COVID-19 exhibit peripheral immune profiles predictive of mortality and reflective of SARS-CoV-2 lung viral burden.
34308390 2021. Longitudinal metabolomics of human plasma reveals prognostic markers of COVID-19 disease severity.
33778787 2021. Spatial mapping of SARS-CoV-2 and H1N1 lung injury identifies differential transcriptional signatures.
34790908 2021. Metatranscriptomics to characterize respiratory virome, microbiome, and host response directly from clinical samples.
34737357 2022. Comparison of viral RNA-host protein interactomes across pathogenic RNA viruses informs rapid antiviral drug discovery for SARS-CoV-2.
33473155 2021. Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages.
33510385 2021. The m(6)A methylome of SARS-CoV-2 in host cells.
32913304 2021. Single-cell transcriptomic atlas of primate cardiopulmonary aging.
32071427 2020. Virus against virus: a potential treatment for 2019-nCov (SARS-CoV-2) and other RNA viruses.
33159154 2020. Mucus production stimulated by IFN-AhR signaling triggers hypoxia of COVID-19.
35461900 2022. Exosomal mediated signal transduction through artificial microRNA (amiRNA): A potential target for inhibition of SARS-CoV-2.
33142113 2020. Three-Dimensional Human Alveolar Stem Cell Culture Models Reveal Infection Response to SARS-CoV-2.
33128895 2020. Human Lung Stem Cell-Based Alveolospheres Provide Insights into SARS-CoV-2-Mediated Interferon Responses and Pneumocyte Dysfunction.
32979316 2020. SARS-CoV-2 Infection of Pluripotent Stem Cell-Derived Human Lung Alveolar Type 2 Cells Elicits a Rapid Epithelial-Intrinsic Inflammatory Response.
33096026 2021. Large-Scale Multi-omic Analysis of COVID-19 Severity.
33053371 2021. A Sweep of Earth's Virome Reveals Host-Guided Viral Protein Structural Mimicry and Points to Determinants of Human Disease.
34139154 2021. A time-resolved proteomic and prognostic map of COVID-19.
32673562 2020. RNA-GPS Predicts SARS-CoV-2 RNA Residency to Host Mitochondria and Nucleolus.
32619549 2020. Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection.
35326463 2022. Multi-Design Differential Expression Profiling of COVID-19 Lung Autopsy Specimens Reveals Significantly Deregulated Inflammatory Pathways and SFTPC Impaired Transcription.
35269470 2022. Severe COVID-19 Shares a Common Neutrophil Activation Signature with Other Acute Inflammatory States.
35053299 2022. Hypoxia-Inducible Factor Signaling in Inflammatory Lung Injury and Repair.
35159296 2022. Competitive Endogenous RNA Network Activates Host Immune Response in SARS-CoV-2-, panH1N1 (A/California/07/2009)-, and H7N9 (A/Shanghai/1/2013)-Infected Cells.
35203278 2022. The ACE2 Receptor for Coronavirus Entry Is Localized at Apical Cell-Cell Junctions of Epithelial Cells.
35406806 2022. Plasma Metabolomic Alterations Induced by COVID-19 Vaccination Reveal Putative Biomarkers Reflecting the Immune Response.
35563697 2022. Cannabinoids Alleviate the LPS-Induced Cytokine Storm via Attenuating NLRP3 Inflammasome Signaling and TYK2-Mediated STAT3 Signaling Pathways In Vitro.
34572076 2021. Host Cell and SARS-CoV-2-Associated Molecular Structures and Factors as Potential Therapeutic Targets.
34831176 2021. Impacts of p97 on Proteome Changes in Human Cells during Coronaviral Replication.
34831321 2021. In Silico Identification and Clinical Validation of a Novel Long Non-Coding RNA/mRNA/miRNA Molecular Network for Potential Biomarkers for Discriminating SARS CoV-2 Infection Severity.
34831290 2021. Endothelial Dysfunction through Oxidatively Generated Epigenetic Mark in Respiratory Viral Infections.
34831243 2021. Characterization of RNA Sensing Pathways in Hepatoma Cell Lines and Primary Human Hepatocytes.
34943787 2021. SARS-CoV-2 Spike Protein and Its Receptor Binding Domain Promote a Proinflammatory Activation Profile on Human Dendritic Cells.
33801464 2021. SARS-CoV-2 Nucleocapsid Protein Targets RIG-I-Like Receptor Pathways to Inhibit the Induction of Interferon Response.
34204705 2021. In Silico Identification of miRNA-lncRNA Interactions in Male Reproductive Disorder Associated with COVID-19 Infection.
34440669 2021. Multisystemic Cellular Tropism of SARS-CoV-2 in Autopsies of COVID-19 Patients.
34359957 2021. MiRNA Profiling in Plasma and Placenta of SARS-CoV-2-Infected Pregnant Women.
34359932 2021. Viral MicroRNAs Encoded by Nucleocapsid Gene of SARS-CoV-2 Are Detected during Infection, and Targeting Metabolic Pathways in Host Cells.
33540583 2021. Mechanisms of Coronavirus Nsp1-Mediated Control of Host and Viral Gene Expression.
35011641 2021. The Genomic Physics of COVID-19 Pathogenesis and Spread.
35011584 2021. Role of Human Antigen R (HuR) in the Regulation of Pulmonary ACE2 Expression.
34944012 2021. Identifying Putative Causal Links between MicroRNAs and Severe COVID-19 Using Mendelian Randomization.
34944005 2021. Transcriptomic Profiles Reveal Downregulation of Low-Density Lipoprotein Particle Receptor Pathway Activity in Patients Surviving Severe COVID-19.
34440765 2021. Autophagy and Mitophagy-Related Pathways at the Crossroads of Genetic Pathways Involved in Familial Sarcoidosis and Host-Pathogen Interactions Induced by Coronaviruses.
34571855 2021. Two-Step In Vitro Model to Evaluate the Cellular Immune Response to SARS-CoV-2.
34571838 2021. Transcriptomic Analysis of HCN-2 Cells Suggests Connection among Oxidative Stress, Senescence, and Neuron Death after SARS-CoV-2 Infection.
33917481 2021. Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19.
33919784 2021. The Role of Macrophages in the Development of Acute and Chronic Inflammatory Lung Diseases.
33143316 2020. Aprotinin Inhibits SARS-CoV-2 Replication.
33138195 2020. Single-Cell Transcriptome Analysis Highlights a Role for Neutrophils and Inflammatory Macrophages in the Pathogenesis of Severe COVID-19.
33086697 2020. Effects of Coronavirus Persistence on the Genome Structure and Subsequent Gene Expression, Pathogenicity and Adaptation Capability.
32526950 2020. Host Gene Expression of Macrophages in Response to Feline Coronavirus Infection.
32283711 2020. scRNA-seq Profiling of Human Testes Reveals the Presence of the ACE2 Receptor, A Target for SARS-CoV-2 Infection in Spermatogonia, Leydig and Sertoli Cells.
32872802 2020. Fractional diffusion on the human proteome as an alternative to the multi-organ damage of SARS-CoV-2.
35598647 2022. TRPC6 is altered in COVID-19 pneumonia.
34163728 2021. CRISPR technology incorporating amplification strategies: molecular assays for nucleic acids, proteins, and small molecules.
33879756 2021. Single-cell analysis of angiotensin-converting enzyme II expression in human kidneys and bladders reveals a potential route of 2019 novel coronavirus infection.
35430876 2022. Human Coronary Plaque T Cells Are Clonal and Cross-React to Virus and Self.
32967859 2020. The pulmonary pathology of COVID-19.
33428900 2021. CRISPR-based tools: Alternative methods for the diagnosis of COVID-19.
34332518 2021. Could metabolomics drive the fate of COVID-19 pandemic? A narrative review on lights and shadows.
34774827 2022. Serum level of testosterone predicts disease severity of male COVID-19 patients and is related to T-cell immune modulation by transcriptome analysis.
34819170 2021. Epigenetic modifications in thymic epithelial cells: an evolutionary perspective for thymus atrophy.
34034806 2021. Blood DNA methylation and COVID-19 outcomes.
33087172 2020. The epigenetic implication in coronavirus infection and therapy.
32758273 2020. Management of epigenomic networks entailed in coronavirus infections and COVID-19.
33639276 2021. The role of A-to-I RNA editing in infections by RNA viruses: Possible implications for SARS-CoV-2 infection.
34252574 2021. Complement activation and increased expression of Syk, mucin-1 and CaMK4 in kidneys of patients with COVID-19.
32325252 2020. COVID-19 pathophysiology: A review.
32311462 2020. On the molecular determinants of the SARS-CoV-2 attack.
32461193 2020. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases.
33270107 2021. Viral Cultures for Coronavirus Disease 2019 Infectivity Assessment: A Systematic Review.
33596592 2021. Plasma Metabolomic Profiling of Patients Recovered From Coronavirus Disease 2019 (COVID-19) With Pulmonary Sequelae 3 Months After Discharge.
32463434 2021. Metatranscriptomic Characterization of Coronavirus Disease 2019 Identified a Host Transcriptional Classifier Associated With Immune Signaling.
32307550 2020. Downregulated Gene Expression Spectrum and Immune Responses Changed During the Disease Progression in Patients With COVID-19.
32327413 2020. Genetic Roadmap for Kidney Involvement of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.
33631334 2021. Prolonged SARS-CoV-2 cell culture replication in respiratory samples from patients with severe COVID-19.
34620315 2021. mNUTRIC tool is capable to predict nutritional needs and mortality early in patients suffering from severe pneumonia.
34330510 2021. Gene signatures of autopsy lungs from obese patients with COVID-19.
34330463 2021. The snapshot of metabolic health in evaluating micronutrient status, the risk of infection and clinical outcome of COVID-19.
33855294 2021. Possible Involvement of Central Nervous System in COVID-19 and Sequence Variability of SARS-CoV-2 Revealed in Autopsy Tissue Samples: A Case Report.
32828489 2020. Epigenetic susceptibility to severe respiratory viral infections and its therapeutic implications: a narrative review.
32628270 2020. Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on polymerase chain reaction and serology testing.
33125711 2021. Unfractionated heparin inhibits live wild type SARS-CoV-2 cell infectivity at therapeutically relevant concentrations.
34915155 2022. SARS-CoV-2 spike S1 subunit induces neuroinflammatory, microglial and behavioral sickness responses: Evidence of PAMP-like properties.
34022369 2021. Detection of SARS-CoV-2 genome and whole transcriptome sequencing in frontal cortex of COVID-19 patients.
33892139 2021. Double stranded RNA drives anti-viral innate immune responses, sickness behavior and cognitive dysfunction dependent on dsRNA length, IFNAR1 expression and age.
32497778 2020. A pharmacological interactome between COVID-19 patient samples and human sensory neurons reveals potential drivers of neurogenic pulmonary dysfunction.
34384361 2021. Mass spectrometry-based proteomics in basic and translational research of SARS-CoV-2 coronavirus and its emerging mutants.
33292691 2020. Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies.
35538880 2022. Proteomic profiling of lung diffusion impairment in the recovery stage of SARS-CoV-2-induced ARDS.
34586723 2021. Host transcriptional response to SARS-CoV-2 infection in COVID-19 patients.
34047474 2021. Preliminary analyses of scRNA sequencing and immunohistochemistry of children's lung tissues indicate the expression of SARS-CoV-2 entry-related genes may not be the key reason for the milder syndromes of COVID-19 in children.
33135345 2020. The noncoding and coding transcriptional landscape of the peripheral immune response in patients with COVID-19.
32799423 2020. Effect of Common Medications on the Expression of SARS-CoV-2 Entry Receptors in Kidney Tissue.
32578831 2020. Human Leukocyte Transcriptional Response to SARS-CoV-2 Infection.
33425046 2021. COV19-CNNet and COV19-ResNet: Diagnostic Inference Engines for Early Detection of COVID-19.
35091696 2022. Epigenomic and transcriptomic analyses reveal differences between low-grade inflammation and severe exhaustion in LPS-challenged murine monocytes.
35022513 2022. SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-kappaB.
35017628 2022. InterCellar enables interactive analysis and exploration of cell-cell communication in single-cell transcriptomic data.
35136165 2022. An extended motif in the SARS-CoV-2 spike modulates binding and release of host coatomer in retrograde trafficking.
34686777 2021. Accurate detection and quantification of SARS-CoV-2 genomic and subgenomic mRNAs by ddPCR and meta-transcriptomics analysis.
34002013 2021. Genome-wide bioinformatic analyses predict key host and viral factors in SARS-CoV-2 pathogenesis.
33674719 2021. IFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infection.
34326461 2021. FIP200 restricts RNA virus infection by facilitating RIG-I activation.
33580175 2021. Immunoreactive peptide maps of SARS-CoV-2.
34465887 2021. Trans-ethnic genome-wide association study of severe COVID-19.
34552685 2021. Infrared light therapy relieves TLR-4 dependent hyper-inflammation of the type induced by COVID-19.
35465056 2022. BNT162b2 vaccination enhances interferon-JAK-STAT-regulated antiviral programs in COVID-19 patients infected with the SARS-CoV-2 Beta variant.
35602196 2021. Reduced subgenomic RNA expression is a molecular indicator of asymptomatic SARS-CoV-2 infection.
35072167 2021. Host methylation predicts SARS-CoV-2 infection and clinical outcome.
33845430 2021. The role of human C5a as a non-genomic target in corticosteroid therapy for management of severe COVID19.
35427985 2022. Subtractive proteomics assisted therapeutic targets mining and designing ensemble vaccine against Candida auris for immune response induction.
35339845 2022. Integration of omics data to generate and analyse COVID-19 specific genome-scale metabolic models.
35114443 2022. Systems pharmacology-based drug discovery and active mechanism of natural products for coronavirus pneumonia (COVID-19): An example using flavonoids.
35605482 2022. Unveiling the nature's fruit basket to computationally identify Citrus sinensis csi-mir169-3p as a probable plant miRNA against Reference and Omicron SARS-CoV-2 genome.
35533462 2022. Network for network concept offers new insights into host- SARS-CoV-2 protein interactions and potential novel targets for developing antiviral drugs.
35533463 2022. Enrichment analysis on regulatory subspaces: A novel direction for the superior description of cellular responses to SARS-CoV-2.
34320442 2021. Decrypting the role of predicted SARS-CoV-2 miRNAs in COVID-19 pathogenesis: A bioinformatics approach.
34478921 2021. Meta-analysis of single-cell RNA-seq data reveals phenotypic switching of immune cells in severe COVID-19 patients.
34655901 2021. Interactome of human and SARS-CoV-2 proteins to identify human hub proteins associated with comorbidities.
34020131 2021. Identification and host response interaction study of SARS-CoV-2 encoded miRNA-like sequences: an in silico approach.
33310371 2021. Recent trends on omics and bioinformatics approaches to study SARS-CoV-2: A bibliometric analysis and mini-review.
33301953 2021. Next-generation computational tools and resources for coronavirus research: From detection to vaccine discovery.
33260034 2021. Comparative transcriptome analysis of SARS-CoV, MERS-CoV, and SARS-CoV-2 to identify potential pathways for drug repurposing.
33217661 2021. Evaluation of acridinedione analogs as potential SARS-CoV-2 main protease inhibitors and their comparison with repurposed anti-viral drugs.
34246161 2021. High-throughput analysis of the interactions between viral proteins and host cell RNAs.
34157472 2021. Multilevel systems biology analysis of lung transcriptomics data identifies key miRNAs and potential miRNA target genes for SARS-CoV-2 infection.
33662681 2021. Network pharmacology and RNA-sequencing reveal the molecular mechanism of Xuebijing injection on COVID-19-induced cardiac dysfunction.
33131530 2020. Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs against COVID-19.
35558576 2022. Identification of Diagnostic Gene Markers and Immune Infiltration in Systemic Lupus.
34603483 2021. Identification of Novel COVID-19 Biomarkers by Multiple Feature Selection Strategies.
33631640 2021. Artificial Intelligence-Based Prediction of Covid-19 Severity on the Results of Protein Profiling.
34777716 2021. Lipidomics and metabolomics signatures of SARS-CoV-2 mediators/receptors in peripheral leukocytes, jejunum and colon.
34109017 2021. The evolving proteome of SARS-CoV-2 predominantly uses mutation combination strategy for survival.
33907612 2021. Comparisons of the immunological landscape between COVID-19, influenza, and respiratory syncytial virus patients by clustering analysis.
33841749 2021. Metabolomics reveals sex-specific metabolic shifts and predicts the duration from positive to negative in non-severe COVID-19 patients during recovery process.
33815688 2021. Nanopore sequencing and its application to the study of microbial communities.
33584997 2021. 3044 Cases reveal important prognosis signatures of COVID-19 patients.
33520118 2021. Meta-analysis of transcriptome datasets: An alternative method to study IL-6 regulation in coronavirus disease 2019.
33425248 2021. Host transcriptomic profiling of COVID-19 patients with mild, moderate, and severe clinical outcomes.
33312453 2021. Transcriptomic signatures and repurposing drugs for COVID-19 patients: findings of bioinformatics analyses.
33312454 2020. L1000 connectivity map interrogation identifies candidate drugs for repurposing as SARS-CoV-2 antiviral therapies.
33106757 2020. Probing infectious disease by single-cell RNA sequencing: Progresses and perspectives.
34781986 2021. Metabolomic diferences between COVID-19 and H1N1 influenza induced ARDS.
34112226 2021. Comparison of renal histopathology and gene expression profiles between severe COVID-19 and bacterial sepsis in critically ill patients.
33134953 2020. Metabolomics Profiling of Critically Ill Coronavirus Disease 2019 Patients: Identification of Diagnostic and Prognostic Biomarkers.
35584589 2022. Roles of PIKfyve in multiple cellular pathways.
32838054 2021. Subcellular hot spots of GPCR signaling promote vascular inflammation.
34534994 2021. Host genetics of pediatric SARS-CoV-2 COVID-19 and multisystem inflammatory syndrome in children.
33969287 2021. Reduced A-to-I editing of endogenous Alu RNAs in lung after SARS-CoV-2 infection.
34841355 2021. A next generation sequencing (NGS) analysis to reveal genomic and proteomic mutation landscapes of SARS-CoV-2 in South Asia.
34725650 2021. The severity of SARS-CoV-2 infection is dictated by host factors? Epigenetic perspectives.
32142596 2020. Machine Learning, COVID-19 (2019-nCoV), and multi-OMICS.
33394568 2021. Illuminating the immunopathology of SARS-CoV-2.
32864402 2020. Dataset of mutational analysis, miRNAs targeting SARS-CoV-2 genes and host gene expression in SARS-CoV and SARS-CoV-2 infections.
32835036 2020. Quantitative proteomic dataset from oro- and naso-pharyngeal swabs used for COVID-19 diagnosis: Detection of viral proteins and host's biological processes altered by the infection.
32775582 2020. Dataset for homologous proteins in Drosophila melanogaster for SARS-CoV-2/human interactome.
35134150 2022. SCANNER: a web platform for annotation, visualization and sharing of single cell RNA-seq data.
33787872 2021. Drugmonizome and Drugmonizome-ML: integration and abstraction of small molecule attributes for drug enrichment analysis and machine learning.
33009914 2021. A database resource and online analysis tools for coronaviruses on a historical and global scale.
33206959 2020. The IMEx coronavirus interactome: an evolving map of Coronaviridae-host molecular interactions.
35233542 2022. Mass spectrometry and proteome analysis to identify SARS-CoV-2 protein from COVID-19 patient swab samples.
35141569 2022. Transcriptome profiling of PBMCs and formalin-fixed autopsy tissues from COVID-19 patients.
34901888 2022. Detection of N6-methyladenosine in SARS-CoV-2 RNA by methylated RNA immunoprecipitation sequencing.
34877545 2022. Global metabolome profiling of COVID-19 respiratory specimen using high-resolution mass spectrometry (HRMS).
34870243 2022. Protocol for global proteome, virome, and metaproteome profiling of respiratory specimen (VTM) in COVID-19 patient by LC-MS/MS-based analysis.
35611119 2022. An antibody-based proximity labeling protocol to identify biotinylated interactors of SARS-CoV-2.
35582459 2022. Analyzing single cell transcriptome data from severe COVID-19 patients.
35310073 2022. SARS-CoV-2 proteome microarray for COVID-19 patient sera profiling.
34462737 2021. An antigen microarray protocol for COVID-19 serological analysis.
34002169 2021. Sample processing and single cell RNA-sequencing of peripheral blood immune cells from COVID-19 patients.
33907739 2021. Analysis workflow of publicly available RNA-sequencing datasets.
34746856 2021. Computational workflow for functional characterization of COVID-19 through secondary data analysis.
34405154 2021. Luciferase reporter assays to monitor interferon signaling modulation by SARS-CoV-2 proteins.
33377120 2020. Optimized workflow for single-cell transcriptomics on infectious diseases including COVID-19.
33377107 2020. Glycomics-informed glycoproteomic analysis of site-specific glycosylation for SARS-CoV-2 spike protein.
35180397 2022. A human pluripotent stem cell-based model of SARS-CoV-2 infection reveals an ACE2-independent inflammatory activation of vascular endothelial cells through TLR4.
35063125 2022. The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2.
33852884 2021. Human Pluripotent Stem Cell-Derived Intestinal Organoids Model SARS-CoV-2 Infection Revealing a Common Epithelial Inflammatory Response.
33161843 2021. Flow-Mediated Susceptibility and Molecular Response of Cerebral Endothelia to SARS-CoV-2 Infection.
34151035 2021. Association between the nasopharyngeal microbiome and metabolome in patients with COVID-19.
33354650 2020. Host-Viral Interactions Revealed among Shared Transcriptomics Signatures of ARDS and Thrombosis: A Clue into COVID-19 Pathogenesis.
35664076 2022. The interplay between lncRNAs, RNA-binding proteins and viral genome during SARS-CoV-2 infection reveals strong connections with regulatory events involved in RNA metabolism and immune response.
34335977 2021. Multi-omic profiling of plasma reveals molecular alterations in children with COVID-19.
33391477 2021. Immunopathogenesis and treatment of cytokine storm in COVID-19.
34048985 2021. Circulating microRNA profiles predict the severity of COVID-19 in hospitalized patients.
33221483 2021. The role of the lectin pathway of the complement system in SARS-CoV-2 lung injury.
33994605 2021. Mass spectrometry analytical responses to the SARS-CoV2 coronavirus in review.
33309104 2021. Using Genetics To Dissect SARS-CoV-2 Infection.
33451855 2021. Dysregulation of Cell Signaling by SARS-CoV-2.
32595353 2020. Integration of transcriptomic profile of SARS-CoV-2 infected normal human bronchial epithelial cells with metabolic and protein-protein interaction networks.
32851697 2021. Single-cell RNA expression profiling of SARS-CoV-2-related ACE2 and TMPRSS2 in human trophectoderm and placenta.
33521688 2021. COVID-19 impacts the expression of molecular markers associated with neuropsychiatric disorders.
33956332 2021. Functional and tissue enrichment analyses suggest that SARS-CoV-2 infection affects host metabolism and catabolism mediated by interference on host proteins.
35229157 2022. Unheeded SARS-CoV-2 proteins? A deep look into negative-sense RNA.
34864875 2022. Multiomics integration-based molecular characterizations of COVID-19.
34849574 2022. SC-MEB: spatial clustering with hidden Markov random field using empirical Bayes.
34718395 2022. A comprehensive review of the analysis and integration of omics data for SARS-CoV-2 and COVID-19.
34505137 2022. Serverless computing in omics data analysis and integration.
33907801 2021. Analyzing master regulators and scRNA-seq of COVID-19 patients reveals an underlying anti-SARS-CoV-2 mechanism of ZNF proteins.
33847347 2021. Bioinformatics and system biology approach to identify the influences of SARS-CoV-2 infections to idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease patients.
33839760 2021. Bioinformatics and machine learning approach identifies potential drug targets and pathways in COVID-19.
33535230 2021. jSRC: a flexible and accurate joint learning algorithm for clustering of single-cell RNA-sequencing data.
33406224 2021. HISNAPI: a bioinformatic tool for dynamic hot spot analysis in nucleic acid-protein interface with a case study.
34424948 2021. DeepDRIM: a deep neural network to reconstruct cell-type-specific gene regulatory network using single-cell RNA-seq data.
34260684 2021. Discovering common pathogenetic processes between COVID-19 and diabetes mellitus by differential gene expression pattern analysis.
34254996 2021. ADEIP: an integrated platform of age-dependent expression and immune profiles across human tissues.
34245241 2021. Published anti-SARS-CoV-2 in vitro hits share common mechanisms of action that synergize with antivirals.
34160596 2021. LSTM-PHV: prediction of human-virus protein-protein interactions by LSTM with word2vec.
34117734 2021. DeepR2cov: deep representation learning on heterogeneous drug networks to discover anti-inflammatory agents for COVID-19.
34111889 2021. Single-cell multi-omics sequencing: application trends, COVID-19, data analysis issues and prospects.
34076249 2021. Transcriptomic studies revealed pathophysiological impact of COVID-19 to predominant health conditions.
34036326 2021. A multi-modal data harmonisation approach for discovery of COVID-19 drug targets.
34009288 2021. Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19.
33993223 2021. Bioinformatics and system biology approaches to identify the diseasome and comorbidities complexities of SARS-CoV-2 infection with the digestive tract disorders.
33956950 2021. The peripheral and core regions of virus-host network of COVID-19.
32393985 2021. Therapeutic targets and signaling mechanisms of vitamin C activity against sepsis: a bioinformatics study.
33620066 2021. Lysosome activation in peripheral blood mononuclear cells and prognostic significance of circulating LC3B in COVID-19.
33611340 2021. Identification of biomarkers and pathways for the SARS-CoV-2 infections that make complexities in pulmonary arterial hypertension patients.
33592108 2021. Data science in unveiling COVID-19 pathogenesis and diagnosis: evolutionary origin to drug repurposing.
33569598 2021. Integrated network analysis reveals new genes suggesting COVID-19 chronic effects and treatment.
33539530 2021. Diseasome and comorbidities complexities of SARS-CoV-2 infection with common malignant diseases.
33479725 2021. An integrated approach to determine the abundance, mutation rate and phylogeny of the SARS-CoV-2 genome.
33458761 2021. Bioinformatics and system biology approach to identify the influences of COVID-19 on cardiovascular and hypertensive comorbidities.
33458747 2021. Serial co-expression analysis of host factors from SARS-CoV viruses highly converges with former high-throughput screenings and proposes key regulators.
33423067 2021. Transcriptome analysis of cepharanthine against a SARS-CoV-2-related coronavirus.
33416848 2021. SARS-CoV-2 3D database: understanding the coronavirus proteome and evaluating possible drug targets.
33341900 2021. SARS-CoV-2 hot-spot mutations are significantly enriched within inverted repeats and CpG island loci.
33341869 2021. Inferring microenvironmental regulation of gene expression from single-cell RNA sequencing data using scMLnet with an application to COVID-19.
33333559 2021. Gene expression profiling of SARS-CoV-2 infections reveal distinct primary lung cell and systemic immune infection responses that identify pathways relevant in COVID-19 disease.
33279989 2021. Next generation sequencing of SARS-CoV-2 genomes: challenges, applications and opportunities.
33126244 2021. Compositional diversity and evolutionary pattern of coronavirus accessory proteins.
33057582 2021. Web tools to fight pandemics: the COVID-19 experience.
33024988 2021. Network-based identification genetic effect of SARS-CoV-2 infections to Idiopathic pulmonary fibrosis (IPF) patients.
32778874 2021. Pathogenetic profiling of COVID-19 and SARS-like viruses.
33381809 2021. Improving gene network inference with graph wavelets and making insights about ageing-associated regulatory changes in lungs.
34402498 2022. Infection outcome needs two to tango: human host and the pathogen.
33491070 2021. Noncoding RNAs: modulators and modulatable players during infection-induced stress response.
33907373 2021. Identification of selected genes associated with the SARS-CoV-2: a therapeutic approach and disease severity.
33508216 2021. Inflammatory Leptomeningeal Cytokines Mediate COVID-19 Neurologic Symptoms in Cancer Patients.
35093087 2022. Dynamic regulation and functions of mRNA m6A modification.
33636047 2021. An integrated genetic-epigenetic analysis shed light on the mechanisms linking coronavirus disease 2019 (COVID-19) and cancer.
32444466 2020. The Landscape of Human Cancer Proteins Targeted by SARS-CoV-2.
35194198 2022. Next generation self-replicating RNA vectors for vaccines and immunotherapies.
34090218 2021. COVID-19 patients' sera induce epithelial mesenchymal transition in cancer cells.
34830872 2021. Blood Cytokine Analysis Suggests That SARS-CoV-2 Infection Results in a Sustained Tumour Promoting Environment in Cancer Patients.
34425843 2021. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin.
33906662 2021. Expression of the SARS-CoV-2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system.
34755842 2022. Association of cardiometabolic microRNAs with COVID-19 severity and mortality.
34647998 2022. Cardiac SARS-CoV-2 infection is associated with pro-inflammatory transcriptomic alterations within the heart.
33705542 2021. Human cardiosphere-derived stromal cells exposed to SARS-CoV-2 evolve into hyper-inflammatory/pro-fibrotic phenotype and produce infective viral particles depending on the levels of ACE2 receptor expression.
32227090 2020. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2.
32966582 2020. SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes.
32856216 2020. Roles of MicroRNA-122 in Cardiovascular Fibrosis and Related Diseases.
35618891 2022. Host genetic basis of COVID-19: from methodologies to genes.
35577935 2022. A comprehensive SARS-CoV-2 and COVID-19 review, Part 1: Intracellular overdrive for SARS-CoV-2 infection.
35322240 2022. Allelic imbalance of HLA-B expression in human lung cells infected with coronavirus and other respiratory viruses.
33649539 2021. Lung expression of genes putatively involved in SARS-CoV-2 infection is modulated in cis by germline variants.
32404885 2020. The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic.
34837225 2022. COVID-19-specific metabolic imprint yields insights into multiorgan system perturbations.
34333764 2022. Maturation signatures of conventional dendritic cell subtypes in COVID-19 suggest direct viral sensing.
35419822 2022. Anti-IFN-alpha/-omega neutralizing antibodies from COVID-19 patients correlate with downregulation of IFN response and laboratory biomarkers of disease severity.
35416291 2022. Natural killer cell-mediated ADCC in SARS-CoV-2-infected individuals and vaccine recipients.
34107055 2021. Tofacitinib therapy intercepts macrophage metabolic reprogramming instigated by SARS-CoV-2 Spike protein.
33772767 2021. Peptide microarray-based analysis of antibody responses to SARS-CoV-2 identifies unique epitopes with potential for diagnostic test development.
34534839 2021. Indomethacin-based PROTACs as pan-coronavirus antiviral agents.
34256840 2021. The relative expression of miR-31, miR-29, miR-126, and miR-17 and their mRNA targets in the serum of COVID-19 patients with different grades during hospitalization.
34920753 2021. An integrative bioinformatics analysis for identifying hub genes associated with infection of lung samples in patients infected with SARS-CoV-2.
33137330 2021. Functional and druggability analysis of the SARS-CoV-2 proteome.
33038418 2021. Targeting pivotal inflammatory pathways in COVID-19: A mechanistic review.
32971089 2020. Integrative transcriptomics analysis of lung epithelial cells and identification of repurposable drug candidates for COVID-19.
34675048 2022. Profiling of lung SARS-CoV-2 and influenza virus infection dissects virus-specific host responses and gene signatures.
34289974 2022. Metabolomic analyses reveal new stage-specific features of COVID-19.
32675206 2020. Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue.
34730223 2021. Identification of hub genes and molecular subtypes in COVID-19 based on WGCNA.
34661254 2021. Modulation of host epigenome by coronavirus infections and developing treatment modalities for COVID-19 beyond genetics.
33506945 2021. High expression of ACE2 in the human lung leads to the release of IL6 by suppressing cellular immunity: IL6 plays a key role in COVID-19.
34919255 2021. SARS-CoV-2 associated pathogenesis, immune dysfunction and involvement of host factors: a comprehensive review.
33877681 2021. Prediction of potential therapeutic drugs against SARS-CoV-2 by using Connectivity Map based on transcriptome data.
33215473 2020. Deep learning applications to combat the dissemination of COVID-19 disease: a review.
32894568 2020. Three critical clinicobiological phases of the human SARS-associated coronavirus infections.
32563676 2020. Pathological Findings in the Testes of COVID-19 Patients: Clinical Implications.
34898980 2021. Evolutionary Dynamics of Indels in SARS-CoV-2 Spike Glycoprotein.
33149541 2020. New Pathways of Mutational Change in SARS-CoV-2 Proteomes Involve Regions of Intrinsic Disorder Important for Virus Replication and Release.
33467896 2021. Inter-proteomic posttranslational modifications of the SARS-CoV-2 and the host proteins A new frontier.
32735892 2020. Network perturbation analysis in human bronchial epithelial cells following SARS-CoV2 infection.
33953323 2021. Type I and III interferon responses in SARS-CoV-2 infection.
34566994 2021. Characterization by Quantitative Serum Proteomics of Immune-Related Prognostic Biomarkers for COVID-19 Symptomatology.
34566957 2021. Redefining COVID-19 Severity and Prognosis: The Role of Clinical and Immunobiotypes.
34531865 2021. Host Genetics and Antiviral Immune Responses in Adult Patients With Multisystem Inflammatory Syndrome.
34504502 2021. The Molecular Mechanism of Multiple Organ Dysfunction and Targeted Intervention of COVID-19 Based on Time-Order Transcriptomic Analysis.
34504487 2021. Biomarkers and Immune Repertoire Metrics Identified by Peripheral Blood Transcriptomic Sequencing Reveal the Pathogenesis of COVID-19.
34489933 2021. Cytokine Signature Associated With Disease Severity in COVID-19.
34447375 2021. SARS-CoV-2 Proteome Harbors Peptides Which Are Able to Trigger Autoimmunity Responses: Implications for Infection, Vaccination, and Population Coverage.
34408749 2021. Long Noncoding RNAs as Emerging Regulators of COVID-19.
34408743 2021. Fast and Efficient Genome Editing of Human FOXP3(+) Regulatory T Cells.
34394120 2021. Transcriptome Analysis of Peripheral Blood Mononuclear Cells Reveals Distinct Immune Response in Asymptomatic and Re-Detectable Positive COVID-19 Patients.
34394108 2021. Identification of COVID-19 and Dengue Host Factor Interaction Networks Based on Integrative Bioinformatics Analyses.
34394094 2021. Single-Cell Transcriptomic Profiling of MAIT Cells in Patients With COVID-19.
34367190 2021. Monocytes and Macrophages in COVID-19.
34367154 2021. Gene Expression Meta-Analysis Reveals Interferon-Induced Genes Associated With SARS Infection in Lungs.
34341659 2021. Severe COVID-19 Is Characterized by an Impaired Type I Interferon Response and Elevated Levels of Arginase Producing Granulocytic Myeloid Derived Suppressor Cells.
34335605 2021. High-Density Blood Transcriptomics Reveals Precision Immune Signatures of SARS-CoV-2 Infection in Hospitalized Individuals.
34335580 2021. Chronic Obstructive Pulmonary Disease Patients Have Increased Levels of Plasma Inflammatory Mediators Reported Upregulated in Severe COVID-19.
33828231 2021. From bedside to bench: regulation of host factors in SARS-CoV-2 infection.
35261621 2022. Post-treatment with propofol inhibits inflammatory response in LPS-induced alveolar type II epithelial cells.
33769912 2021. Analysis of the SARS-CoV-2-host protein interaction network reveals new biology and drug candidates: focus on the spike surface glycoprotein and RNA polymerase.
32452701 2020. An up-to-date overview of computational polypharmacology in modern drug discovery.
34633277 2022. Indomethacin: an exploratory study of antiviral mechanism and host-pathogen interaction in COVID-19.
32814446 2021. COVID-19: fighting the invisible enemy with microRNAs.
33929923 2021. Can proteomics-based approaches further help COVID-19 prevention and therapy?
33084449 2020. Deep mutagenesis in the study of COVID-19: a technical overview for the proteomics community.
34177037 2021. Convolutional neural network for diagnosis of viral pneumonia and COVID-19 alike diseases.
34511738 2021. CovH2SD: A COVID-19 detection approach based on Harris Hawks Optimization and stacked deep learning.
33209992 2020. nSARS-Cov-2, pulmonary edema and thrombosis: possible molecular insights using miRNA-gene circuits in regulatory networks.
34377996 2021. COVID-19-associated inhibition of energy accumulation pathways in human semen samples.
35106136 2021. Toxin-like peptides in plasma, urine and faecal samples from COVID-19 patients.
33456761 2020. SARS-CoV-2 meta-interactome suggests disease-specific, autoimmune pathophysiologies and therapeutic targets.
34105201 2021. Quantitative proteomics of hamster lung tissues infected with SARS-CoV-2 reveal host factors having implication in the disease pathogenesis and severity.
33749902 2021. Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages.
33710662 2021. Evidence for CAT gene being functionally involved in the susceptibility of COVID-19.
34228902 2021. Identification of a special cell type as a determinant of the kidney tropism of SARS-CoV-2.
33864728 2021. Host PDZ-containing proteins targeted by SARS-CoV-2.
33185982 2021. Interferon-stimulated gene products as regulators of central carbon metabolism.
32790936 2020. Nicotine and the nicotinic cholinergic system in COVID-19.
34409594 2021. Genome-scale metabolic modelling of SARS-CoV-2 in cancer cells reveals an increased shift to glycolytic energy production.
34375459 2021. A glycosaminoglycan microarray identifies the binding of SARS-CoV-2 spike protein to chondroitin sulfate E.
32880920 2020. Transcriptomic analyses suggest that mucopolysaccharidosis patients may be less susceptible to COVID-19.
35445579 2022. Recent insights into the structure and function of coronavirus ribonucleases.
35429230 2022. Viral and cellular translation during SARS-CoV-2 infection.
34137202 2021. Optimization of a modeling platform to predict oncogenes from genome-scale metabolic networks of non-small-cell lung cancers.
32741461 2020. Endometrial susceptibility to SARS CoV-2: explained by gene expression across the menstrual cycle?
32641214 2020. SARS-CoV-2 infection risk assessment in the endometrium: viral infection-related gene expression across the menstrual cycle.
34023458 2021. SARS-CoV-2 suppresses mRNA expression of selenoproteins associated with ferroptosis, endoplasmic reticulum stress and DNA synthesis.
33253764 2021. Exploring the magic bullets to identify Achilles' heel in SARS-CoV-2: Delving deeper into the sea of possible therapeutic options in Covid-19 disease: An update.
34058321 2021. Nrf2 activator PB125(R) as a carnosic acid-based therapeutic agent against respiratory viral diseases, including COVID-19.
34186206 2021. Upregulation of oxidative stress gene markers during SARS-COV-2 viral infection.
35141213 2021. A Novel Prognostic Signature for Survival Prediction and Immune Implication Based on SARS-CoV-2-Related Genes in Kidney Renal Clear Cell Carcinoma.
33520952 2020. Evolutionarily Conserved Long Non-coding RNA Regulates Gene Expression in Cytokine Storm During COVID-19.
35226991 2022. Thymosin-alpha1 binds with ACE and downregulates the expression of ACE2 in human respiratory epithelia.
35402570 2022. In silico Drug Screening Approach Using L1000-Based Connectivity Map and Its Application to COVID-19.
35127841 2021. Molecular Mechanisms of Cardiac Injury Associated With Myocardial SARS-CoV-2 Infection.
34917662 2021. Detailed Analyses of the Expression Patterns of Potential Severe Acute Respiratory Syndrome Coronavirus 2 Receptors in the Human Heart Using Single-Nucleus RNA Sequencing.
34912867 2021. Novel Knowledge-Based Transcriptomic Profiling of Lipid Lysophosphatidylinositol-Induced Endothelial Cell Activation.
34859078 2021. Platelet Phenotype Analysis of COVID-19 Patients Reveals Progressive Changes in the Activation of Integrin alphaIIbbeta3, F13A1, the SARS-CoV-2 Target EIF4A1 and Annexin A5.
33718452 2021. Single-Cell Transcriptome Analysis Decipher New Potential Regulation Mechanism of ACE2 and NPs Signaling Among Heart Failure Patients Infected With SARS-CoV-2.
33521069 2020. Gene Expression Profiling Reveals the Shared and Distinct Transcriptional Signatures in Human Lung Epithelial Cells Infected With SARS-CoV-2, MERS-CoV, or SARS-CoV: Potential Implications in Cardiovascular Complications of COVID-19.
33240937 2020. Molecular Basis of Cardiac and Vascular Injuries Associated With COVID-19.
35223838 2022. Protein Posttranslational Signatures Identified in COVID-19 Patient Plasma.
35186917 2022. Profiling Selective Packaging of Host RNA and Viral RNA Modification in SARS-CoV-2 Viral Preparations.
35141230 2021. Cancer and COVID-19 Susceptibility and Severity: A Two-Sample Mendelian Randomization and Bioinformatic Analysis.
34497809 2021. Transcriptomic Signatures of Airway Epithelium Infected With SARS-CoV-2: A Balance Between Anti-infection and Virus Load.
34336867 2021. Genome Editing Technologies as Cellular Defense Against Viral Pathogens.
34195193 2021. COVID-19 Pathology on Various Organs and Regenerative Medicine and Stem Cell-Based Interventions.
33505977 2020. Identifying Transcriptomic Signatures and Rules for SARS-CoV-2 Infection.
33123533 2020. Designing a Network Proximity-Based Drug Repurposing Strategy for COVID-19.
32974353 2020. SARS-CoV-2 Codon Usage Bias Downregulates Host Expressed Genes With Similar Codon Usage.
35586248 2022. Sera Metabolomics Characterization of Patients at Different Stages in Wuhan Identifies Critical Biomarkers of COVID-19.
35531330 2022. Possible Mechanism of SARS-CoV-2 Nsp1-Mediated Control of Viral Gene Expression.
35186784 2021. Transcriptome Analysis of Peripheral Blood Mononuclear Cells in SARS-CoV-2 Naive and Recovered Individuals Vaccinated With Inactivated Vaccine.
35083167 2021. SARS-CoV-2 Spike Antagonizes Innate Antiviral Immunity by Targeting Interferon Regulatory Factor 3.
34950606 2021. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Membrane (M) and Spike (S) Proteins Antagonize Host Type I Interferon Response.
34926320 2021. Pathogen-Host Interaction Repertoire at Proteome and Posttranslational Modification Levels During Fungal Infections.
34869070 2021. Detection of Antibodies Against the SARS-CoV-2 Spike Protein and Analysis of the Peripheral Blood Mononuclear Cell Transcriptomic Profile, 15 Years After Recovery From SARS.
34722346 2021. Genomic Variations in the Structural Proteins of SARS-CoV-2 and Their Deleterious Impact on Pathogenesis: A Comparative Genomics Approach.
34282405 2021. Deleterious Effects of SARS-CoV-2 Infection on Human Pancreatic Cells.
33996638 2021. The Unfolded Protein Response and Autophagy on the Crossroads of Coronaviruses Infections.
33791231 2021. SARS-CoV-2-Indigenous Microbiota Nexus: Does Gut Microbiota Contribute to Inflammation and Disease Severity in COVID-19?
33732659 2021. Exogenous Coronavirus Interacts With Endogenous Retrotransposon in Human Cells.
33194826 2020. miR-1207-5p Can Contribute to Dysregulation of Inflammatory Response in COVID-19 via Targeting SARS-CoV-2 RNA.
33194800 2020. Systems Biology Approaches for Therapeutics Development Against COVID-19.
32574283 2020. Methylation Pathways and SARS-CoV-2 Lung Infiltration and Cell Membrane-Virus Fusion Are Both Subject to Epigenetics.
34776871 2021. PTSD as an Endothelial Disease: Insights From COVID-19.
35252121 2022. Editorial: Protein Glycosylation-Advances in Identification, Characterization and Biological Function Elucidation Using Mass Spectrometry.
34660538 2021. Machine Learning of Serum Metabolic Patterns Encodes Asymptomatic SARS-CoV-2 Infection.
33511102 2020. Structural Insight Into the SARS-CoV-2 Nucleocapsid Protein C-Terminal Domain Reveals a Novel Recognition Mechanism for Viral Transcriptional Regulatory Sequences.
33364229 2020. Identification of Small Molecule Inhibitors of the Deubiquitinating Activity of the SARS-CoV-2 Papain-Like Protease: in silico Molecular Docking Studies and in vitro Enzymatic Activity Assay.
35242109 2022. Identification of Crucial Genes and Key Functions in Type 2 Diabetic Hearts by Bioinformatic Analysis.
35178029 2021. Luteolin Potentially Treating Prostate Cancer and COVID-19 Analyzed by the Bioinformatics Approach: Clinical Findings and Drug Targets.
34248840 2021. Type 2 Diabetes Coagulopathy Proteins May Conflict With Biomarkers Reflective of COVID-19 Severity.
35480316 2022. Global Gene Expression and Docking Profiling of COVID-19 Infection.
35186014 2021. Single-Cell Differential Network Analysis with Sparse Bayesian Factor Models.
35173764 2021. KeyPathwayMineR: De Novo Pathway Enrichment in the R Ecosystem.
35003208 2021. COVID-19 Transcriptomic Atlas: A Comprehensive Analysis of COVID-19 Related Transcriptomics Datasets.
34858473 2021. Identification of Intercellular Signaling Changes Across Conditions and Their Influence on Intracellular Signaling Response From Multiple Single-Cell Datasets.
34659373 2021. Theoretical Analysis of S, M and N Structural Proteins by the Protein-RNA Recognition Code Leads to Genes/proteins that Are Relevant to the SARS-CoV-2 Life Cycle and Pathogenesis.
34603366 2021. Graph Representation Forecasting of Patient's Medical Conditions: Toward a Digital Twin.
34539756 2021. Network-Based Identification and Experimental Validation of Drug Candidates Toward SARS-CoV-2 via Targeting Virus-Host Interactome.
34512723 2021. ACE2 Netlas: In silico Functional Characterization and Drug-Gene Interactions of ACE2 Gene Network to Understand Its Potential Involvement in COVID-19 Susceptibility.
34367265 2021. Metabolomics in the Diagnosis and Prognosis of COVID-19.
34290742 2021. Identification of Causal Genes of COVID-19 Using the SMR Method.
34122515 2021. Transcriptional Start Site Coverage Analysis in Plasma Cell-Free DNA Reveals Disease Severity and Tissue Specificity of COVID-19 Patients.
34093642 2021. Machine Learning Assisted Prediction of Prognostic Biomarkers Associated With COVID-19, Using Clinical and Proteomics Data.
33828579 2021. Epigenetic Lens to Visualize the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Infection in COVID-19 Pandemic.
33796130 2021. Network Analysis and Transcriptome Profiling Identify Autophagic and Mitochondrial Dysfunctions in SARS-CoV-2 Infection.
33767730 2021. Structural and Drug Screening Analysis of the Non-structural Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 Virus Extracted From Indian Coronavirus Disease 2019 Patients.
33719350 2021. A Negative Feedback Model to Explain Regulation of SARS-CoV-2 Replication and Transcription.
33679887 2021. SARS-CoV-2 Infection-Induced Promoter Hypomethylation as an Epigenetic Modulator of Heat Shock Protein A1L (HSPA1L) Gene.
33537060 2020. The Dynamic Expression of Potential Mediators of Severe Acute Respiratory Syndrome Coronavirus 2 Cellular Entry in Fetal, Neonatal, and Adult Rhesus Monkeys.
33519902 2020. Detecting the Multiomics Signatures of Factor-Specific Inflammatory Effects on Airway Smooth Muscles.
33469465 2020. Single-Cell RNA Sequencing of Tocilizumab-Treated Peripheral Blood Mononuclear Cells as an in vitro Model of Inflammation.
33343631 2020. CRFK and Primary Macrophages Transcriptomes in Response to Feline Coronavirus Infection Differ Significantly.
33329730 2020. Whole Genome Identification of Potential G-Quadruplexes and Analysis of the G-Quadruplex Binding Domain for SARS-CoV-2.
33240326 2020. The Secretive Liaison of Particulate Matter and SARS-CoV-2. A Hypothesis and Theory Investigation.
33193717 2020. Integrative Network Analysis of Predicted miRNA-Targets Regulating Expression of Immune Response Genes in Bovine Coronavirus Infection.
33193639 2020. Underlying Mechanisms and Candidate Drugs for COVID-19 Based on the Connectivity Map Database.
33173539 2020. Identification of Novel SARS-CoV-2 Drug Targets by Host MicroRNAs and Transcription Factors Co-regulatory Interaction Network Analysis.
32973879 2020. Single Cell RNA-seq Data Analysis Reveals the Potential Risk of SARS-CoV-2 Infection Among Different Respiratory System Conditions.
32765592 2020. Epigenetic Regulator miRNA Pattern Differences Among SARS-CoV, SARS-CoV-2, and SARS-CoV-2 World-Wide Isolates Delineated the Mystery Behind the Epic Pathogenicity and Distinct Clinical Characteristics of Pandemic COVID-19.
32582303 2020. Neutrophils, Crucial, or Harmful Immune Cells Involved in Coronavirus Infection: A Bioinformatics Study.
35634344 2022. The Genetic Risk for COVID-19 Severity Is Associated With Defective Immune Responses.
35572561 2022. Laboratory Biomarkers for Diagnosis and Prognosis in COVID-19.
35529862 2022. Identifying Immunological and Clinical Predictors of COVID-19 Severity and Sequelae by Mathematical Modeling.
35493473 2022. Persistence of SARS-CoV-2 Antibodies in Vaccinated Health Care Workers Analyzed by Coronavirus Antigen Microarray.
35479098 2022. Asymptomatic SARS-CoV-2 Infection Is Associated With Higher Levels of Serum IL-17C, Matrix Metalloproteinase 10 and Fibroblast Growth Factors Than Mild Symptomatic COVID-19.
35464437 2022. Long-Read RNA Sequencing Identifies Polyadenylation Elongation and Differential Transcript Usage of Host Transcripts During SARS-CoV-2 In Vitro Infection.

33892145 2021. Web resources facilitate drug discovery in treatment of COVID-19.
34906319 2021. Proteomics advances towards developing SARS-CoV-2 therapeutics using in silico drug repurposing approaches.
35189575 2022. The impact of hypoxia on B cells in COVID-19.
34959132 2022. Quantitative plasma proteome profiling of COVID-19 patients with mild and moderate symptoms.
35124429 2022. SARS-CoV-2 RNA elements share human sequence identity and upregulate hyaluronan via NamiRNA-enhancer network.
35405523 2022. Cardiovascular signatures of COVID-19 predict mortality and identify barrier stabilizing therapies.
34758415 2021. Pathogenic and transcriptomic differences of emerging SARS-CoV-2 variants in the Syrian golden hamster model.
34000623 2021. Defective NET clearance contributes to sustained FXII activation in COVID-19-associated pulmonary thrombo-inflammation.
33993054 2021. An epigenetic signature to fight COVID-19.
33993053 2021. HERV-W envelope expression in blood leukocytes as a marker of disease severity of COVID-19.
33906069 2021. VB10, a new blood biomarker for differential diagnosis and recovery monitoring of acute viral and bacterial infections.
33691247 2021. Temporal dynamics of the host molecular responses underlying severe COVID-19 progression and disease resolution.
34127431 2021. AI-guided discovery of the invariant host response to viral pandemics.
34157486 2021. 50-gene risk profiles in peripheral blood predict COVID-19 outcomes: A retrospective, multicenter cohort study.
33279860 2021. Metabolomics of exhaled breath in critically ill COVID-19 patients: A pilot study.
34844191 2021. Next generation plasma proteome profiling of COVID-19 patients with mild to moderate symptoms.
34775353 2021. Genome-wide association study of hospitalized COVID-19 patients in the United Arab Emirates.
34392148 2021. Identification of COVID-19 prognostic markers and therapeutic targets through meta-analysis and validation of Omics data from nasopharyngeal samples.
33867313 2021. Epigenome-wide association study of COVID-19 severity with respiratory failure.
33867312 2021. Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients.
33969282 2021. A urinary peptidomic profile predicts outcome in SARS-CoV-2-infected patients.
35293857 2022. SARS-CoV-2 Nsp14 mediates the effects of viral infection on the host cell transcriptome.
35037854 2022. A human-based multi-gene signature enables quantitative drug repurposing for metabolic disease.
33683204 2021. SARS-CoV-2 suppresses anticoagulant and fibrinolytic gene expression in the lung.
33724185 2021. Seroconversion stages COVID19 into distinct pathophysiological states.
33704068 2021. Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of death.
34424199 2021. Integrated single-cell analysis unveils diverging immune features of COVID-19, influenza, and other community-acquired pneumonia.
34402426 2021. A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance.
33164753 2020. Single-cell multiomic profiling of human lungs reveals cell-type-specific and age-dynamic control of SARS-CoV2 host genes.
33231169 2020. COVID-19 research risks ignoring important host genes due to pre-established research patterns.
32463365 2020. Knowledge synthesis of 100 million biomedical documents augments the deep expression profiling of coronavirus receptors.
34232536 2021. Interactomes of SARS-CoV-2 and human coronaviruses reveal host factors potentially affecting pathogenesis.
34101213 2021. SARS-CoV-2 sensing by RIG-I and MDA5 links epithelial infection to macrophage inflammation.
33140861 2020. Blood molecular markers associated with COVID-19 immunopathology and multi-organ damage.
34260159 2021. Individual COVID-19 disease trajectories revealed by plasma proteomics.
34232570 2021. High-resolution serum proteome trajectories in COVID-19 reveal patient-specific seroconversion.
34133077 2021. Long-lived macrophage reprogramming drives spike protein-mediated inflammasome activation in COVID-19.
34914162 2022. A virus-derived microRNA targets immune response genes during SARS-CoV-2 infection.
35476817 2022. Virus-host interaction networks as new antiviral drug targets for IAV and SARS-CoV-2.
35343384 2022. Transcriptomic analysis of the innate immune signatures of a SARS-CoV-2 protein subunit vaccine ZF2001 and an mRNA vaccine RRV.
32691695 2020. Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells.
32619390 2020. Shotgun proteomics analysis of SARS-CoV-2-infected cells and how it can optimize whole viral particle antigen production for vaccines.
32228226 2020. Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients.
32223537 2020. Competing endogenous RNA network profiling reveals novel host dependency factors required for MERS-CoV propagation.
34815890 2021. Multimodal Identification by Transcriptomics and Multiscale Bioassays of Active Components in Xuanfeibaidu Formula to Suppress Macrophage-Mediated Immune Response.
35309096 2021. Multi-Omics-Guided Discovery of Omicsynins Produced by Streptomyces sp. 1647: Pseudo-Tetrapeptides Active Against Influenza A Viruses and Coronavirus HCoV-229E.
34150352 2021. Identification of Monocytes Associated with Severe COVID-19 in the PBMCs of Severely Infected patients Through Single-Cell Transcriptome Sequencing.
34562480 2022. Periodically aperiodic pattern of SARS-CoV-2 mutations underpins the uncertainty of its origin and evolution.
35202626 2022. A multi-tissue study of immune gene expression profiling highlights the key role of the nasal epithelium in COVID-19 severity.
34197816 2021. From the environment to the cells: An overview on pivotal factors which affect spreading and infection in COVID-19 pandemic.
34775559 2022. Bioinformatics approach to identify common gene signatures of patients with coronavirus 2019 and lung adenocarcinoma.
34383213 2021. Deciphering epigenetic(s) role in modulating susceptibility to and severity of COVID-19 infection and/or outcome: a systematic rapid review.
35464423 2022. Bioinformatics and System Biology Approach to Identify the Influences of COVID-19 on Rheumatoid Arthritis.
35464396 2022. Multi-Omics Integration Reveals Only Minor Long-Term Molecular and Functional Sequelae in Immune Cells of Individuals Recovered From COVID-19.
35422810 2022. Alterations of Urinary Microbial Metabolites and Immune Indexes Linked With COVID-19 Infection and Prognosis.
35401574 2022. An Autoantigen Atlas From Human Lung HFL1 Cells Offers Clues to Neurological and Diverse Autoimmune Manifestations of COVID-19.
35401544 2022. Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2.
35401515 2022. Differential Transcriptomics Analysis of IPEC-J2 Cells Single or Coinfected With Porcine Epidemic Diarrhea Virus and Transmissible Gastroenteritis Virus.
35386719 2022. Causal Association and Shared Genetics Between Asthma and COVID-19.
35371005 2022. Comparison of Lung-Homing Receptor Expression and Activation Profiles on NK Cell and T Cell Subsets in COVID-19 and Influenza.
35350779 2022. Metabolic Landscape of Bronchoalveolar Lavage Fluid in Coronavirus Disease 2019 at Single Cell Resolution.
35320939 2022. Aorta in Pathologies May Function as an Immune Organ by Upregulating Secretomes for Immune and Vascular Cell Activation, Differentiation and Trans-Differentiation-Early Secretomes may Serve as Drivers for Trained Immunity.
35309299 2022. Signaling Through FcgammaRIIA and the C5a-C5aR Pathway Mediate Platelet Hyperactivation in COVID-19.
35251015 2022. SARS-CoV-2 Infection Triggers Phosphorylation: Potential Target for Anti-COVID-19 Therapeutics.
35211117 2022. Are There Hidden Genes in DNA/RNA Vaccines?
35185890 2022. Immune Response Is Key to Genetic Mechanisms of SARS-CoV-2 Infection With Psychiatric Disorders Based on Differential Gene Expression Pattern Analysis.
35173714 2022. All-Trans Retinoic Acid Attenuates Transmissible Gastroenteritis Virus-Induced Inflammation in IPEC-J2 Cells via Suppressing the RLRs/NF-kappaB Signaling Pathway.
35154090 2022. SARS-CoV-2 Infection Triggers Auto-Immune Response in ARDS.
35126398 2022. Alu RNA Structural Features Modulate Immune Cell Activation and A-to-I Editing of Alu RNAs Is Diminished in Human Inflammatory Bowel Disease.
35154070 2021. T-Cell Repertoire Characteristics of Asymptomatic and Re-Detectable Positive COVID-19 Patients.
35145507 2021. Identification of Robust Protein Associations With COVID-19 Disease Based on Five Clinical Studies.
35126380 2021. Swine Enteric Coronaviruses (PEDV, TGEV, and PDCoV) Induce Divergent Interferon-Stimulated Gene Responses and Antigen Presentation in Porcine Intestinal Enteroids.
35111156 2021. Exosomes Recovered From the Plasma of COVID-19 Patients Expose SARS-CoV-2 Spike-Derived Fragments and Contribute to the Adaptive Immune Response.
35095900 2021. Metabolic and Immune Markers for Precise Monitoring of COVID-19 Severity and Treatment.
35095877 2021. Cytokine Elevation in Severe COVID-19 From Longitudinal Proteomics Analysis: Comparison With Sepsis.
35095875 2021. Monolaurin Confers a Protective Effect Against Porcine Epidemic Diarrhea Virus Infection in Piglets by Regulating the Interferon Pathway.
35095855 2021. Pulmonary Mesenchymal Stem Cells in Mild Cases of COVID-19 Are Dedicated to Proliferation; In Severe Cases, They Control Inflammation, Make Cell Dispersion, and Tissue Regeneration.
35082790 2021. The Potential Mechanism of Cancer Patients Appearing More Vulnerable to SARS-CoV-2 and Poor Outcomes: A Pan-Cancer Bioinformatics Analysis.
35069552 2021. Cardiovascular Risk After SARS-CoV-2 Infection Is Mediated by IL18/IL18R1/HIF-1 Signaling Pathway Axis.
35003084 2021. SARS-CoV-2-Encoded MiRNAs Inhibit Host Type I Interferon Pathway and Mediate Allelic Differential Expression of Susceptible Gene.
34975885 2021. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.
34975833 2021. Understanding Gene Expression and Transcriptome Profiling of COVID-19: An Initiative Towards the Mapping of Protective Immunity Genes Against SARS-CoV-2 Infection.
34966385 2021. Vascular Damage, Thromboinflammation, Plasmablast Activation, T-Cell Dysregulation and Pathological Histiocytic Response in Pulmonary Draining Lymph Nodes of COVID-19.
34956213 2021. Extracellular Vesicle Associated miRNAs Regulate Signaling Pathways Involved in COVID-19 Pneumonia and the Progression to Severe Acute Respiratory Corona Virus-2 Syndrome.
34956212 2021. Next-Generation Sequencing and Proteomics of Cerebrospinal Fluid From COVID-19 Patients With Neurological Manifestations.
34950146 2021. IL1beta Promotes TMPRSS2 Expression and SARS-CoV-2 Cell Entry Through the p38 MAPK-GATA2 Axis.
34950134 2021. Imiquimod Boosts Interferon Response, and Decreases ACE2 and Pro-Inflammatory Response of Human Bronchial Epithelium in Asthma.
34938288 2021. Aging-Related Impairments to M Cells in Peyer's Patches Coincide With Disturbances to Paneth Cells.
34917088 2021. m(6)A Regulator-Mediated Methylation Modification Patterns and Characteristics of Immunity in Blood Leukocytes of COVID-19 Patients.
34899693 2021. Single-Cell Immunogenomic Approach Identified SARS-CoV-2 Protective Immune Signatures in Asymptomatic Direct Contacts of COVID-19 Cases.
34899680 2021. Activation of Intracellular Complement in Lungs of Patients With Severe COVID-19 Disease Decreases T-Cell Activity in the Lungs.
34880855 2021. Transcriptional Profiling and Machine Learning Unveil a Concordant Biosignature of Type I Interferon-Inducible Host Response Across Nasal Swab and Pulmonary Tissue for COVID-19 Diagnosis.
34867988 2021. Severe Adaptive Immune Suppression May Be Why Patients With Severe COVID-19 Cannot Be Discharged From the ICU Even After Negative Viral Tests.
34867933 2021. Convalescent COVID-19 Patients Without Comorbidities Display Similar Immunophenotypes Over Time Despite Divergent Disease Severities.
34790191 2021. COVID-19 Mechanisms in the Human Body-What We Know So Far.
34777369 2021. Genome-Wide Profiling Reveals Alternative Polyadenylation of Innate Immune-Related mRNA in Patients With COVID-19.
34777349 2021. Plasma Gradient of Soluble Urokinase-Type Plasminogen Activator Receptor Is Linked to Pathogenic Plasma Proteome and Immune Transcriptome and Stratifies Outcomes in Severe COVID-19.
34745097 2021. The Omic Insights on Unfolding Saga of COVID-19.
34691068 2021. COVID-19 Is a Multi-Organ Aggressor: Epigenetic and Clinical Marks.
34675930 2021. Blood Transcriptomes of Anti-SARS-CoV-2 Antibody-Positive Healthy Individuals Who Experienced Asymptomatic Versus Clinical Infection.
34671355 2021. Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage Interactions.
34659213 2021. Monocyte Chemotactic Protein-Induced Protein 1 (MCPIP-1): A Key Player of Host Defense and Immune Regulation.
34630433 2021. Diversity of Macrophages in Lung Homeostasis and Diseases.
34630432 2021. Comprehensive Immune Profiling of a Kidney Transplant Recipient With Peri-Operative SARS-CoV-2 Infection: A Case Report.
34630427 2021. Profile of Immunoglobulin G N-Glycome in COVID-19 Patients: A Case-Control Study.
34630400 2021. Identification of Unique Peptides for SARS-CoV-2 Diagnostics and Vaccine Development by an In Silico Proteomics Approach.
34616396 2021. SARS-CoV-2 Coronavirus Spike Protein-Induced Apoptosis, Inflammatory, and Oxidative Stress Responses in THP-1-Like-Macrophages: Potential Role of Angiotensin-Converting Enzyme Inhibitor (Perindopril).
34603282 2021. On Deep Landscape Exploration of COVID-19 Patients Cells and Severity Markers.
34594344 2021. Combined Transcriptome and Proteome Leukocyte's Profiling Reveals Up-Regulated Module of Genes/Proteins Related to Low Density Neutrophils and Impaired Transcription and Translation Processes in Clinical Sepsis.
34567001 2021. Persistent High Percentage of HLA-DR(+)CD38(high) CD8(+) T Cells Associated With Immune Disorder and Disease Severity of COVID-19.
32385990 2020. [Visualization analysis on treatment of coronavirus based on knowledge graph].
32228827 2020. [Exploration of omics mechanism and drug prediction of coronavirus-induced heart failure based on clinical bioinformatics].

34604700 2021. Association of Asthma and Rhinitis with Epigenetics of Coronavirus Related Genes.
32686577 2021. Epigenetic mechanisms regulating COVID-19 infection.
34895312 2021. Risk-focused differences in molecular processes implicated in SARS-CoV-2 infection: corollaries in DNA methylation and gene expression.
35645252 2022. Insights into Cardiovascular Defects and Cardiac Epigenome in the Context of COVID-19.
35021853 2022. The unfavorable clinical outcome of COVID-19 in smokers is mediated by H3K4me3, H3K9me3 and H3K27me3 histone marks.
33876664 2021. Epigenomics in COVID-19; the link between DNA methylation, histone modifications and SARS-CoV-2 infection.
33685230 2021. An immune epigenetic insight to COVID-19 infection.
34225477 2021. Implication of epitranscriptomics in trained innate immunity and COVID-19.
33242255 2020. An integrative analysis identifying transcriptional features and key genes involved in COVID-19.
32495654 2020. Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents.
32875809 2020. Potential use of noncoding RNAs and innovative therapeutic strategies to target the 5'UTR of SARS-CoV-2.
32529795 2020. Detection of viral SARS-CoV-2 genomes and histopathological changes in endomyocardial biopsies.
34502134 2021. SARS-CoV-2 Impairs Dendritic Cells and Regulates DC-SIGN Gene Expression in Tissues.
34502105 2021. microRNA-146a-5p, Neurotropic Viral Infection and Prion Disease (PrD).
34445741 2021. SARS-CoV-2 Proteins Bind to Hemoglobin and Its Metabolites.
33946479 2021. Metabolic Signatures Associated with Severity in Hospitalized COVID-19 Patients.
33946341 2021. Proteomics: A Tool to Study Platelet Function.
32993015 2020. Role of SARS-CoV-2 in Altering the RNA-Binding Protein and miRNA-Directed Post-Transcriptional Regulatory Networks in Humans.
33207699 2020. Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2.
32481719 2020. The Role of MicroRNA in the Airway Surface Liquid Homeostasis.
32521790 2020. IGF-1 Deficiency Rescue and Intracellular Calcium Blockade Improves Survival and Corresponding Mechanisms in a Mouse Model of Acute Kidney Injury.
32629995 2020. Putative Roles for Peptidylarginine Deiminases in COVID-19.
33396899 2020. Role of Host-Mediated Post-Translational Modifications (PTMs) in RNA Virus Pathogenesis.
32872332 2020. Delta9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression.
32867123 2020. Using All-Atom Potentials to Refine RNA Structure Predictions of SARS-CoV-2 Stem Loops.
32344568 2020. RT-qPCR Testing of SARS-CoV-2: A Primer.
32325642 2020. A Novel Reverse Transcription Loop-Mediated Isothermal Amplification Method for Rapid Detection of SARS-CoV-2.
32468052 2020. Pancancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARSCoV2 infection leading to COVID-19.
35392323 2022. SARS-CoV-2 Interaction with Human DNA Methyl Transferase 1: A Potential Risk for Increasing the Incidence of Later Chronic Diseases in the Survived Patients.
34032881 2021. Integrative omics provide biological and clinical insights into acute respiratory distress syndrome.
32236644 2020. Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis.
34476621 2021. Progranulin signaling in sepsis, community-acquired bacterial pneumonia and COVID-19: a comparative, observational study.
33721144 2021. Longitudinal multi-omics transition associated with fatality in critically ill COVID-19 patients.
35422859 2022. Combination of Enrichment Using Gene Ontology and Transcriptomic Analysis Revealed Contribution of Interferon Signaling to Severity of COVID-19.
35133633 2022. Clinical and Laboratory Approach to Diagnose COVID-19 Using Machine Learning.
35394619 2022. Single-Cell Transcriptome Analysis Reveals the Role of Pancreatic Secretome in COVID-19 Associated Multi-organ Dysfunctions.
33454715 2021. Structures of SARS-CoV-2 RNA-Binding Proteins and Therapeutic Targets.
33049061 2020. Co-Expression of Mitochondrial Genes and ACE2 in Cornea Involved in COVID-19.
35634577 2022. Immunopathogenic overlap between COVID-19 and tuberculosis identified from transcriptomic meta-analysis and human macrophage infection.
35502318 2022. Synthetic lethality-based prediction of anti-SARS-CoV-2 targets.
35224468 2022. Multi-omics evaluation of SARS-CoV-2 infected mouse lungs reveals dynamics of host responses.
35005527 2022. SARS-CoV-2 infection enhances mitochondrial PTP complex activity to perturb cardiac energetics.
34901782 2022. SARS-CoV-2 nucleocapsid protein binds host mRNAs and attenuates stress granules to impair host stress response.
34877479 2022. Roles of antiviral sensing and type I interferon signaling in the restriction of SARS-CoV-2 replication.
35036860 2022. Optical genome mapping identifies rare structural variations as predisposition factors associated with severe COVID-19.
35342878 2022. Identified human breast milk compositions effectively inhibit SARS-CoV-2 and variants infection and replication.
34458692 2021. Single-cell transcriptome identifies FCGR3B upregulated subtype of alveolar macrophages in patients with critical COVID-19.
34608452 2021. Limited TCR repertoire and ENTPD1 dysregulation mark late-stage COVID-19.
34604720 2021. The nasal symbiont Staphylococcus species restricts the transcription of SARS-CoV-2 entry factors in human nasal epithelium.
34545347 2021. The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cells.
34522848 2021. An interactive single cell web portal identifies gene and cell networks in COVID-19 host responses.
34746710 2021. Influenza A induces lactate formation to inhibit type I IFN in primary human airway epithelium.
34723157 2021. Maturation trajectories and transcriptional landscape of plasmablasts and autoreactive B cells in COVID-19.
33937724 2021. Experimental and natural evidence of SARS-CoV-2-infection-induced activation of type I interferon responses.
33898942 2021. Cell-type-resolved quantitative proteomics map of interferon response against SARS-CoV-2.
33615195 2021. Structural insight reveals SARS-CoV-2 ORF7a as an immunomodulating factor for human CD14(+) monocytes.
33585804 2021. Transcriptomic profiling of SARS-CoV-2 infected human cell lines identifies HSP90 as target for COVID-19 therapy.
33558857 2021. Proteomic investigation reveals dominant alterations of neutrophil degranulation and mRNA translation pathways in patients with COVID-19.
34027315 2021. Phenome-wide and expression quantitative trait locus associations of coronavirus disease 2019 genetic risk loci.
34179732 2021. Dissecting the common and compartment-specific features of COVID-19 severity in the lung and periphery with single-cell resolution.
33437935 2021. Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infections.
33319166 2021. Transcriptional response modules characterize IL-1beta and IL-6 activity in COVID-19.
34812416 2021. Immune system cells from COVID-19 patients display compromised mitochondrial-nuclear expression co-regulation and rewiring toward glycolysis.
34786539 2021. Epigenetic glycosylation of SARS-CoV-2 impact viral infection through DC&L-SIGN receptors.
34345808 2021. JAK inhibitors dampen activation of interferon-activated transcriptomes and the SARS-CoV-2 receptor ACE2 in human renal proximal tubules.
34308298 2021. Multi-omics analysis of respiratory specimen characterizes baseline molecular determinants associated with SARS-CoV-2 outcome.
32895641 2020. Integrative Network Biology Framework Elucidates Molecular Mechanisms of SARS-CoV-2 Pathogenesis.
33043283 2020. SARS-CoV-2 Infection Dysregulates the Metabolomic and Lipidomic Profiles of Serum.
33015591 2020. PPARgamma Cistrome Repression during Activation of Lung Monocyte-Macrophages in Severe COVID-19.
33103068 2020. Integrative Transcriptome Analyses Empower the Anti-COVID-19 Drug Arsenal.
35598057 2022. Bioinformatic Analysis Underpinning the Frequent Occurrence of Immune Thrombocytopenic Purpura in COVID-19 Patients.
34390301 2022. Endoplasmic reticulum stress and NF-kB activation in SARS-CoV-2 infected cells and their response to antiviral therapy.
34118117 2021. The lethal internal face of the coronaviruses: Kidney tropism of the SARS, MERS, and COVID19 viruses.
32936531 2020. SARS-CoV-2 multifaceted interaction with the human host. Part II: Innate immunity response, immunopathology, and epigenetics.
33282419 2021. Micro-RNAs in the regulation of immune response against SARS CoV-2 and other viral infections.
34224783 2021. Mechanisms underlying genetic susceptibility to multisystem inflammatory syndrome in children (MIS-C).
33485957 2021. Associations between COVID-19 and skin conditions identified through epidemiology and genomic studies.
35179038 2022. Phenome-Wide Association Study of Severe COVID-19 Genetic Risk Variants.
34121407 2021. Revealing the Structural Plasticity of SARS-CoV-2 nsp7 and nsp8 Using Structural Proteomics.
32880453 2020. Mass Spectrometry Techniques in Emerging Pathogens Studies: COVID-19 Perspectives.
34513131 2021. Mass Spectrometry-based Proteomics and Glycoproteomics in COVID-19 Biomarkers Identification: A Mini-review.
35143839 2022. The spike protein of SARS-CoV-2 induces endothelial inflammation through integrin alpha5beta1 and NF-kappaB signaling.
34562452 2021. An atomistic model of the coronavirus replication-transcription complex as a hexamer assembled around nsp15.
33895135 2021. Inhibition of acid sphingomyelinase by ambroxol prevents SARS-CoV-2 entry into epithelial cells.
33891947 2021. Repression of transcription by the glucocorticoid receptor: A parsimonious model for the genomics era.
33229438 2021. The SARS-CoV-2 envelope and membrane proteins modulate maturation and retention of the spike protein, allowing assembly of virus-like particles.
32661197 2020. The molecular virology of coronaviruses.
32587093 2020. Inhibition of SARS-CoV-2 by type I and type III interferons.
33051211 2020. Coronavirus infection and PARP expression dysregulate the NAD metabolome: An actionable component of innate immunity.
33161818 2021. The Circadian Clock and Viral Infections.
33965637 2021. A scheme for inferring viral-host associations based on codon usage patterns identifies the most affected signaling pathways during COVID-19.
33146070 2022. Pathway enrichment analysis of virus-host interactome and prioritization of novel compounds targeting the spike glycoprotein receptor binding domain-human angiotensin-converting enzyme 2 interface to combat SARS-CoV-2.
34168100 2021. Triglyceride regulate ACE2 level through MTHFD1.
35037717 2022. Integrative multiomics and in silico analysis revealed the role of ARHGEF1 and its screened antagonist in mild and severe COVID-19 patients.
35525888 2022. Bioinformatics analysis reveals molecular connections between non-alcoholic fatty liver disease (NAFLD) and COVID-19.
34487344 2021. A pathway map of signaling events triggered upon SARS-CoV infection.
33426541 2020. Potentials of Interferons and Hydroxychloroquine for the Prophylaxis and Early Treatment of COVID-19.
35593050 2022. ScoMorphoFISH: A deep learning enabled toolbox for single-cell single-mRNA quantification and correlative (ultra-)morphometry.
34951103 2022. Multi-omics of the expression and clinical outcomes of TMPRSS2 in human various cancers: A potential therapeutic target for COVID-19.
33759345 2021. Risk stratification by long non-coding RNAs profiling in COVID-19 patients.
33969601 2021. Interplay between SARS-CoV-2 and human long non-coding RNAs.
32924263 2020. Identification of Hub genes associated with infection of three lung cell lines by SARS-CoV-2 with integrated bioinformatics analysis.
35460571 2022. SARS-CoV-2 infection of human-induced pluripotent stem cells-derived lung lineage cells evokes inflammatory and chemosensory responses by targeting mitochondrial pathways.
32959892 2021. Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment.
35060381 2022. Structural Insights into the Cofactor Role of Heparin/Heparan Sulfate in Binding between the SARS-CoV-2 Spike Protein and Host Angiotensin-Converting Enzyme II.
33326239 2020. Supercomputer-Based Ensemble Docking Drug Discovery Pipeline with Application to Covid-19.
35133977 2022. Single-cell RNA sequencing reveals induction of distinct trained-immunity programs in human monocytes.
34437303 2021. The autoimmune signature of hyperinflammatory multisystem inflammatory syndrome in children.
34032635 2021. Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier.
34196300 2021. SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes.
34802985 2021. HDL proteome remodeling associates with COVID-19 severity.
34441862 2021. Weighted Gene Co-Expression Network Analysis Combined with Machine Learning Validation to Identify Key Modules and Hub Genes Associated with SARS-CoV-2 Infection.
34899557 2021. A Combined Clinical and Serum Biomarker-Based Approach May Allow Early Differentiation Between Patients With Minor Stroke and Transient Ischemic Attack as Well as Mid-term Prognostication.
32244779 2020. Master Regulator Analysis of the SARS-CoV-2/Human Interactome.
32873700 2020. Gene of the month: TMPRSS2 (transmembrane serine protease 2).
35397534 2022. The serum of COVID-19 asymptomatic patients up-regulates proteins related to endothelial dysfunction and viral response in circulating angiogenic cells ex-vivo.
33576464 2021. Severe acute respiratory syndrome coronavirus 2 for physicians: Molecular characteristics and host immunity (Review).
34709564 2022. SARS-CoV-2 Spike Glycoprotein S1 Induces Neuroinflammation in BV-2 Microglia.
33683626 2021. Divulging the Intricacies of Crosstalk Between NF-Kb and Nrf2-Keap1 Pathway in Neurological Complications of COVID-19.
34664389 2021. COVID19 Disease Map, a computational knowledge repository of virus-host interaction mechanisms.
34709727 2021. SARS-CoV-2-host proteome interactions for antiviral drug discovery.
34709707 2021. Genome-scale metabolic modeling reveals SARS-CoV-2-induced metabolic changes and antiviral targets.
33749993 2021. Integrated intra- and intercellular signaling knowledge for multicellular omics analysis.
33590968 2021. SARS-CoV-2 infection remodels the host protein thermal stability landscape.
34339582 2021. A systems-level study reveals host-targeted repurposable drugs against SARS-CoV-2 infection.
35339689 2022. Key benefits of dexamethasone and antibody treatment in COVID-19 hamster models revealed by single-cell transcriptomics.
33352107 2021. Innate Inhibiting Proteins Enhance Expression and Immunogenicity of Self-Amplifying RNA.
33823303 2021. A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice.
35506060 2022. Transcriptomic analysis reveals optimal cytokine combinations for SARS-CoV-2-specific T cell therapy products.
33200082 2021. Enhanced expression of immune checkpoint receptors during SARS-CoV-2 viral infection.
35313658 2022. The accessible promoter-mediated supplementary effect of host factors provides new insight into the tropism of SARS-CoV-2.
35164139 2022. A New Butyrate Releaser Exerts a Protective Action against SARS-CoV-2 Infection in Human Intestine.
35458690 2022. The Dysregulation of the Renin-Angiotensin System in COVID-19 Studied by Serum Proteomics: Angiotensinogen Increases with Disease Severity.
34771023 2021. Zinc as a Drug for Wilson's Disease, Non-Alcoholic Liver Disease and COVID-19-Related Liver Injury.
32927621 2020. Mass Spectrometry and Structural Biology Techniques in the Studies on the Coronavirus-Receptor Interaction.
32604797 2020. Data and Text Mining Help Identify Key Proteins Involved in the Molecular Mechanisms Shared by SARS-CoV-2 and HIV-1.
34698547 2021. Pathogenesis, Symptomatology, and Transmission of SARS-CoV-2 through Analysis of Viral Genomics and Structure.
34519533 2021. Target Discovery for Host-Directed Antiviral Therapies: Application of Proteomics Approaches.
32437596 2020. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.
35300459 2022. Transcriptogram analysis reveals relationship between viral titer and gene sets responses during Corona-virus infection.
35265835 2022. Feature selection for kernel methods in systems biology.
33884369 2021. Platypus: an open-access software for integrating lymphocyte single-cell immune repertoires with transcriptomes.
32948854 2020. Ultrasensitive high-resolution profiling of early seroconversion in patients with COVID-19.
34108657 2021. Single-cell epigenomic landscape of peripheral immune cells reveals establishment of trained immunity in individuals convalescing from COVID-19.
34887515 2021. Supermeres are functional extracellular nanoparticles replete with disease biomarkers and therapeutic targets.
34876692 2021. A single-cell transcriptomic landscape of the lungs of patients with COVID-19.
34031561 2021. SARS-CoV-2 simulations go exascale to predict dramatic spike opening and cryptic pockets across the proteome.
35577777 2022. An Artificial Intelligence-guided signature reveals the shared host immune response in MIS-C and Kawasaki disease.
35064122 2022. Single-cell multi-omics reveals dyssynchrony of the innate and adaptive immune system in progressive COVID-19.
35022412 2022. Postmortem high-dimensional immune profiling of severe COVID-19 patients reveals distinct patterns of immunosuppression and immunoactivation.
35115549 2022. Myeloid cell interferon responses correlate with clearance of SARS-CoV-2.
35169146 2022. Cell specific peripheral immune responses predict survival in critical COVID-19 patients.
34504087 2021. Sequences in the cytoplasmic tail of SARS-CoV-2 Spike facilitate expression at the cell surface and syncytia formation.
34584097 2021. In vivo structure and dynamics of the SARS-CoV-2 RNA genome.
34580297 2021. Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2.
34548480 2021. Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential.
34535662 2021. A CRISPR/Cas9 genetically engineered organoid biobank reveals essential host factors for coronaviruses.
34799561 2021. Large scale discovery of coronavirus-host factor protein interaction motifs reveals SARS-CoV-2 specific mechanisms and vulnerabilities.
34795232 2021. Jumper enables discontinuous transcript assembly in coronaviruses.
34782627 2021. SARS-CoV-2 inhibits induction of the MHC class I pathway by targeting the STAT1-IRF1-NLRC5 axis.
33972535 2021. Identification and characterization of a SARS-CoV-2 specific CD8(+) T cell response with immunodominant features.
33785765 2021. SARS-CoV-2 in severe COVID-19 induces a TGF-beta-dominated chronic immune response that does not target itself.
33723254 2021. SARS-CoV-2 hijacks folate and one-carbon metabolism for viral replication.
33712622 2021. Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications.
33712587 2021. Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions.
34108465 2021. Clinical and molecular characteristics of COVID-19 patients with persistent SARS-CoV-2 infection.
34099652 2021. SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care.
34155207 2021. SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals.
34078893 2021. A metal ion orients SARS-CoV-2 mRNA to ensure accurate 2'-O methylation of its first nucleotide.
34140500 2021. Combining machine learning and nanopore construction creates an artificial intelligence nanopore for coronavirus detection.
34321474 2021. IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro.
34315903 2021. Integrative genomic analyses identify susceptibility genes underlying COVID-19 hospitalization.
34315893 2021. Single-cell transcriptome of bronchoalveolar lavage fluid reveals sequential change of macrophages during SARS-CoV-2 infection in ferrets.
34315889 2021. The trans-omics landscape of COVID-19.
34312385 2021. Single-cell RNA sequencing reveals ex vivo signatures of SARS-CoV-2-reactive T cells through 'reverse phenotyping'.
34272374 2021. SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance.
34262047 2021. Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity.
34257311 2021. Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance.
33397975 2021. The aging transcriptome and cellular landscape of the human lung in relation to SARS-CoV-2.
33397903 2021. Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray.
33597532 2021. Dysregulated transcriptional responses to SARS-CoV-2 in the periphery.
33589624 2021. Causal network models of SARS-CoV-2 expression and aging to identify candidates for drug repurposing.
33574281 2021. A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry.
34893640 2021. Proteomic profiling of MIS-C patients indicates heterogeneity relating to interferon gamma dysregulation and vascular endothelial dysfunction.
34446707 2021. Tracheal aspirate RNA sequencing identifies distinct immunological features of COVID-19 ARDS.
34433827 2021. A high-resolution temporal atlas of the SARS-CoV-2 translatome and transcriptome.
34433821 2021. Comprehensive mapping of SARS-CoV-2 interactions in vivo reveals functional virus-host interactions.
34381049 2021. Downregulation of exhausted cytotoxic T cells in gene expression networks of multisystem inflammatory syndrome in children.
34381043 2021. Temporal omics analysis in Syrian hamsters unravel cellular effector responses to moderate COVID-19.
33033248 2020. Two distinct immunopathological profiles in autopsy lungs of COVID-19.
33009401 2020. SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate.
33046696 2020. Type 2 and interferon inflammation regulate SARS-CoV-2 entry factor expression in the airway epithelium.
33247099 2020. SARS-CoV-2 genomic and subgenomic RNAs in diagnostic samples are not an indicator of active replication.
33208736 2020. Architecture of a SARS-CoV-2 mini replication and transcription complex.
33203890 2020. Upper airway gene expression reveals suppressed immune responses to SARS-CoV-2 compared with other respiratory viruses.
33203833 2020. Immune suppression in the early stage of COVID-19 disease.
34782790 2022. Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19.
33879890 2021. Single-cell multi-omics analysis of the immune response in COVID-19.
32694793 2020. A metabolic handbook for the COVID-19 pandemic.
34594031 2021. Systematic investigation of cytokine signaling activity at the tissue and single-cell levels.
34845387 2021. A 3D structural SARS-CoV-2-human interactome to explore genetic and drug perturbations.
33349665 2021. The SARS-CoV-2 RNA-protein interactome in infected human cells.
34127837 2021. How COVID-19 disrupts glycometabolic control.
33277640 2021. Host genetics and infectious disease: new tools, insights and translational opportunities.
32782358 2020. The role of IgG Fc receptors in antibody-dependent enhancement.
34535791 2021. Structural biology of SARS-CoV-2 and implications for therapeutic development.
34824452 2022. Structures and functions of coronavirus replication-transcription complexes and their relevance for SARS-CoV-2 drug design.
34234324 2021. Single-cell transcriptomics reveals neuroinflammation in severe COVID-19.
34876996 2021. Post-mortem tissue proteomics reveals the pathogenesis of multi-organ injuries of COVID-19.
34676128 2020. Plasma metabolomic and lipidomic alterations associated with COVID-19.
35045565 2022. The cGAS-STING pathway drives type I IFN immunopathology in COVID-19.
34758478 2022. Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2.
34942634 2022. Evolution of enhanced innate immune evasion by SARS-CoV-2.
34875673 2022. Signature of long-lived memory CD8(+) T cells in acute SARS-CoV-2 infection.
34153974 2021. Dysregulation of brain and choroid plexus cell types in severe COVID-19.
33915569 2021. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets.
33915568 2021. A molecular single-cell lung atlas of lethal COVID-19.
34237774 2021. Mapping the human genetic architecture of COVID-19.
32353859 2020. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.
33495710 2020. A contemporary insight of metabolomics approach for COVID-19: Potential for novel therapeutic and diagnostic targets.
33274348 2020. CovMulNet19, Integrating Proteins, Diseases, Drugs, and Symptoms: A Network Medicine Approach to COVID-19.
33680474 2021. Severe acute respiratory syndrome coronavirus 2 may exploit human transcription factors involved in retinoic acid and interferon-mediated response: a hypothesis supported by an in silico analysis.
34708437 2022. Uneven metabolic and lipidomic profiles in recovered COVID-19 patients as investigated by plasma NMR metabolomics.
34940755 2021. Co-Regulation of Protein Coding Genes by Transcription Factor and Long Non-Coding RNA in SARS-CoV-2 Infected Cells: An In Silico Analysis.